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Abstract 
Demand for goat milk produced in New Zealand (NZ) is rapidly growing, 
particularly in expanding Asian markets. The aim of this study was to investigate 
how genetic and nutritional factors influence milk composition of NZ dairy goats. 
Little is known about these two factors in dairy goats, especially when compared 
to extensive research conducted in the area on dairy cows. Therefore in an attempt 
to improve goat milk production and composition, one important gene and three 
common nutritional supplements were investigated as part of this study.  
The gene CSN1S1 was chosen for genetic analysis as it is highly polymorphic and 
can produce a range of effects on milk composition. 126 dairy goats were 
genotyped and 100 of these were aligned to herd-test and fatty acid data. Key 
findings include (a) ‘medium’ and ‘low’ CSN1S1 variants are the most common in 
the NZ dairy goat population, (b) CSN1S1 genotype significantly influences milk 
protein content, (c) in some circumstances CSN1S1 genotype can affect milk yield 
and fat content (d) CSN1S1 genotype has no effect on somatic cell count or the 
kilograms yielded of fat and protein or milk solids and (e) CSN1S1 genotypes 
produce small differences in two fatty acids (C10:0 and C18:3n3).   
Due to their increasing popularity as alternative animal feeds, palm kernel extract 
(PKE), biscuit waste (BW) and yeast nutritional factors were investigated. PKE 
significantly increased C12:0 and C14:0 fatty acids which were reduced to 
control-farm levels following removal of the supplement in the next season. BW 
had no clear effects on milk fatty acid composition while yeast supplementation 
had no effect on any aspect of milk composition. Significant seasonal effects were 
observed for some fatty acids. 
 
Overall this research has shown that milk produced from NZ dairy goats has the 
potential to be modified through genetic and dietary means. Genetic factors such 
as CSN1S1 and nutritional supplements, especially PKE can alter milk 
composition. The healthfulness of goat milk can therefore be optimised to better 
suit the nutritional needs of the consumer.  
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1 Chapter One: Introduction 
 
Goats (Capra hircus) were one of the first domesticated animals and have been 
raised by humans for meat, fibre, hides and dairy products since around 10,500 ca. 
BP (Naderi et al., 2008). At last count there were over 800 million goats 
worldwide (FAOSTAT, 2009), with over half of those stocks in Asia (including 
India). Goat milk and meat remain key commodities, particularly in Asian and 
African continents where the goat’s climatic tolerance and efficient production 
makes them a highly valuable resource. Given that over three-quarters of the 
world’s population live in these continents (Population Reference Bureau, 2011), 
goat products are one of the most widely consumed of any species. 
 
By contrast, New Zealand (NZ) has a comparatively small number of goats 
(111,981 according to Statistics NZ, 2007). In NZ goats are raised predominantly 
for the production of dairy products in a highly organised commercial operation 
(Dubeuf et al., 2004) . There is one major dairy factory for goat milk in NZ, Dairy 
Goat Co-operative (DGC). DGC processes on average 17,250,000 litres of milk 
each year from a total of 56 goat farms. Virtually all of this milk is processed into 
goat milk powder, infant formula and specialty nutritional products which are 
exported to growing Asian and African markets. 
 
Milk is designed to meet the entire nutritional needs of new-borns, making it a 
highly valuable nutritional source. Fat and protein are the most demanded 
fractions of goat milk, with recent emphasis being on the types of fat and protein. 
‘Good fats’ such as omega 3, omega 6 and conjugated linoleic acid (CLA) have 
received much attention given their benefits over and above their regular nutritive 
value. The different types of proteins are of importance as well, particularly 
regarding milk allergies (such as alpha-s1 and alpha-s2 caseins) and different 
protein functions (for example immunoglobulins and whey proteins). These 
beneficial components in goat milk have the potential to be enhanced by both diet 
and genetics.  
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New Zealand goat farms have undertaken a number of nutritional changes in the 
last five years due to two factors. Firstly, in order to simplify animal management 
and reduce parasite problems, the majority of farmers have moved to an indoor 
farming system. Indoor farming combined with an increased range of alternative 
feedstuffs available has meant that the diet of dairy goats has changed from what 
was fed in traditional farming systems.  Secondly, at the start of 2011 DGC 
removed Palm Kernel Extract (PKE) and Biscuit Waste (BW, leftovers from 
confectionary production) as allowable diets for DGC dairy goats. These highly 
utilised feed sources were removed due to the unknown effect of foreign (PKE) 
and human-food (BW) as animal feed supplements.  
 
Protein levels in goat milk are typically very difficult to modify via diet, however 
genetics can play a significant role in the synthesis of milk protein. One of the 
most studied genes in the goat is CSN1S1. CSN1S1 encodes the protein alpha-s1-
casein (αs1-casein) which forms around 80% of total casein in goat milk. In 
addition to influencing the level of milk protein, CSN1S1 can also influence fatty 
acid composition and milk allergenicity (discussed later in Chapter 2). Given that 
this gene is highly polymorphic in the goat (so far 18 variants have been 
identified), breeding programmes can select for different forms of this gene to 
alter the level of protein in goat milk. 
 
From the current information available, no studies on the effect of nutritional or 
CSN1S1 genetic factors on milk composition have been conducted in New 
Zealand dairy goats. Therefore, in order to address these problems, this thesis will 
investigate how CSN1S1 genotype as well as PKE, BW and yeast diets influence 
goat milk composition in New Zealand dairy goats. Such findings could then be 
used to better understand dairy goat nutrition and genetics to ultimately improve 
the quality of goat milk produced in New Zealand. 
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2 Chapter Two: Literature Review 
 
2.1 Milk  
Milk is a specialised, exceptionally complex and nutrient rich fluid produced by 
mammals designed specifically to meet the needs of the young. Key components 
include protein, fat, lactose, and various vitamins and minerals which exist in 
different phases in milk (Table 1).  
 
 
Table 1: Major constituents of milk. Adapted from Jensen et al, (1991). 
Compartment Major constituents 
Aqueous phase Solution ash, Ca, Mg, PO4, Na, K, Cl, CO2, whey proteins (α-
lactalbumin, β-lactoglobulin), lactoferrin, immunoglobulin, lysozyme, 
serum albumin, lactose, oligosaccharides, amino acids, urea, B-
vitamins, ascorbic acid.  
Colloidal dispersion Caseins (α, β, κ), Ca, PO4 
Emulsion Fat globules, triacylglycerols, fat soluble vitamins, cholesterol esters  
Fat globule membrane Milk fat globule membrane proteins, phospholipids, enzymes, trace 
minerals  
Cells Macrophages, neutrophils, lymphocytes, epithelial cells, leukocytes 
 
 
 
The composition of ruminant milk is to be affected by diet, stage of lactation, 
environment, breed, nutrition, energy balance, health status of the udder, diet and 
genetic factors (Goetsch et al., 2011, Chilliard and Ferlay, 2004, Chilliard et al., 
2000, Chilliard et al., 2003, Jensen et al., 1991, Park et al., 2007b, Walker et al., 
2004). Although milk is the common feature among all mammals, each species 
differs in composition (Table 2). 
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Table 2: Gross milk composition across different species. Adapted from Park et al, (2007) and 
USDA National Nutrient Database for Standard Reference. g and kJ are per 100g milk.   
Nutrient  Unit Goat Sheep Cow Human 
Water g 87.03 80.7 88.13 87.5 
Energy  kJ 288 451 255 291 
Fat g 4.14 7 3.25 4.38 
Protein  g 3.56 5.98 3.15 1.03 
Carbohydrate  g 4.45 5.36 4.8 6.89 
Casein  % 2.4 4.2 2.6 0.4 
Lactose % 4.1 4.9 4.7 6.9 
 
 
 
2.2 Desired characteristics of milk for human consumption   
Early nutritional studies identified milk as a healthy, complete food source to 
provide a versatile combination of fat, protein, vitamins and minerals. However 
milk and dairy products began to receive negative attention from around 1950 
when saturated fats were identified as a contributor to coronary heart disease 
(Segall, 1977, Keys, 1953). More recent evidence now highlights the fact that not 
all saturated fats have negative effects (Woodside and Kromhout, 2005) and that 
some saturated fats can have positive health effects (Aro et al., 1997).   
 
Most of the nutritive value of goat milk (both regular and functional) is derived 
from fat and protein components. Goat milk in NZ is primarily produced for 
infant formula products which have strict compositional requirements. Infant 
formula is designed to match human breast milk and it must meet the normal 
growth needs of the infant (Prosser et al., 2010). Recommendations for infant 
formula specific to protein and fat composition are outlined below in Table 3.  
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Table 3: Recommended standards for the composition of infant formula. Adapted from 
(Koletzko et al., 2005, MacLean Jr et al., 2010). NS = Not specified. LC-PUFA = Long Chain-
Polyunsaturated Fatty Acids. LA = Linoleic acid. ALA = α-linoleic acid. 
Component Unit Min Max Comments 
     
Protein g/100 kcal 1.8 3 Required to provide essential and ‘conditionally 
essential’ amino acids. 
Total Fat g/100 kcal 4.4 6.0 40-54% of energy intake similar to human milk 
C18:2n6 (LA) g/100 kcal 0.3 1.2 - 
C18:3n3 (ALA) mg/100 kcal 50 NS Considered a dietary indispensable fatty acid 
LA:ALA ratio 5:1 15:1 Ensures proper balance of these fatty acids and LC-
PUFA resulting from their metabolism. 
C12:0 + C14:0 % of fat NS 20 Due to potential negative effects of these fatty acids 
on cholesterol and lipoprotein concentration 
Trans fatty 
acids 
% of fat NS 3 No known nutritional benefit for infants and a 
number of less desirable biological effects 
 
 
Of particular importance is the maximum allowable level of C12:0 and C14:0 
fatty acids due to their contribution to cholesterol and lipoprotein elevation in 
humans (reviewed later in section 2.3.6). Trans-fatty acids and long chain 
polyunsaturated fatty acids (LC-PUFAs) such as linoleic acid (LA) and alpha-
linolenic acid (ALA) are also important components when considering goat milk 
composition for infant formula applications. A more detailed description of these 
fatty acids is presented in the following section.   
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2.3 Milk Fat  
Milk fat contains approximately 400 different fatty acids, making it the most 
complex of natural fats (Mansson, 2008). These fatty acids exist in a milk fat 
globule predominantly as triglycerides (97.5%), diacyglycerides (0.48%), 
monoacylglycerides (0.04%) or free fatty acids (0.4%). Also in the milk fat 
globule are phospholipids (1.0%), cholesterol (0.4%) and glycolipids in trace 
amounts (Jensen et al., 1991).   
 
 
2.3.1  Fatty acid structure and nomenclature 
Fatty acids are classified based on the number of carbons and their level of 
saturation (number of double bonds between the carbon atoms of the fatty acid 
chain). Most fatty acids in biological systems have an even number of carbons 
in the carbon chain. Short chain fatty acids (SCFA) are typically four to ten 
carbons in length, medium chain fatty acids (MCFA) twelve to 16 carbons and 
long chain fatty acids (LCFA) 17 carbons or more.  
 
Saturated fats have no double bonds (for example C18:0 is an eighteen-carbon 
chain with no double bonds), while unsaturated fats can be monounsaturated 
(one double bond e.g. C18:1, referred to as MUFAs) or polyunsaturated (more 
than one double bond e.g. C18:3, known as PUFAs). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Structural differences between a saturated fatty acid (a) and an unsaturated fatty 
acid (b) with one double bond (monounsaturated). Adapted from Nelson and Cox, (2008).  
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Where different fatty acid isomers exist, the conformation and position of that 
isomer is noted (e.g. C18:1 cis-9). Omega 3 or omega 6 fatty acids are 
commonly referred to as n-3 or n-6 respectively. These omega fatty acids have 
a double bond starting after the third or sixth carbon atom from the methyl end 
of the carbon chain (Voet and Voet, 2004). Fatty acids also have a systematic 
name derived from the parent hydrocarbon and a common name (outlined 
below in section 2.3.2). For the purpose of this thesis fatty acid symbols and 
common names will be used.  
 
2.3.2  Fatty acids in goat milk 
Common fatty acids in goat milk are outlined below in Table 4. As with many 
ruminant and animal products, palmitic acid (C16:0) is the most prevalent fatty 
acid in goat milk (Månsson, 2008). Caproic, capryllic and capric acids (6:0 – 
C10:0) are named after the goat species (Capra hircus) due to the higher 
proportion of these SCFA in goat milk compared with other milks such as 
bovine (Tomotake et al., 2006). 
 
 
Table 4: Common fatty acids in milk. Table adapted from (Park et al., 2007b). * value for all 
C18:1 isomers combined. ** sytematic name for the most common CLA isomer (cis9, trans11).  
Symbol Common name  Systematic Name   % in goat milk  
C4:0  Butanoic  Butyric  2.18 
C6:0  Caproic  Hexanoic 2.39 
C8:0 Caprylic  Octanoic  2.73 
C10:0 Capric  Decanoic 9.97 
C12:0 Lauric  Dodecanoic 4.99 
C14:0 Myristic  Tetradecanoic 9.81 
C14:1 Myristoleic  cis-9-tetradecenoic 0.18 
C15:0 Pentadecylic  Pentadecanoic 0.71 
C15:1 - Pentadecenoic   
C16:0 Palmitic  Hexadecanoic 28.2 
C16:1 Palmitoleic  cis-9-hexadecenoic  1.59 
C17:0 Margaric  Heptadecanoic  0.72 
C18:0 Stearic  Octadecanoic  8.88 
C18:1 trans 11 trans-Vaccenic (TVA) trans-11- octadecenoic 
19.3* C18:1 cis 9 Oleic cis-9-octadecenoic 
C18:1 cis 11 cis-Vaccenic (CVA) cis-11-octadecenoic 
C18:2n6 Linoleic (LA) cis-9,cis12-octadecadienoic 3.19 
C18:2n7 Conjugated linoleic (CLA) cis-9, trans-11-octadecadienoic**   
C18:3n3 Alpha-linolenic (ALA) all-cis-9,12,15-octadecatrienoic  0.70 
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2.3.3  Fatty acid formation  
Fatty acids in milk fat globules are primarily formed from the microbial 
degradation and fermentation of dietary carbohydrates, protein and fat in the 
rumen. The rumen is effectively a fermentation vat consisting of bacteria, 
protozoa and fungi (Ishler et al., 1996) . The environment of the rumen dictates 
the presence and activity of various microorganisms which break-down dietary 
components. Such breakdown produces fatty acids and fatty acid precursors 
which are used for the animal’s energy needs and the production of milk fat. 
These fatty acids are absorbed directly through the rumen or large intestine and 
circulated in the blood as chylomicrons (CM), very-low-density lipoproteins 
(VLDL) or free fatty acids.   
 
Approximately 50% of triglycerides are formed through the ‘diet pathway’ 
from fatty acids in CMs or VLDLs (Figure 2). The remaining 40-45% are 
synthesised from free fatty acids via the ‘de novo pathway’ in the mammary 
gland through the actions of acetyl-CoA carboxylase (ACC) and fatty acid 
synthase (FAS). Around 5% may be mobilised from the lipid reserves of the 
animal depending on the energy balance of the animal (Chilliard et al., 2003) .  
 
Virtually all LCFA and some MCFA (C12-C22) are pre-formed in the rumen 
and follow the ‘diet pathway’ to be subsequently modified in the mammary 
gland by SCD. C16:0 in milk is derived half from the diet pathway and half via 
de novo fatty acid synthesis from VFA precursors and the actions of ACC and 
FAS. Almost all SCFA (C4:0-C10:0) are synthesised via the de novo pathway.  
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Figure 2: Milk fat synthesis and secretion in the lactating ruminant. Shown in the rumen are 
the key processes contributing to fatty acid production. Enzymes associated with each process are 
shown in rectangular boxes. ACC= Acetyl-CoA carboxylase. CM = chylomicron. FAS= Fatty acid 
synthase. G-3-P= Glyceraldehyde 3-phosphate. LPL= Lipoprotein lipase. MFG= Milk Fat Globule. 
SCD = Stearoyl-CoA Desaturase, also known as 9-desaturase. TG= Triglyceride. VFA = Volatile 
fatty acids. VLDL = Very low-density lipoprotein. Figure adapted from (Chilliard et al., 2000, 
Mele et al., 2008, Harvatine et al., 2009a) and not drawn to scale.  
 
 
 
2.3.4  Biohydrogenation and isomerisation 
Biohydrogenation and isomerisation are two key processes affecting the 
conversion of diet into milk fatty acids, particularly LCFA (Figure 3). 
Microbial biohydrogenation is the process of converting unsaturated fatty acids 
to more saturated end products by gut microbes (Mosley et al., 2002). The 
main bacterium involved in biohydrogenation is Butyrivibrio fibrisolves, first 
described by Kepler and Tove (1967).  
 
 
Isomerisation by rumen microbes on the other hand gives rise to several 
geometric and positional fatty acid isomers (Laverroux et al., 2011). Therefore 
although linoleic (LA, C18:2n6) and alpha-linolenic (ALA, C18:3n3) acids are 
the main unsaturated fatty acids in the diet of ruminants, these processes within 
the rumen mean that the major fatty acid leaving the rumen is C18:0 (Woods 
and Fearon, 2009).  
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Figure 3: Biohydrogenation and isomerisation pathways of linoleic and alpha-
linolenic acids in the rumen. Solid arrows represent isomerisation processes while 
dashed arrows symbolise hydrogenation (reduction). Adapted from (Mele et al., 
2008, Harvatine et al., 2009a).  
 
 
2.3.5  Stearoyl-Co A desaturase (SCD) activity 
The activity of SCD in the mammary gland has an important effect on the level 
of saturated fats in the milk. SCD (alternatively known as 9 desaturase) 
introduces a double bond in position 9 of the carbon chain, thereby partially 
reversing any hydrogenation that occurred in the rumen. In this way much of 
the stearic acid (C18:0) is desaturated back to oleic acid (C18:1cis9) while 
approximately 30% of vaccenic acid (C18:1 trans 11 (TVA)) can be 
desaturated to the C18:2 cis9 trans11 CLA isomer (Chilliard and Ferlay, 2004, 
Griinari et al., 2000).  
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2.3.6  Fatty acid benefits for human health  
Following human consumption of milk, fatty acids are released in the upper 
intestine, immediately absorbed, processed, and released into the blood stream, 
where they are rapidly taken up by the liver (Smith et al., 1998). These fatty 
acids can then have a variety of effects on human health  
 
Of the saturated fats in milk, lauric (C12:0) and myristic (C14:0) remain the 
most concerning for their hypercholesterimic effects. Other SFAs such as 
C4:0-C10:0 are less strongly implicated and can exert a range of antimicrobial, 
antiviral and anticancer effects (Table 5). Similarly stearic acid (C18:0) 
appears to have more positive health benefits than negative. 
 
LC-PUFAs are deemed to be the most beneficial for human health, with 
anticarcionogenic, antioxidant, antimicrobial and hypocholestericmic effects 
(Table 5). Special note should be mentioned of CLA. There are 2 isomers of 
CLA, however the cis9 trans11 isomer represents about 75-90% of total CLA 
in milk fat (Tsiplakou et al., 2006). This fatty acid is considered one of the 
most beneficial, with antiadipogenic (Corino et al., 2005, Park et al., 2007a) 
anticarcinogenic (Ip et al., 1999, Ou et al., 2007), antiatherogenic (Kritchevsky 
et al., 2000, Lee et al., 1994), antidiabetogenic (Ryder et al., 1999, Choi et al., 
2007) and having antinflammatory properties (Lee et al., 2009, Yu et al., 2002).  
 
Lastly, goat milk is often seen as an alternative to cow milk because of the 
higher proportion of MCFAs. These are more easily broken down by salivary, 
gastric and pancreatic lipases than LCFA (Greenberger et al., 1966), enabling 
more rapid digestion. MCFA are also absorbed more simply than LCFA 
(Guillot et al., 1993) which is valuable for infants.  
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Table 5: Main health effects associated with common fatty acids found in goat milk. 
Fatty acid Health effect References 
C4:0   Gene expression, cancer prevention - especially colonic cancers. Anti-inflammatory.  (Hague et al., 1995, Kolar et al., 2007, Emenaker et al., 2001)  
C6:0    Antimicrobial agent.  (Huang et al., 2011) 
C8:0  Antimicrobial and antiviral agent  (Huang et al., 2011, Thormar et al., 1994) 
C10:0    Antimicrobial and antiviral. Vasorelaxant. (Huang et al., 2011, Thormar et al., 1994, White et al., 1991) 
C12:0    Antiviral, antibacterial and anti-plaque but increases blood cholesterol (Mensink et al., 2003, Thormar et al., 1994, Schuster et al., 1980) 
C14:0  Can be antiviral, however increases blood cholesterol (Mensink et al., 2003, Parang et al., 1997) 
C14:1  Largely unknown. May be anti-arthritic.  (Diehl and May, 1994) 
C15:0  Unknown  
C15:1 Unknown  
C16:0  Conflicting reports on blood cholesterol. Can improve intestinal and Ca
2+ absorption and have antimicrobial 
effects 
(Mensink et al., 2003, Huang et al., 2011, Carnielli et al., 1996) 
C16:1  Antitumor.  (Ito et al., 1982) 
C17:0  Unknown  
C18:0   Generally regarded as neutral for CHD. Some studies show reducing plasma LDL cholesterol and 
cardiovascular disease contributors.  
(Crupkin and Zambelli, 2008, Hegsted et al., 1965, Keys and 
Parlin, 1966, Woollett and Dietschy, 1994) 
C18:1 trans  The only dietary precursor for beneficial CLA.  (Field et al., 2009, Santora et al., 2000) 
C18:1 cis9  Hypocholestoremic. Anticancer.  (Martin-Moreno et al., 1994, Kris-Etherton et al., 1999, Woollett 
and Dietschy, 1994) 
C18:1 cis11  Unknown for this C18:1 isomer  
C18:2n6  Hypocholestoremic. Anti-atherosclerotic. Precursor for beneficial EPA and DHA.  (Penumetcha et al., 2011, Haug et al., 2007) 
C18:2n7  Main CLA isomer (cis 9 trans 11)  anticarcinogenic, antioxidant and decreases body fat mass  (Delany et al., 1999, Tsuboyama-Kasaoka et al., 2000, Thom et 
al., 2002, O'Shea et al., 2000, Nakamura and Omaye, 2009) 
C18:3n3  Reduced cardiovascular risk, anticarcinogenic. Precursor for beneficial EPA and DHA. (Dawczynski et al., 2010, Bartoli et al., 1993, Haug et al., 2007) 
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2.4 Milk protein  
Protein is a highly important aspect of milk composition. Major proteins in milk 
are the caseins (αs1, αs2, β and κ) and the whey proteins (α-lactglobulin, β-
lactalbumin).  For many of these protein fractions, goat milk is more similar to 
human milk than cow’s milk (Table 6).  
 
Table 6: Milk protein composition across species. * % of total casein ** g per 100g 
milk. Total casein in goat milk represents around 80% of total milk protein. Table 
adapted from (Akers, 2002, Inglingstad et al., 2010, Farrell Jr et al., 2006) 
Protein component Goat Cow Human 
Casein *    
    αs1-casein 5-17 38 Trace 
    αs2-casein 6-20 10 Trace 
    β-casein 50 40 70 
    κ-casein 15 12 27 
Whey protein **    
    α-lactalbumin  0.12 0.12 0.18 
    β-lactoglobulin  0.22 0.33 Absent 
Total Protein 2.7 3.3 0.9 
 
 
2.4.1  Milk protein synthesis 
Milk specific proteins are either synthesised from amino acids in the 
bloodstream or from amino acids synthesised by the mammary secretory cells 
(Akers, 2002).  Synthesis of the amino acids within mammary secretory cells is 
dependent on the transcription and translation of nuclear DNA encoding each 
protein. α-lactalbumin and β-lactoglobulin are each encoded by a relatively 
small, single-copy gene, while the caseins are encoded by a cluster of genes 
(Rosen et al., 1999).  
 
Because milk proteins are destined for secretion, they are synthesised by 
ribosomes attached to the endoplasmic reticulum and then translocated to the 
Golgi (Akers, 2002). Due to their hydrophobicity, caseins are formed into 
micelles in the Golgi by incorporating calcium and inorganic phosphate 
(Mepham, 1987). Milk proteins are then transported via vesicles to be secreted 
from mammary epithelial cells into the alveolar lumen and thus into milk.  
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2.4.2   Alpha-s1-casein (αs1-casein)  
Polymorphisms of the gene encoding αs1-casein (CSN1S1) show that αs1-
casein variants influence milk pH (Devold et al., 2011), fatty acid composition 
(Chilliard et al., 2006, Valenti et al., 2009), protein and fat content (Bevilacqua 
et al., 2001). Goat milk contains lower levels of αs1-casein than cow milk and 
as such, the αs1-casein content serves as a distinguishing factor between milk 
produced by these two species.  
 
The αs-caseins have been implicated in a number of health effects, most 
notably in milk allergies. In most cases, if an individual is allergic to cow milk 
they will also be allergic to goat milk due to the immunological cross-reactivity 
of the proteins (Shimojo et al., 1997, Bellioni-Businco et al., 1999). However 
where an individual is sensitive to cow milk, goat milk can be considered an 
alternative (Park, 1994). This can be attributed to the lower levels of αs1- and 
αs2- caseins in goat milk, thereby reducing the allergenic burden.  Other 
factors also contribute to this lower allergenicity, such as the reduced level of 
αs1-casein in goat milk assisting with the digestion of β-lactoglobulin (Almaas 
et al., 2006, Bevilacqua et al., 2001) which itself can also have allergenic 
effects (Gall et al., 1996).  
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2.5 Nutrition and milk composition  
Diet affects the milk composition of ruminants, primarily by altering rumen pH 
and the precursors available for rumen microbes. Nutritional factors that raise pH 
favour cellulolytic microorganisms that increase acetic (C2:0) and butyric acids 
(C4:0), while feeds that lower the pH favour amylolytic microorganisms that 
increase propionic acid (C3:0) in the rumen (Lu et al., 2005).  Additional factors 
such as the size of feed particles and the degree of protection (e.g. lipid 
encapsulation or calcium salts) can influence the bioavailability of fatty acid 
precursors for microbial transformation and thus milk fatty acid composition.  
 
Traditionally, goats have been raised solely on native pasture; the composition of 
which varies based on the geographical location. For smaller operations this 
remains the case, however with commercial production systems as in New 
Zealand, goats are often raised on cultivated pastures. These pastures are typically 
ryegrass and clover, however goats tend to discriminate against clover  (Langer, 
1990). The FA content of pasture is highly unsaturated (70–90%), with a large 
amount of linoleic (C18:2) and linolenic (C18:3) acids (Chilliard et al., 2003, 
Schroeder et al., 2004). Therefore, the consumption and digestion of pasture can 
influence milk composition by increasing the level of C18:3n-3 (ALA) and CLA 
in milk.  
 
When pasture or forage is limited, concentrates are used to provide a high energy 
source. Concentrates can include any combination of barley, corn grain, beet pulp, 
soyabean cake, chickpeas, cereal, maize, wheat middlings, mustard cake, expeller, 
oats, vitamins and minerals (Atti et al., 2006, Chilliard et al., 2006, Matsushita et 
al., 2007, Pizzoferrato et al., 2007, Ryhanen et al., 2005, Tyagi et al., 2009).  
Typically a concentrate diet increases milk yield, milk fat and alters fatty acid 
composition depending on the type of concentrate. Fat supplements (vegetable 
oils, marine oils, oilseeds) also tend to increase milk LCFA.  A summary of major 
studies of forage, concentrates and fat supplementation on goat milk composition 
are outlined below in Table 7.  
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Table 7: Summary of major studies investigating diet and milk composition in dairy goats. LCFA = Long chain fatty acids. CLA = conjugated linoleic acid. FA= fatty acid. 
SO= sunflower oil. LO= Linseed oil. MCFA = medium chain fatty acids. MUFA = monounsaturated fatty acids. TVA = trans vaccennic acid.  
Diet Country Effect Reference 
Forage or pasture 
Grass or hay vs non-forage Italy Grass and hay increased LCFA  (Rapetti et al., 2005) 
Forage: concentrate ratio Italy Increased concentrate, increased milk production (Tufarelli et al., 2009) 
Lucerne hay vs native pasture Hungary Native pasture increased total fat, protein solids and CLA (Pajor et al., 2009) 
Concentrates 
Concentrate America Increased milk yield, milk fat, and milk protein (slightly) (Min et al., 2005) 
Concentrate + canola seeds France Increased milk yield and milk fat. Altered FA composition.  (Andrade and Schmidely, 2006) 
Fat or oil supplements  
Canola and soybean oilseed (protected)  Australia Altered FA composition (Gulati et al., 1997) 
Calcium salts of CLA France Reduced milk fat yield (inhibits de novo synthesis) (Shingfield et al., 2009) 
Sunflower or linseed oil France SO or LO increased milk fat and LCFA, decreased odd chain FA (Bernard et al., 2009) 
Forage + rapeseeds or sunflower oil  France Altered fatty acid composition   (Ollier et al., 2009) 
Castor or Licuri oil Brazil Decreased fat content, altered flavour and odour  (Pereira et al., 2010) 
Canola oil Canada Increased milk fat, C18:1 and CLA, decreased MCFA (Mir et al., 1999) 
Palm oil Nigeria Increased milk yield and fat % (Otaru et al., 2011) 
Soybean, canola and sunflower oils Brazil Sunflower oil produced highest CLA in milk, while soybean had highest MUFA 
and PUFA.  
(Matsushita et al., 2007) 
Soybean oil Spain Increases milk fat, CLA, and TVA (Bouattour et al., 2008) 
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2.5.1  New Zealand feed supplements  
Pasture remains the main diet for all of New Zealand’s DGC dairy goats. 
However, with many DGC farms shifting to an indoor farming system most of 
the pasture is ‘cut and carried’ to the goats. Indoor farming has made it easier 
to supplement with various feed additives such as palm kernel extract (PKE) 
and biscuit waste (BW). These were two popular supplements fed to NZ dairy 
goats up until their removal in 2011. Yeast supplementation is an additional 
feed supplement suggested to be beneficial for NZ dairy goats. These three 
feedstuffs are outlined below.  
 
2.5.1.1 Palm Kernel Extract  
NZ imports over one-million tonnes of PKE each year for animal nutrition 
purposes (MAF, 2011). PKE is a by-product of palm oil production and can  
vary considerably  in chemical  composition  depending  on  the  extent  and  
methodology  of oil removal and  the  proportion  of endocarp  remaining 
(Hindle et al., 1995). The remaining residue of ‘screw process’ extraction is 
the expeller (PKE), while by-products of solvent extraction are termed palm 
kernel meal (PKM) or palm kernel cake (PKC) (O’Mara et al., 1999). PKM 
and PKC are used commonly overseas as feed supplements, while PKE is 
fed extensively to NZ dairy cows and prior to 2011, dairy goats.  
 
PKE is used as an animal feed as it is cost-effective, high in protein and 
high in fibre (Carvalho et al., 2006, Salama et al., 2002).  Very little is 
published on the effect of PKE (or PKM and PKC) on milk composition, 
even in dairy cows. Carvalho et al,  found this surprising given that PKM is 
a common raw material used in diets for lactating dairy cows in the UK. 
Most studies feeding goats palm kernel have focussed on digestibility and 
nutrient utilisation effects (O’Mara et al., 1999, Hindle et al., 1995, 
Chanjula et al., 2011, Dahlan et al., 2000), however no studies could be 
found with regard to PKE and milk fatty acid composition in any species.  
 
 
 - 18 - 
 
 
2.5.1.2 Biscuit Waste  
Biscuit waste (BW) is an animal feed supplement derived as a by-product of 
confectionary production. A study on BW fed to pigs showed that it could 
be used as an animal supplement for weight gain and cost-effectiveness if 
additional protein was added (Narayanan et al., 2009). However other than 
this paper, very little scientific literature exists with regard to any aspect of 
animal consumption of confectionary wastes.  
 
Commercial information sheets from NZ suppliers of BW state that it is 
very high in energy and highly palatable, with high sugar, starch and oil 
levels (GP Feeds Ltd, 2011). However the lack of scientific research on this 
feed means this alternative animal feed has a largely unknown effect on 
milk composition.   
 
2.5.1.3 Yeast 
Yeast (Saccharomyces ceresvisiae) can be added to animal diets in a dried 
or liquid form. El Ghani (2004) studied the influence of diet 
supplementation with yeast culture on performance of Zaraibi goats and 
found that adding yeast to a mix of concentrate and roughage stimulated 
milk yield. Similarly live yeast supplementation significantly increased milk 
production in early lactation Saanen goats (Stella et al., 2007).  
 
However Hadjipanayiotou et al, (1997) found that the inclusion of yeast did 
not improve the performance of dairy ewes or goats. Similarly Salama et al, 
(2002) found that yeast had no effect on milk parameters but did increase 
body condition of the goats. The only study on fatty acid composition  
(Giger-Reverdin et al., 2004) found no effect of yeast on fatty acid 
constituents in nitrogen deficient goats.  Thus the effect of yeast 
supplementation on milk composition is not clear in dairy goats.  
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2.6  Genetics and milk composition  
In many instances, individual animals of the same breed and fed the same diet 
have different milk compositions, suggesting other factors such as genetics play a 
role. Genes and single nucleotide polymorphisms (SNPs) that influence milk 
composition have long been studied in numerous ruminant species. Research from 
NZ dairy cows has shown that gains of 1 - 2.5% can be achieved each year by 
incorporating genetic information (quantitative trait loci (QTL) or marker-assisted 
selection) in selective breeding programs (Spelman and Garrick, 1997).  
 
The genetics of dairy goats however remains a relatively new area, with very little 
artificial insemination (AI) and only a handful of milk genes sequenced and 
characterised. A reference sequence for the goat genome is yet to be established, 
although some regions have been sequenced. The gene encoding αs1-casein 
(CSN1S1) has been the most widely studied, however others such as αs2-casein 
(CSN1S2), β-casein (CSN2) and growth hormone (GH) have been shown to milk 
composition in dairy goats (see reviews by Ibeagha-Awemu et al, (2008) and 
Moioli et al, (2007)) . 
 
2.6.1  Casein genes 
The casein genes (CSN1S1, CSN1S2, CSN2 and CSN3) are found only in 
mammalian genomes and encode αs1-casein, αs2-casein, β-casein and κ-casein 
proteins. Evolution of the caseins are suggested to have emerged from an 
ancestral gene before mammalian radiation (>300 Myr) (Kawasaki et al., 2011, 
Lefevre et al., 2010) and involved extensive exon shuffling and gene 
duplications (Rijnkels, 2002, Yu-Lee et al., 1986). In ruminants, these genes 
are clustered together over a 250kb stretch (Figure 4) and are closely linked. 
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Figure 4: Casein gene cluster in ruminant species. Amino acid length of each transcribed casein 
gene in the goat is indicated. Adapted from Martin and Leroux (2000) and Marletta et al, (2007). 
 
2.6.2   CSN1S1, gene encoding αs1-casein 
Although a minor protein, CSN1S1 has been the most extensively studied in the 
goat due to its remarkable genetic polymorphism and subsequent variation in 
milk composition. CSN1S1 is 17.5kb long and consists of 19 exons varying in 
length from 24-358bp (Ramunno, Cosenza, Rando et al 1995). Comparative 
analysis of the first 200bp of the CSN1S1 promoter regions shows a homology 
between goat and other ruminants (~96% with cattle, sheep and yak) and less 
with non-ruminants (88% rabbit, 80.5% human and 77% rat) (Ramunno et al., 
2004). The main differences between the bovine and caprine species are 
clustered in the central part of the gene between introns 2 and intron 12 
(Ramunno et al 2004).  
 
 
Figure 5: Structural organisation of the gene encoding αs1-casein (CSN1S1). Dark 
boxes at 5' and 3' ends represent un-translated exons. The white box as part of exon 2 
highlights the region encoding the signal peptide which directs the protein to be secreted 
from the cell following translation.  Figure adapted from Grosclaude et al, (1994).  
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CSN1S1 is the most variable of all the casein genes and the goat is the most 
polymorphic species studied at the CSN1S1 locus to date. The first 7 protein 
variants were described in the early 1980’s by Boulanger et al (1984) on the 
basis of their different electrophoretic motility. Now, with the expansion of 
molecular biology, over 18 CSN1S1 variants have been identified at the 
genomic level in the goat. These variants can be grouped into those producing 
‘high’ (3.6g), ‘intermediate’ (1.6g), ‘low’ (0.6g) and ‘null’ (trace amounts) of 
αs1-casein per kg of milk .  
 
B1 is considered to be the original allele, from which A-type (A,G,I,H,01, and 
02) and B-type (B2,B3,B4,C,E,F,L, and D) originated (Martin et al, 1999). The 
M and N alleles are thought to be the result of inter-allelic recombination 
events between A-type and B-type alleles (Bevilacqua et al., 2002, Ramunno et 
al., 2005). The proposed evolution of these alleles is illustrated below (Figure 6) 
and specific details regarding the mutation events leading to each variant 
outlined in Table 8.  
 
Figure 6: Schematic of proposed evolution of CSN1S1 alleles. Major amino acid changes 
between the A-type and B- type lineages are indicated. Adapted from Martin and Leroux (2000). 
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Table 8: CSN1S1 allelic variants with the mutational event, functional change and predicted αs1-casein in the milk associated with each allele. Table continued over.  
Allele Mutational event Amino acid / functional change 
Predicted milk 
αs1-casein 
Reference 
A Exon 10, nt 22: CG Glu(77)Gln High (Boulanger et al., 1984, 
Brignon et al., 1990a, 
Ramunno et al., 2005) 
B1 Original ‘Reference’ 199aa residues High (Grosclaude et al., 1997) 
B2 Exon 4, nt 8: TC Leu(16)Pro High (Boulanger et al., 1984, 
Brignon et al., 1990b, 
Grosclaude et al., 1997, 
Ramunno et al., 2005) 
B3 Exon 4, 8
th 
nt: TC 
 
Leu(16)Pro. Arg(100)Lys High (Grosclaude et al., 1997, 
Ramunno et al., 2005) 
B4 Exon 4, 8
th 
nt: TC 
 
Leu(16)Pro. Arg(100)Lys. Thr(195)Ala High (Grosclaude et al., 1997, 
Ramunno et al., 2005) 
C Exon 4, 8
th 
nt: TC 
 
Leu(16)Pro. Arg(100)Lys. Thr(195)Ala. His(8)Ile High (Boulanger et al., 1984, 
Brignon et al., 1990b, 
Ramunno et al., 2005) 
H unknown Glu(77)Gln. Arg(1)Lys High (Chianese et al., 1997) 
L Exon 4, 8
th 
nt: TC 
 
Leu(16)Pro. Arg(90)His High (Chianese et al., 1997, 
Ramunno et al., 2005) 
M Exon 9, 23
rd
 nt CT Ser(66)Leu.  Loss of two phosphate groups within the major phosphorylation 
site. 
High (Bevilacqua et al., 2001, 
Chianese et al., 1997, 
Bevilacqua et al., 2002) 
I Unknown Uncharacterised.  Intermediate (Chianese et al., 1997) 
E Exon 4, 8
th
 nt: TC 
Exon 19, 124
th
 nt: 457nt LINE insertion 
Leu(16)Pro. Arg(100)Lys,   
Thr(195)Ala. Instability and 3-fold reduction of mRNA  
 
Intermediate (Grosclaude et al., 1987, 
Perez et al., 1994, Ramunno 
et al., 2005) 
D Exon 4, 8
th 
nt: TC 
Unknown 
Leu(16)Pro. Deletion of 10 a.a (59-69). Abnormal processing of primary 
transcript, loss of multiple phosphorylation sites  
Low (Brignon et al., 1990b, 
Ramunno et al., 2005) 
  
 
 
- 2
3
 - 
Allele Mutational event Amino acid / functional change 
Predicted milk 
αs1-casein 
Reference 
 
F 
 
Promoter region: nt 1319 mutation 
Exon 4, 8
th 
nt: TC 
Exon 4, 24
th
 nt: CG 24th   
Exon 9, 23
rd
 nt:11bp insertion 
Intron 9: 3bp insertion 
Exon 10, 22
nd
 nt: CG  
Intron 14:  7bp deletion 
Exon 19 (3’UTR),132nd nt: TC  
 
Leu(16)Pro.  Premature stop codon in exon 12.  
Multiple alternatively spliced transcripts, mostly alternative skipping of exons 9-
11. Deletion of 37 aa (59-95). Loss of multiple phosphorylation sites. Mutation 
in promoter region suggested creates an extra putative activator protein (AP-1) 
binding motif . 6x less mRNA transcribed than A allele.  
 
 
Low 
 
(Brignon et al., 1990b, 
Grosclaude et al., 1987, 
Leroux et al., 1992, Ramunno 
et al., 2005) 
G Transition GA in 5’ splice site 
consensus sequence of intron 4.   
Glu(77)Gln. Deletion of 13 aa (1426). Alternatively spliced mRNA 
outsplicing of exon4. Affects the proteins middle or N-terminal region. Same 
expression level as F.  
Low (Picariello et al., 2009, Martin 
and Leroux, 1994) 
N Exon 9, 23
rd
 nt: deletion  
Promoter: GA transition  
1 nt frameshift  premature stop codon in exon 12.  
mRNA 1/3 of F despite same mutation. Alternatively spliced. AP-1 of F 
suggested responsible for different expression of F and N.    
Null (Ramunno et al., 2005) 
01 Intron 12: last 7 exons deleted (8.5kb)  
Promoter: GA transition 
Non-functional protein.  Null (Cosenza et al., 2003) 
02 Large insertion, uncharacterised  Null (Martin et al., 1999a, Leroux 
et al., 1990) 
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The most commonly studied CSN1S1 variants are A, B, E, F, N and 01 due to 
their effect on milk composition and relative ease of identification. CSN1S1 A 
and B alleles differ by just one amino acid substitution and are both associated 
with a high level of αs1-casein expression. CSN1S1 allele E is characterised by 
a 457nt LINE insertion in the 3’ UTR of the gene (Perez et al., 1994). Although 
un-translated, this AT-rich insertion is presumed to cause an instability of the 
mRNA and thus result in less αs1-casein than high CSN1S1 alleles (Perez et al., 
1994). The CSN1S1 F variant is interesting due to multiple insertions that cause 
exon skipping and the production of alternatively spliced transcripts (Leroux et 
al., 1992, Ferranti et al., 1997, Ferranti et al., 1999). This results in a low level 
of αs1-casein expression and the production of only 0.45g/L of αs1-casein per 
allele (Martin et al., 1999a). N and 01 are null variants which produce no 
functional protein, resulting in no detectable levels of αs1-casein. This is due to 
a single-nucleotide deletion causing a premature stop codon in the N allele and 
an extensive 8.5kb deletion in the 01 allele (Cosenza et al., 2003, Ramunno et 
al., 2005).  
 
With regard to fatty acid composition, significant differences between CSN1S1 
genotypes have been found in two studies.  Pierre et al, (1998) compared A and 
O variants and found more short and medium-chain SFAs in A milk, but lower 
C16:0 content. Chilliard et al., (2006) found that ‘high’ CSN1S1 goats had 
more C8:0-C12:0 SFA, more stearic acid (C18:0), less palmitic (C16:0), oleic 
(C18:1 cis9), linoleic (C18:2n6)  and CLA (C18:2n7) acids than ‘low’ goats. 
These authors also found that SCD desaturation ratios were higher in ‘low’ 
CSN1S1 goats, suggesting these animals had higher mammary activity. 
 
 
2.6.3  CSN1S1 allele frequencies 
NZ dairy goats are bred from a fairly limited stock, with very little use of 
artificial insemination or foreign bucks. Over 80% of DGC dairy goats are 
Saanens with the remaining breeds mostly Toggenburg, British Alpine and 
Nubian. Saanens are the predominant breed due to their higher days in milk 
and milk yield, making them better performers for dairy goat industry 
(Serradilla, 2001, Singireddy Sr, 1997). Toggenburgs are similarly strong dairy 
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goats, as are British Alpines which are renowned for their consistency and long 
lactations (Coleby, 2001).  
 
CSN1S1 allele frequencies for any NZ dairy goat breed could not be found in 
the scientific literature. Based on overseas studies Saanens have a high 
frequency of ‘intermediate’ E and ‘low’ F CSN1S1 alleles (Maga et al., 2009, 
Soares et al., 2009, Torres-Vázquez et al., 2008). Toggenburgs show a high 
average frequency of allele F (0.69) (Clark and Sherbon, 2000, Torres-Vázquez 
et al., 2008) while data on CSN1S1 allele frequencies of the British Alpine 
breed (which is different to French Alpine) could not be found.  
 
2.6.4  Methods for CSN1S1 genotyping   
Early analysis of CSN1S1 was at the protein level, using isoelectric focussing 
(IEF), two dimensional electrophoresis, SDS-PAGE, immunoelectrophoresis, 
reverse-phase high-pressure liquid chromatography (RP-HPLC) and/or mass 
spectrometry (MS) to identify the different protein variants (Grosclaude et al., 
1987, Jordana et al., 1996, Martin et al., 1999a, Leroux et al., 1990). Today, 
molecular techniques are used to genotype based on SNPs and mutations at the 
nucleotide level that lead to various αs1-casein phenotypes.  
 
The restriction fragment length polymorphism (RFLP) technique was first used 
for genotyping goat caseins by Leroux et al, (1990). The most common RFLP 
is the use of restriction enzyme XmnI on exon 9 amplified products, originally 
used for CSN1S1 genotyping by Ramunno et al., (2000). This method allows 
simultaneous identification of A*, B*, N and F alleles. However it does not 
distinguish between A and G, H, I, 01 and 02 or B and B1, B2, B3, B4, B’, E, 
C and L alleles as these have SNPs in other regions of CSN1S1. Further allele-
specific PCRs (AS-PCR) are then needed to distinguish between variants of 
interest.  
 
A key limitation in the genotyping of goats at the CSN1S1 locus is that 
although the complete sequence of the gene encoding the goat αs1-casein has 
been determined by Rammuno et al (2004), only alleles A, F and N have been 
entirely sequenced (Table 9). Partial sequences exist for CSN1S1 01 (intron 12), 
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and E (exon 19), however full sequences for these and the other 12 un-
sequenced variants have not been reported on public databases.   
 
 
Table 9: Sequenced CSN1S1 variants submitted to NCBI BLAST 
Allele Region sequenced Length of sequence (bp) Accession # 
A Entire (exons1-19) 19,408 AJ504710.2 
F Entire (exons1-19) 19,414 AJ504711.2 
N Entire (exons1-19) 19,406 AJ504712.2 
E Exon 19 437 FJ164044.1 
O1 Intron 12 283 AJ252126.1 
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2.7 Purpose and Scope  
This study will investigate how genetic factors (CSN1S1 genotype) and nutritional 
factors (PKE, BW and yeast) affect NZ goat milk composition. The overall 
purpose is to enhance our understanding of these genetic and nutritional aspects of 
goat milk production, with specific reference to how they influence key 
components in goat milk.  
 
Given the relevance of this research for the dairy goat industry, the study will take 
place a commercial setting involving DGC goat farms which are carrying out their 
everyday farming practice. The CSN1S1 locus is chosen as the genetic factor of 
interest due to little knowledge of this gene in the NZ dairy goat population and 
its importance for milk parameters. For these reasons, alleles A, B, E, F, N and 01 
will be the focus of CSN1S1 genotyping.  
 
In light of dietary changes recently implicated on DGC dairy goats, the effect of 
alternative supplements (PKE, BW and yeast) will be the focus of nutritional 
factor analysis. Milk volume, protein, fat and fatty acid composition parameters 
are the key milk components of interest due to their commercial implications and 
importance for human health.  
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3 Chapter 3: Genetic Methods 
This genetic methods chapter outlines the processes used to select goats for 
genetic analysis, collect and extract DNA samples, genotype at the CSN1S1 locus, 
correlate to milk composition data and determine statistical significance.  
 
 
3.1 Sampling 
Ethical approval for the collection of milk and hair samples was obtained from 
The University of Waikato Animal Ethics Committee (Protocol # 805). All 
provisos made by the ethics committee were adhered to throughout the course of 
this research.  
 
DNA samples were taken from male (buck) and female (doe) goats from two 
Waikato farms; Farm A and Farm B. Both farms were feeding a combination of 
pasture, forage and grain and had similar breed compositions. 55 does and 9 
bucks from Farm A and 68 does and 5 bucks from Farm B were selected for 
genotyping. Buck samples were taken from current season bucks used for 
breeding, while doe samples were chosen randomly from the order they walked 
into the milking shed.  Only multiparous does between 2 and 8 years of age were 
used in the alignment of CSN1S1 genotype to milk composition data.  
 
Milk from each individual doe was collected by hand milking into a 15mL 
falcon tube (Greiner Bio-One). Hair samples were plucked from the rump of 
bucks (or does if not in milk) and placed into individual envelopes. All milk and 
hair samples were labelled with the doe or buck’s farm identification number. 
Samples were transported to the laboratory and kept at 4°C until further analysis. 
DNA was extracted from all samples within 24hrs of collection.  
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3.2 DNA extraction from milk 
Milk samples were centrifuged at 3000xg (Heraeus mµLtifuge 1S-R) for 10 
minutes, the fat rimmed off using a 200µL pipette tip and all supernatant 
discarded. Pellets were rinsed in PBS (NaCl 137mmol/L, KCl 2.7 mmol/L, 
Na2HPO4 10.0 mmol/L, KH2PO4, 2.0 mmol/L pH 7.4) to remove any residual 
protein and fat. Cells were re-suspended in 750µL 5M GITC (20mM sarkosyl, 
30mM tri-sodium citrate, 0.7% mercaptoethanol, pH 7) by flushing up and down 
with a transfer pipette.  
 
Suspended cells were transferred to a 1.7mL microtube (Axygen) and mixed on 
a rotator wheel (Global Science) for 10 minutes. 500µL of pH5.2 phenol (Sigma) 
was added to each sample, mixed vigorously by hand and placed back on the 
rotator wheel for 10 minutes. Following this 250µL of chloroform (Ajax 
Chemicals) was added, shaken vigorously and then placed on to the rotator 
wheel for another 5 minutes. These were then centrifuged at 16100rcf for 15 
minutes using a bench-top centrifuge (Eppendorf 5415D). The aqueous layer 
was removed using a transfer pipette, placed into a new 1.7mL microtube along 
with 100µL of 3M NaAc (pH 5.2, Ajax Chemicals) and an equal volume of 
isopropanol (Ajax Chemicals). These were then inverted several times to mix 
and placed at -20°C for at least 30 minutes to allow the DNA to precipitate.  
 
Samples were centrifuged at 16100rcf for 10 minutes. The supernatant was 
removed and pellets rinsed with 1mL of 70% ethanol (Ajax Chemicals, diluted 
with DEPC water). All ethanol was removed using an autopipette (Eppendorf) 
and sample tubes left open in fume cabinet for 20 minutes to evaporate. Pellets 
were re-suspended in 50µL of TE (10mM Tris, 1mM EDTA, pH 8) and vortexed 
to mix. The concentration (ng/µL) and purity (260/280 absorbance ratio) of the 
DNA was then detected using a ND-1000 spectrophotometer (Nanodrop).  
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3.3 DNA extraction from hair 
Hair samples were trimmed using sterile scissors and placed into a 1.7mL 
microtube, bulb down. 350µL of lysis solution (100mM Tris pH9, 0.5% SDS, 
50mM EDTA, 142mM NaCl) and 20µL of Proteinase K (20mg/mL, Invitrogen) 
were added to each tube and incubated at 56°C for 2-3 hours using an Eppendorf 
thermomixer.  
 
Following incubation tubes were centrifuged briefly (10 seconds) to draw hair to 
bottom and enable easy removal of hair from liquid. Hair was discarded and an 
equal volume of 5M LiCl (Ajax Chemicals) was added to the remaining solution. 
This was inverted and an equal volume of chloroform added, vigorously mixed 
by hand and placed on the rotator mixer for 15 minutes.  
 
Samples were then centrifuged for 10 minutes at 16100rcf. The top aqueous 
layer was removed using a transfer pipette and placed into a new 1.7mL 
microtube. An equal volume of isopropanol was added, samples were inverted 
and put at -20°C for at least 30 minutes to allow DNA to precipitate.  
 
Following precipitation samples were centrifuged for 10 minutes and the 
supernatant carefully removed using a transfer pipette. The pellet was washed 
with 70% ethanol and tubes left open to air-dry in fume-cupboard for 
approximately 30 minutes. DNA was then re-suspended in 20µL of TE and 
measured using the Nanodrop spectrophotometer as per the quantification of 
DNA extracted from milk.   
 
 
 
 
 
 
 
 
 -31- 
 
3.4 DNA purification  
Any samples extracted from milk or hair which did not render sufficient DNA 
quality (a 260/280 ratio of less than 1.5 or an excessive peak at 230nm) 
underwent CTAB clean up. Any pellets which were large, bright white and 
difficult to dissolve were cleaned up by the SDS method.  
 
3.4.1  CTAB DNA clean-up 
470µL of TE and 30µL of 10% w/v SDS (Roche) was added to 100µL of DNA. 
This was incubated at 65°C and mixed at 800rpm for 10 minutes. 100µL of 5M 
NaCl (Ajax) was added along with 80µL of pre-warmed CTAB (10% w/v 
CTAB in 0.7M NaCl) and further incubated at 65°C, 800rpm for 10 minutes. 
An equal volume of chloroform was added, mixed vigorously by hand and then 
placed on the rotator mixer for 10 minutes. Samples were then centrifuged at 
16.1 rcf for 15 minutes and the top aqueous layer collected using a transfer 
pipette. An equal volume of isopropanol was added and the same final 
precipitation methods described for previous extractions were applied. Samples 
were re-suspended in 50µL of TE.  
 
3.4.2  SDS DNA clean-up 
470µL of TE and 30µL of 10% SDS were added to 100µL of DNA. This was 
incubated at 65°C and mixed at 800rpm for 10 minutes. An equal volume of 
5M LiCl was added and inverted to mix, followed by the addition of double the 
volume of chloroform. The solution was vigorously mixed by hand and placed 
on the rotator mixer for 15 minutes. Samples were then centrifuged for 15 
minutes, the aqueous layer removed and an equal volume of isopropanol added. 
The same final precipitation methods described for previous extractions were 
applied. Samples were re-suspended in 20µL of TE.  
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3.5 General CSN1S1 genotyping methods 
The following sections outline the general methods used to genotype at the 
CSN1S1 locus. Methods specific to each exon are outlined in later in section 3.6.  
 
3.5.1  Primers 
Primers were synthesised by Integrated DNA Technologies Ltd and diluted to 
200pmol/µL in TE (10mM Tris, 1mM EDTA, pH8). Working primer solutions 
were made by diluting the 200pmol stock in TE to make a final concentration 
of 20pmol/µL. For most reactions, all primers (forward and reverse) were 
mixed in the one 20pmol/µL working solution. Individual primer sequences for 
each exon are outlined in section 3.6. 
 
3.5.2  PCR 
PCR reactions (ranging from 20µL-50µL) were carried out in 200µL PCR 
tubes (Axygen). Each reaction mix contained 250µM dNTPs (Invitrogen), 2.5 
mM MgCl2 (Ajax Chemicals), 0.6U Hot-fire Pol
®
 Taq DNA polymerase (Solis 
BioDyne), 1x HotFirePol B1 PCR Buffer (Solis BioDyne), 1 ng template DNA 
and 5pmol of each forward and reverse primer. The reactants were put in a 
thermal cycler (Bio Rad), which carried out the appropriate PCR program.  
 
3.5.3  Agarose Gel Electrophoresis  
PCR products were electrophoresed on TAE (0.04M Tris-Acetate, 0.001M 
EDTA) agarose (SeaKem
®
) gels, stained with 0.5µg/mL EtBr (USB), ranging 
from 2-4% (w/v) depending on the exon amplified. 5-10µL of PCR product 
was mixed with 2µL of loading dye (0.05% Bromophenol Blue, 0.05% Xylene 
Cyanol, 6% Glycerol) and loaded into the gel. Gels tanks were filled with TAE 
buffer and gels electrophoresed at 90-110V. Product base-pair lengths were 
compared to a 100bp ladder (2-3% gels) or 20bp ladder (4% gels). Both ladders 
were supplied by Solis BioDyne. All gels were visualised using UV light (Life 
Technologies) and images captured using COHU High Performance CCD 
camera.  
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3.5.4  Product removal from agarose gels 
Gel-punching was used to remove bands separated by gel electrophoresis in 
cases where unknown PCR products resulted. PCR products were 
electrophoresed on a 4% agarose gel stained with 0.05µL/mL of 20,000x Red-
safe™ dye (Intron Biotechnology). Gels were visualised using Safe Imager™ 
(Invitrogen) and bands punched using an X-Tracta Gel Extraction Tool 
(Sigma-Aldrich). Punched bands were cleaned up using the following freeze-
thaw method.  
 
For each sample a 0.6mL microtube was punctured at the base by inserting a 
flamed 19G1 needle (Becton Dickinson). A 3mm glass bead (Ajax Chemicals) 
was placed inside the 0.6mL tube which was then put inside a 1.7mL 
microtube. The punched gel fragment was inserted into the 0.6mL tube and 
frozen at -80°C for 30 minutes. Tubes were removed and thawed at room 
temperature for 30 minutes and then centrifuged at 16100rcf for 15 minutes. 
The 0.6mL tube and its contents were discarded and the liquid captured in the 
1.7mL tube was cleaned up using the following Polyethelene Glycol (PEG) 
precipitation method. 
 
An equal volume of PEG solution containing 20% PEG 8000 (AppliChem) in 
2.5M NaCl was added to the liquid, vortexed to mix and left to stand at room 
temperature for 10 minutes. Samples were centrifuged at 16100rcf for 10 
minutes, the supernatant removed and the pellet rinsed in 70% ethanol. Tubes 
were left open to air-dry and product was re-suspended in 15µL of MilliQ-H20 
(Barnstead). Samples were then re-amplified using the same primers and PCR 
they were originally extracted from to ensure they yielded a single band and 
then sent for sequencing.  
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3.5.5  Cloning 
Where direct sequencing was unsuccessful, cloning was used prior to DNA 
sequencing in order to attain cleaner, full length sequences.  
 
One E. coli (DH5α) colony was inoculated into Luria Base (LB) broth 
(Invitrogen) and incubated at 37°C, 200rpm overnight. For each sample a 
ligation mix was made containing 5.5µLwater, 1µL 10x T4 DNA Ligase 
Buffer (Fermentas), 1µL KS/SK+ vector (Bluescript), 2.5U T4 DNA Ligase 
(Fermentas) and 2µL of PCR product. The ligation solution was vortexed and 
incubated at 22°C for 10 minutes then kept at 4°C overnight.   
 
The following day 1.5mL of DH5α culture was removed, placed into a 1.7mL 
microtube and centrifuged at 16.1rcf for 1 minute. The supernatant was 
discarded and 100µL of transformation solution (0.1M CaCl2, 1% PEG 8000) 
was added. Cells were re-suspended by flicking the tube and placed on ice for 
5 minutes.  All 10µL of ligation mix was then added to the microtube, flicked 
to mix and placed on ice for 20 minutes. This was followed by precisely 1.5 
minutes at 42°C then on ice for another 5 minutes.  
 
1mL of sterile LB broth was added and incubated at 37°C for 1hr, mixing at 
9rpm. Samples were centrifuged for 1 minute at 16100rcf and the supernatant 
removed. 100µL of sterile LB broth was added to re-suspend the pellet and 
flicked to mix. All of the solution was spread onto an LB+ agar plate (2.5% 
w/v Luria Base Broth, 1.5% w/v agarose, 100µg/mL ampicillin) which 3 hours 
prior to transformation was incubated with 40µL of Xgal (20mg/mL, 
Invitrogen), and 4µL IPTG (8uM, Fermentas). Each plate was incubated at 
37°C overnight.  
 
Next day plates were checked for blue and white colonies. If not visible, plates 
were incubated for a further 4 hours and placed at 4°C for 30 minutes to better 
visualise colonies. Using a sterile pipette tip single white colonies were 
selected and streaked onto LB+ plates which were incubated at 37°C for 24hrs.  
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The following day individual colonies were removed from the LB+ plate using 
a sterile loop (Raylab) and placed in a 1.7mL microtube with 100µL of PEG-
KOH lysis solution (60% PEG200, 18.6 mM KOH, pH 13.5). The solution was 
mixed and incubated at 95°C for 5 minutes.  
 
2µL of lysed cells were added to a 50 µL PCR reaction mix containing 250µM 
dNTPs, 2.5 mM MgCl2, 1x HotFirePol B1 PCR Buffer,  1.25U HOT FIREPol® 
DNA Polymerase and 5pmol of each T7 / T3 primer (IDT).  PCR conditions 
were 95°C for 15 minutes, followed by 39 cycles of 95°C for 20 seconds, 55°C 
for 20 seconds, 72°C for 30 seconds, and then a final extension of 68°C for 
5 minutes. Products were run on a 1.5% agarose gel stained with EtBr and run 
in TAE buffer at 120V for 30 minutes.  
 
 
3.5.6  DNA sequencing  
One sample of each genotype was sent for DNA sequencing to check the 
correct region was amplified and to compare sequences to previously 
sequenced variants. PCR products were purified by adding 10U of 
ExonucleaseI (Fermentas) and 1U of Alkaline Phosphatase (Roche) to 20µL of 
PCR product. This was incubated at 37°C and mixed at 750rpm for 30minutes. 
Deactivation was initiated by incubating at 85°C for 10 minutes.   
  
Sequencing was conducted by the Waikato DNA sequencing facility (Hamilton, 
New Zealand) using an Applied Biosystems 3130xl Genetic Analyzer. Both 
forward and reverse sequencing reactions were conducted. Sequences were 
analysed using Applied Biosystems software, FASTA sequence comparison 
and BLAST online tools.  
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3.6 CSN1S1 exon-specific genotyping methods 
All DNA from hair and milk samples was PCR amplified over the exon 9 region 
and digested with XmnI for preliminary genotyping. Depending on the exon 9 
product, subsequent PCRs were carried out at exon 12 and / or exon 19 regions 
to determine the final CSN1S1 genotype. 
 
3.6.1 Exon 9 
Primers for the amplification of exon 9 were the same as those used in other 
goat CSN1S1 genotyping studies designed by Ramunno et al., (2000). Primer 
sequences are outlined below in Table 10 and the PCR reaction protocol in 
Table 11. Product lengths were expected to be between 212 - 224bp depending 
on the genotype.  
 
 
Table 10: Primers used in the amplification of CSN1S1 exon 9.  
Primer  Primer Sequence (5’-3’) 
Exon9 F TTCTAAAAGTCTCAGAGGCAG 
Exon9 R GGGTTGATAGCCTTGTATGT 
 
 
Table 11: Touch-down PCR cycling conditions for amplification of CSN1S1 exon 9. 
Reactions were carried out in 25µL volumes.  
Step Conditions No. Cycles 
1. Activation 95°C for 15minutes  1 
2. TD-PCR 95°C for 20sec, 65°C for 20sec (decreasing 
by 1°C per cycle), 72°C for 30sec 
10 
3. PCR 95°C for 20sec, 55°C for 30sec, 72°C for 
30sec 
35 
4. Final extension 68°C for 5 minutes. 1 
 
 
5µL of PCR product was electrophoresed on a 2% TAE agarose gel, with the 
remaining 20µL digested with 2U of XmnI (New England Biolabs). The 
digestion was carried out in a thermomixer (Eppendorf) for 4 hours at 37°C 
followed by deactivation at 65°C for 20minutes.  
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The XmnI recognition site occurs at 5’GAANN≠NNTTC 3’ (NEB). The 
cytosine at the 3’ end is deleted in F and N variants, meaning these alleles do 
not to cut under XmnI. Alleles A (including G, H, I, 01 and 02) and E 
(including B,C and L) do have the cytosine in position 23 of exon 9, creating 
the restriction site.  
 
Digested samples were electrophoresed on a 4% (w/v) agarose TAE gel stained 
with EtBr at 90V for 2-3 hours. An additional 10µL (0.1mg) of EtBr was added 
to gel running buffer (TAE) to better visualise products. Product base-pair 
lengths were compared to a 20bp ladder (Invitrogen).  
 
3.6.2 Intron 12 
Samples which produced a band at 150bp following exon 9 PCR-RFLP were 
subsequently amplified at intron 12 to distinguish between A* and 01 variants. 
The 8.5kb deletion characterising the 01 allele begins within intron 12 and can 
be detected using primers designed by Sztankòová et al., (2006) outlined in 
Table 12.  
 
Table 12: Primers used in the amplification of exon 12 for A/01 variants. Primer A is at 
the beginning of intron 12 and amplifies both A and 01 alleles. Primer B is specific to the 
01 allele and amplifies in the reverse direction Primer C is the reverse primer for allele A.  
Primer  Primer Sequence (5’-3’) 
Intron12 A CCCCAGCTGGTAATGTTTTA 
Intron12 B GGTCCATCAATTCCCTGTGT 
Intron12 C TGTATGGATCCCTGATTCCTT 
 
 
PCR conditions were as follows: An initial denaturation of 95°C for 15 
minutes, followed by 35 cycles of 95°C for 20 seconds, 62°C for 35 seconds, 
72°C for 30 seconds and a final extension of 68°C for 5 minutes. Products were 
electrophoresed on a 3% TAE agarose gel at 100V for 30 minutes. Base-pair 
lengths were expected to be 249-281 depending on the CSN1S1 genotype.  
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3.6.3 Exon 19 
Genotyping at exon 19 was essential for samples which produced a band at 
161bp following PCR-RFLP of exon 9 to distinguish between B*(B1-B4, B’,C, 
L) and E variants. CSN1S1 E alleles have a 457nt AT rich insertion which is 
not present in the B* allele and can be identified through standard PCR or real-
time PCR.  
 
Standard PCR of exon 19 was conducted using primers designed by Dettori et 
al., (2009) (Table 13). PCR conditions were altered from the original paper by 
extending initial activation and lowering the annealing temperature. This was 
done to suit the DNA polymerase and produce better quality product. Refined 
conditions were 95°C for 15 minutes, followed by 30 cycles of 95 °C for 20 
seconds, 55°C for 30 seconds, 72°C for 40 seconds, with a final extension step 
at 72°C for 5 minutes.  
 
Table 13: Primers used for the amplification of Exon 19. The F primer is at the 
beginning of exon 19 and amplifies both A and E variants. The reverse primer occurs after 
the LINE insertion while the LINE primer is internal to the LINE insertion characterising 
the E-allele, but not in an AT-rich region.  
Primer Primer Sequence (5’-3’) 
Ex19 F TCAGGAGCAGTGGGTATGTG 
Ex19 R CCTCCCAATGGAATAATGACA 
Ex19 LINE TGTTTGGGAACGCATGTAAG 
 
 
PCR products were electrophoresed on a 2% TAE agarose gel, as described in 
the general methods (section 3.5). Product lengths were expected at 437-583bp 
depending on the genotype.  
  
Real-time PCR and melt curve analyses were used as an alternative method for 
distinguishing between E and B* variants. The PCR reaction mix remained the 
same as described in general genotyping methods, however less primers 
(0.01pmol), more DNA Polymerase (0.625U) and 0.025mM of Syto82 
fluorescent dye (Invitrogen) were added to each reaction. 
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Real-time primers were different to those used in exon 19 standard PCR to 
improve the efficiency of real-time PCR by reducing product lengths. Two 
primer sets (designed by Feligini et al.,(2005)) were used in separate reactions: 
F1/R and F2/R. The F1 primer occurs in the region of consensus between B* 
and E alleles before the LINE insertion and thus amplifies both alleles while 
the F2 primer is internal to the LINE insertion and specific to the E-allele.  
 
Table 14: Real-time PCR primers used in the amplification of exon 19. 
Primer Name Primer Sequence 
RT F1 CAACCTCAAATTGAAGGCACT 
RT F2 TGGTGTTTTTCTTTCTGGCTTA 
RT R CAAGCTCTTAGGACAATTTCA 
 
 
Real-time PCR was conducted using a Corbett Rotor Gene 6000 Real-time 
PCR machine. Cycling parameters were: 95°C for 15 minutes, followed by 45 
cycles of 95°C for 15 seconds, 51°C for 15 seconds, 72°C for 30 seconds 
(acquiring on cycling A, yellow) and 80°C for 10 seconds (acquiring on 
cycling B, yellow). Following PCR, products were melted from 60°C to 95°C, 
rising by 0.5°C each step.  
 
The cycle threshold (Ct) value was set at the steepest part of the curve with 
values before approximately cycle 15 eliminated. Melt curve dF/dT thresholds 
were set below the main peak of the lowest negative sample while the 
temperature threshold was set just prior to the first main peak. The method 
used for genotyping CSN1S1 E variants based on Exon 9 PCR-RFLP results 
and real-time PCR results is outlined in (Table 15). 
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Table 15: Method for genotyping using exon 19 Real-time PCR. Average Ct and melt 
temperatures (°C) values for each genotype are given. ‘E’ alleles in the exon 9 PCR-RFLP 
g/t column are either E or B*. B* include alleles B1-B4, B’, C or L. Any sample with a Ct 
higher than the average negative Ct was withdrawn from Real-time analysis. G/t= genotype. 
N/r = not required for genotyping.  
Exon 9 
PCR-RFLP 
g/t 
F2/R primers 
F1/R  average 
melt temp 
Final Real- 
time g/t Average melt 
temp 
Possible g/ts 
AE 77.5 AE n/r AE 
AE 81.5 AB n/r AB* 
EE 77.5 EE or BE 
> 77 B*E 
74-76.5 EE 
EF 81.5 BF n/r B*F 
EF 77.5 EF n/r EF 
 
 
Following real-time amplification, products were electrophoresed a 2% agarose 
gel and selected samples sent for sequencing to verify that the product of 
interest was reproduced. CSN1S1 E allele products using F2/R were expected 
at 90bp while A alleles do not produce any discernible product using this 
primer set. F1/R primers amplify allele A at 90bp and allele E at 549bp. 
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3.7 Milk composition analysis 
Whole herd tests were carried out by Livestock Improvement Corporation (LIC) 
in accordance with standard herd testing protocols. Milk from individual goats 
was automatically siphoned off using wide-bore milk meters provided by LIC. 
The quantity partitioned into sample cups depended on the volume from each 
goat to the main vat milk. Sample cups were lined with bronopol preservative to 
prevent bacterial contamination influencing component analysis results. Samples 
were labelled with the goat identification number and sent to LIC for milk 
volume, protein, fat, solids and somatic cell count (SCC) analysis using an 
automatic milk analyser.   
   
Samples for fatty acid analysis were collected by hand-milking. The first 
secretions of milk were directed to waste and then approximately 50mL was 
collected in a 50mL tube (Sterlin) labelled with the individual goat number. 
Samples were immediately frozen and then sent to AgResearch (Hamilton, New 
Zealand) for fatty acid analysis once the dietary samples were also collected and 
ready for fatty acid analysis.  
 
3.8 Data analysis 
CSN1S1 genotypes from both doe and buck samples were used for allele and 
genotype frequency data. Hardy Weinberg calculations were conducted for 
genotype frequencies on each farm using the conventional test for HWE based 
on chi-squared statistic. Farm A’s p-values for chi-square analysis were 
calculated with 4 degrees of freedom (9 genotypes – 5 alleles) while Farm B had 
3 degrees of freedom (8 genotypes – 5 alleles).  
 
Alignment to milk composition data was done using STATISTICA. Farm A had 
four herd tests from November-March for feed trial purposes, however for 
genotype analysis only November data was used as this was when all goats were 
on the same dietary treatment (no yeast supplementation) and at a similar stage 
of lactation to Farm B. Herd test data from farm B was collected early in 
lactation (October). For these and other varying factors between farms (such as 
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quantity and quality of pasture, farm management and location), data for 
compositional analysis was not pooled between the two farms.  
 
Data was checked for normality using the Shapiro–Wilk test using 
STATISTICA software.  ANOVA was used to determine significant differences 
between genotypes for each milk parameter. A p-value <0.05 was considered 
significant, with a p-value <0.01 highly significant. 
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4 Chapter 4: Genetic Results 
 
The following chapter outlines the results of goat DNA extraction, CSN1S1 
genotyping and the effect of genotype on goat milk composition.  
 
4.1 DNA extraction 
Genomic DNA was isolated from 24 hair and 129 milk samples sourced from 
two Waikato dairy goat farms. 91% of samples were taken from Saanen goats, 
the breed which made up the majority of both herds. A small number of British 
Alpine x Saanen, Toggenburg x Saanen, Nubian x Saanen and Nubian were also 
sampled (Appendix B).  
 
DNA extracted from milk and hair ranged in concentration from 1.5ng/µL to 
over 3000 ng/µL and with a variety of purities. 40 samples required CTAB 
clean-up while 13 required SDS. 25 were removed due to low DNA yields 
(<5ng/µL), lab error or insufficient purity for PCR amplification. A summary 
can be found below in Table 16, with full extraction records in Appendix B.  
 
 
Table 16: Summary table of DNA extraction from goat milk and hair. 
Farm Sample type No. extracted No. withdrawn 
Final no. available 
for genotyping 
A Milk 66 13 53 
A Hair 9 4 5 
B Milk 63 4 59 
B Hair 15 5 10 
Total  153 26 127 
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4.2 Identification of CSN1S1 alleles 
The identification of CSN1S1 genotype was carried out by investigating 
polymorphisms in exon 9, intron 12 and exon 19.  
 
4.2.1 Exon 9 
PCR amplification of exon 9 produced fragments at 224, 223, 213 and 212 bp 
(Figure 7). Based on other studies these fragments can be identified as CSN1S1 
allele F (223bp) and either E,B,C or L at 224bp. CSN1S1 allele A (including G 
H, I, 01 and 02) produced one band at 213bp while the CSN1S1 N allele 
attained product at 212bp. All exon 9 PCR products were sequenced to confirm 
these variants (section 4.2.4).  
 
 
Figure 7: Exon 9 prior to digestion. PCR products were electrophoresed on a 4% 
agarose gel, stained with EtBr, run at 90V in TAE buffer for three hours. A-variants 
include A,G,H,I,01 and 02 while E variants include B1-B4,C,E and L. U= unknown 
genotype.  
 
CSN1S1 F and N alleles did not digest under XmnI and produced fragments at 
the same bp lengths as their undigested products (223 for allele F and 212 for 
allele N). CSN1S1 E(B,C,L) variants cut to produce two bands, 161 + 63bp in 
length. A(G,H,I,01,02) variants also cut with bands at 150 + 63bp (Figure 8).  
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Figure 8: Exon 9 following digestion with XmnI. Products were electrophoresed on a 4% 
agarose gel, stained with EtBr, run at 90V in TAE buffer for 3.5 hours. A-variants include 
A, G H, I, 01 and 02 while E-variants include B1-B4, C, E and L. The band present in the 
negative sample represents primer-dimers which are similar in size to the 63bp products of 
cut samples.  
 
Therefore amplification of exon 9 allowed the identification of A(G,H,I,01,02), 
E(B,C,L), F and N alleles. A full list of all genotypes resulting from exon 9 
amplification and digestion can be found in Appendix C. Further PCRs were 
required to distinguish between important alleles grouped together at exon 9. 
Amplification at intron 12 was necessary to distinguish between A*(G,H,I,02) 
and the null 01 variant. PCR of exon 19 was required to separate E (medium 
αs1-casein) from B* alleles (B1-4, B’, C and L) which produce high αs1-casein.  
 
4.2.2 Intron 12 
All 52 samples which carried an A* variant were screened for 01. CSN1S1 A* 
alleles were successfully amplified over intron 12, as identified by product at 
281bp.  No CSN1S1 01 variants (expected to be 249bp in length) were detected.  
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Figure 9: Intron 12 PCR products. Electrophoresed on a 2% agarose gel, stained with 
EtBr, run at 100V in TAE buffer for 45 minutes. Lane 1, negative. Lanes 2 and 3, A*-allele 
positive samples (281bp).  
 
 
 
4.2.3 Exon 19 
77 samples required E versus B* genotyping. The presence of the 457nt AT-
rich LINE insertion in the E-variant made it difficult to discriminate between 
B* and E variants using ordinary PCR. Amplification using primers specified 
by Dettori et al, (2009) did produce B*allele product at 583bp and product 
from the E allele at 437bp. However the PCR was precarious as carriers of the 
E allele amplified variably. Conducting gradient PCRs on B*B* and EE 
variants showed that reducing annealing temperatures improved E allele 
amplification, however E variants still amplified poorly using this method 
(Figure 10).   
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Figure 10: Gradient PCRs of B*B* (top) and EE (bottom) samples at identical 
temperatures showing the E variant is poorly amplified at temperatures suited for A 
variants. Lane 1 = 65.0°C, 2= 64.8°C, 3=64.3°C, 4=63.5°C, 5=62.4°C, 6=61.0°C, 
7=59.3°C, 8=57.8°C, 9=56.7°C, 10=55.9°C, 11=55.3°C, 12=55.0°C 13= 100bp ladder. 
Products were electrophoresed on a 2% TAE agarose gel for 30 minutes.  
 
Employing real-time PCR and melt-curve analysis allowed more reliable and 
efficient differentiation E and B* variants.  For 80% of samples, only the F2/R 
primer set was required to complete genotyping. CSN1S1 genotypes that 
carried an E allele produced a distinct peak at approximately 77.5°C whereas A, 
B, F and N homozygotes produced a melt curve at around 81.5°C (Figure 11). 
Negative controls melted at approximately 75.5°C with a low peak and high ct 
value.  
 
 
Figure 11: Real-time PCR melt curves using F2/R primer set. Samples carrying an E-
allele had a peak at 77°C while those without an E had a peak at approximately 81.5°C. 
Threshold is set below the negative samples, which melt at around 75°C.  
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14 samples required amplification with the F1/R primer set as EE and BE 
genotypes could not be discriminated using the F2/R primer set and exon 9 
PCR-RFLP alone.  The F2/R primers produced less distinct results (only one 
degree difference) however was sufficient to allow genotyping (Figure 12).  
 
 
 
Figure 12: Real-time melt curves resulting from amplification with F1/R primer set. 
Negative samples melted at around 75°C, EE at 76°C and BE >77°C 
 
Selected ‘unknown’ genotypes were also analysed through real-time to aid 
in their characterisation. Unknown genotype samples were positively 
identified as carrying an E-allele using real-time PCR.  
 
One sample from non-E genotypes (AA, AF, AN) were run as positive 
controls for method validation. None of these three genotypes produced E-
allele real-time profiles.  
 
Multiplexing all primers could be used for B* E discrimination, however it 
was more difficult to determine genotypes as the melt curves for each 
genotype were similar. Moreover both primers produced product at 90bp for 
E (using F1/R) and non-E alleles (using F2/R). All gel images, melt 
temperatures and Ct values used to genotype via real-time PCR can be 
found in Appendix D.   
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4.2.4 Verification of CSN1S1 genotypes via sequencing 
All PCR reactions amplified the correct region, as shown through the 
alignment of sequenced PCR products to documented sequences of the goat 
CSN1S1 gene. These positive identifications and unique sequence findings are 
outlined in sections 4.2.4.1- 4.2.4.7 below.  
 
4.2.4.1 Exon 9, A allele sequences 
Sequencing of AA genotyped samples returned a 100% alignment with the 
documented Capra hircus CSN1S1 gene for alpha s1 casein, allele A 
(AJ504710.2). The region which matched documented sequences was from 
9879-10031 which extended from the end of intron 8, over exon 9 (9864-
9896) and to the beginning of intron 9. The exon 9 primers allowed the 
detection of the cytosine at position 9886 of the A allele which causess 
genotypes carrying the A allele to cut with XmnI digestion.  The alignment 
can be found in Appendix E.  
 
4.2.4.2 Exon 9, F allele sequences 
Sequencing of selected FF samples yielded a 100% alignment to Capra 
hircus CSN1S1 gene for alpha s1 casein, allele F (AJ504711.2). The 
alignment was from 9881-10040 of the F variant, which similar to the 
CSN1S1 A-allele covered intron 8 through to intron 9. Importantly this 
sequence detected the 11bp insertion, as well as the deletion of the cytosine 
at position 9886 characterising the F-allele. The sequence alignment can be 
found in Appendix E.  
  
4.2.4.3 Exon 9, E allele sequences 
As outlined in Chapter 2, no sequences have been submitted to BLAST 
characterising the E allele at exon 9. Sequencing results of EE homozygotes 
aligned best to Capra hircus CSN1S1 gene for alpha s1 casein, allele F 
(AJ504711.2). Like CSN1S1 allele  F, the 11bp insertion was present, 
however unlike the F-allele the cytosine at position 9888 was not deleted 
(highlighted in Figure 13 alignment below). The presence of this cytosine 
will cause genotypes carrying the E allele to cut under XmnI digestion.  
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Figure 13: Sequence alignment of EE sample (Query) to F allele (Subject) using BLAST. Note 
the presence of the 11bp insertion typically characterising the F allele (highlighted) as well as the 
cytosine present in the E-allele but absent in the F.  
 
4.2.4.4 Exon 9, N allele sequences 
Only heterozygotes for the N allele were found in the samples genotyped 
and AN heterozygotes only sequenced successfully in the reverse 
direction. The sequence partially aligned with both A and N variants 
(9973-9987 allele A) and (9971-9885 allele N), meaning the correct 
region was amplified. However the second half of the reverse sequence 
returned data which did not match any BLAST sequence (Figure 15). 
This was due to the reverse sequence of the N-allele having the guanidine 
deleted (which would be the cytosine at position 9886 on the forward 
strand), meaning that all of the sequence after the deletion was shifted by 
one nucleotide (Figure 15).  
 
 
Figure 14: BLAST sequence alignment of AN heterozygote 'clean' sequence in the 
reverse direction (Query), aligned to documented allele A sequence (Sbjct). This 
sequence covers intron 10 and half of exon 9.  
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Figure 15: Electropherogram results showing the transition from clean sequence to 
'double peaks' following the deletion of guanidine from the reverse strand). Note 
the sequence is in the reverse direction (left-right intron 10, exon 9, intron 9). Image 
from sequence data analysed in Applied Biosystems sequence scanner software.  
 
 
4.2.4.5 Intron 12 sequences 
PCR of intron 12 did amplify the correct region, as shown through the 100% 
identity with CSN1S1 allele A (AJ504710.2) from position 12253-12448. 
Intron 12 starts at 12193-12835 in the A allele, and the deletion 
characterising the 01 variant begins at 181
st
 nucleotide (12374) of 12
th
 intron 
extending nearly 8.5kb (Cosensa et al., 2003). The sequence data covered 
this region and therefore PCR of intron 12 should detect the deletion. No 
samples were found containing the 01 variant and therefore could not be 
sequenced.  
 
 
 
 
 
Figure 16: BLAST sequence alignment of intron 12 sequence of A genotyped samples (query) 
to the documented CSN1S1-A-allele (subject). The sequenced region covers intron 12 and 
thereby intron 12 primers have amplified the correct region.  
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4.2.4.6 Exon 19, sequences 
The B* allele attained quality sequences which aligned with exon 19 of the 
Capra hircus CSN1S1 gene for alpha s1 casein, allele A (AJ504710.2). At 
exon 19, all non-E variants are the same, hence why B* variants matched 
CSN1S1 A allele sequences on BLAST (no B allele sequences have been 
submitted to this database). Using sequences from forward and reverse 
primers, the sequenced region extended from intron 18 to the very end of 
the CSN1S1 gene (end of exon 19). The sequence alignment can be found in 
Appendix E.  
 
 
Exon 19 of the E-allele proved difficult to sequence due to the presence of 
an AT-rich LINE insertion. Despite cloning EE samples prior to sequencing, 
poor sequence quality remained. Only the forward primer returned useable 
sequences, which were ‘clean’ up until the LINE insertion (Figure 17 and  
Figure 18). The clean region aligned to the documented CSN1S1 E-allele 
exon 19 sequence (AJ504712.2). The position of sequence quality change 
matched where the LINE insertion begins in the documented sequence 
(position 287). A and T signals dominated the region of poor sequence 
quality. For these reason this sequence was deemed sufficient to confirm the 
presence of the CSN1S1 E-allele in such samples.  
 
 
 
Figure 17: Electropherogram of E-allele sequence data. Image from sequence data viewed in 
Applied Biosystems sequence scanner software.  
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Figure 18: Sequence alignment of EE sample sequence (query) to documented exon 
19 E allele (Subject). The LINE insertion part of the sequence shows partial alignment to 
that of the E variant despite low quality sequence data for this region.  
 
 
4.2.4.7 Exon 19 Real-time PCR sequences  
Only short lengths of sequences could be obtained using primers used for 
real-time PCR analysis. Despite this, the correct region was amplified as 
partial alignments were made to exon 19 of the A-allele (AJ504710.2). The 
sequence alignment can be found in Appendix E. 
 
 
4.2.5 ‘Unknown’ CSN1S1 genotype 
Nine ‘unknown’ variants were found at reasonably high frequency on Farm A 
(0.161) and were present in three of the new-season bucks. The unknown 
variants were characterised by three bands following the amplification of exon 
9 (Figure 8). One product appears between 200 and 220bp, while two products 
are produced between 220-240bp (Figure 19). This was observed in both hair 
and milk samples and was not a reflection of DNA quality or purity. Digestion 
of exon 9 products with XmnI produced three bands, one at ~160bp, one 
between 200 and 220bp and another between 220 and 240bp. Direct 
sequencing could not be used as the presence of three products meant no 
quality sequence data could be produced. Samples were also re-collected and 
re-extracted in case it was contamination however none of these methods 
changed the ‘three-product’ outcome.  
 - 54 - 
 
 
Figure 19: Image of 4% agarose gel with 'unknown' genotype products. Lane 1, 20bp 
ladder. Lane 2, negative control. Lane 3, undigested unknown genotype sample. Lane 4, 
XmnI digested unknown genotype sample. Gel was electrophoresed in TAE buffer with 
additional EtBr for 3 hours.  
 
To overcome direct sequencing issues, multiple gel-extraction methods were 
tried to extract individual bands for sequencing. Gel-punching proved the most 
successful, particularly for the bottom and middle undigested fragments.   
 
The bottom band of the undigested sample (lane 3 of Figure 19 above) 
extracted with 32ng/µL of DNA and sequence data showed a 100% alignment 
to Allele N. This product had the cytosine deletion in exon 9, and thus would 
not cut under XmnI (Figure 20). This is evidenced in the gel image which 
shows the bottom band remaining following digestion (lane 4). 
 
 
   1            2           3          4  
200 bp 
160 bp 
240 bp 
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Gel extraction of the undigested middle band produced sufficient DNA 
(18.4ng/µL) and sequence data showed a similar sequence to the exon 9 E 
allele found in this study (no exon 9 E allele sequences have been published to 
BLAST). The sequence aligned to allele F (had the 11bp insertion) but had the 
cytosine insertion which would allow it to cut under XmnI. The middle band 
disappears following digestion as it is cut into 161bp and 63bp fragments (lane 
4). The 63bp fragment is too faint to see in the gel image following three hours 
of electrophoresis, despite the addition of extra EtBr. Identifying this product 
as CSN1S1 allele E is supported exon 19 real-time PCR results which showed 
the presence of the E allele in these unknown samples (Appendix D).  
 
 
Figure 21: Sequence alignment of the middle band extracted from the gel of undigested 
unknown variant amplified at exon 9 (query) to the documented sequence for CSN1S1 
allele F (subject). Note the presence of the cytosine at the 13
th
 nucleotide of the query 
(unknown) sequence which creates the XmnI restriction site and is not present in the CSN1S1 
F-allele.   
 
Figure 20: Sequence alignment of the bottom band extracted from gel of the unknown genotype, 
amplified at exon 9 (query) to the documented exon 9 sequence of the CSN1S1 allele N (sbjct).   
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DNA of sufficient quantity and quality could not be obtained from the top band 
(5.4ng/µL), despite multiple methods (gel-stab, gel capture and gel-punch). 
The top band was very close to the middle band and required at least three 
hours of electrophoresis to separate on a 4% agarose gel. By which time, the 
products had faded significantly and were difficult to sequence. Attempts at 
cloning the top band also failed, presumably due to low DNA concentration 
and / or contamination remaining from 4% agarose gels. A sample of top-band 
sequence data is outlined below (Figure 22). 
 
 
Figure 22: Sequencing of the unknown genotype ‘top band’ extracted from 4% gels 
produced poor quality sequence results. Image from sequence data analysed in Applied 
Biosystems Sequence Scanner software.  
 
Therefore these ‘unknown’ variants do possess CSN1S1 E and N alleles in the 
middle and bottom bands respectively however the top band remains 
unidentified. As a result these samples retain the ‘unknown’ genotype status.  
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4.3 CSN1S1 allele and genotype frequencies 
A total of 126 bucks and does were genotyped at the CSN1S1 locus for A*, B*, E, 
F, N and 01 variants. Allele frequencies showed that CSN1S1 E,F and A* alleles 
were the most common at the CSN1S1 locus in both herds. Only two CSN1S1 N 
alleles were found on Farm A and no 01 variants were found on either farm.  
 
Table 17: Allele frequencies of CSN1S1 between two DGC farms. The 9 unknown 
variants were excluded from allele frequency analysis. A* include G,H,I, and 02 variants. 
B* include B1-B4, B’, C and L.  
Allele 
Farm A Farm B 
No.  Frequency  No.  Frequency  
A* 22 0.229 44 0.310 
B* 5 0.052 4 0.035 
E 37 0.385 44 0.327 
F 30 0.313 48 0.342 
N 2 0.020 0 0.000 
01 0 0.000 0 0.000 
Total  96  140  
 
 
Genotype frequencies showed that EF and AE genotypes were the most frequent 
on both farms, with A*F and FF genotypes more frequent on Farm B than Farm A 
(Table 18). Hardy Weinberg analysis showed that neither population was in Hardy 
Weinberg Equilibrium (HWE), with Farm B trending further away from HWE 
than Farm A (Table 19 and Table 20).  
 
Table 18: Genotype frequencies of CSN1S1 between two DGC farms. A* include G,H,I, 
and 02 variants. B* include B1-B4, B’, C and L.  
Genotype 
Farm A Farm B 
No.  Frequency No.  Frequency 
A*A* 4 0.071 8 0.104 
A*E 10 0.179 18 0.254 
A*F 2 0.036 10 0.149 
A*N 2 0.036 0 0.000 
B*E 3 0.054 1 0.015 
B*F 2 0.036 3 0.045 
EE 5 0.089 5 0.075 
EF 13 0.232 15 0.209 
FF 6 0.107 10 0.149 
Unknown  9 0.161 0 0.000 
Total 56  70  
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Table 19: Hardy Weinberg Analysis, Farm A. P-value is chi-square with 4 degrees of freedom 
(9 genotypes – 5 alleles). P-value is > 0.05 and therefore reject the null hypothesis that the Farm A 
population is in HWE. A* include G,H,I, and 02 variants. B* include B1-B4, B’, C and L. 
Unknown genotypes were excluded from HWE analysis.  
 Observed  HW - Expected  
p-value  no A B E F N % Freq  % Chi-sq. 
A*A* 4 8 0 0 0 0 8.51 2.57  6.45 0.789   
A*E 10 10 0 10 0 0 21.28 8.43  21.09 0.294   
A*F 2 2 0 0 2 0 4.26 1.85  4.63 0.012   
A*N 2 2 0 0 0 2 4.26 0.47  1.17 5.014   
B*E 3 0 3 3 0 0 6.38 2.30  5.75 0.215   
B*F 2 0 3 0 2 0 4.26 1.85  4.63 0.012   
EE 5 0 0 10 0 0 10.64 6.89  17.26 0.520   
EF 13 0 0 13 13 0 27.66 11.11  27.81 0.323   
FF 6 0 0 0 12 0 12.77 4.47  11.20 0.521   
Total 47 22 6 36 29 2 100 39.94  100 7.700 0.1032 
 
 
 
 
Table 20: Hardy Weinberg Analysis, Farm B. P-value is chi-square with 3 degrees of freedom 
(9 genotypes – 5 alleles). P-value is > 0.05 and therefore reject the null hypothesis that the Farm A 
population is in HWE.  A* include G,H,I, and 02 variants. B* include B1-B4, B’, C and L. 
Unknown genotypes were excluded from HWE analysis. 
 Observed  HW - Expected 
p-value 
 no A B E F N % Freq  % Chi-sq. 
A*A* 7 14 0 0 0 0 10.45 6.27  15.70 0.084   
A*E 17 17 0 17 0 0 25.37 12.85  32.17 1.340   
A*F 10 10 0 0 10 0 14.93 14.38  36.00 1.334   
B*E 1 0 1 1 0 0 1.49 1.25  3.14 0.051   
B*F 3 0 3 0 3 0 4.48 1.40  3.51 1.818   
EE 5 0 0 10 0 0 7.46 6.58  16.48 0.380   
EF 14 0 0 14 14 0 20.90 14.73  36.88 0.036   
FF 10 0 0 0 20 0 14.93 8.24  20.64 0.375   
Total 67 41 4 42 47 0 100 65.72  100 5.419 0.1436 
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4.4 CSN1S1 genotype and milk composition 
Only genotyped does aged 2-8 years with milk composition data were used to 
correlate the effect of CSN1S1 on milk parameters. Due to low numbers of some 
genotypes, does were grouped into 5 categories based on the predicted level of 
αs1-casein produced by each genotype (Table 21).  
 
Table 21: Genotype and number of does with composition data in each CSN1S1 genotype 
category.  The placement of genotypes in each category is based on the predicted level of αs1-
casein gene-expression associated with each variant.  
CSN1S1 category CSN1S1 genotypes Farm A Farm B 
Low FF 5 9 
Medium-low EF 13 11 
Medium EE, AF, BF, AN 9 15 
Medium-high AE, BE 12 11 
High AA, BB 3 6 
Total  48 52 
 
 
A significant effect of CSN1S1 genotype was found on one milk parameter on 
Farm A, and three milk parameters on Farm B (Table 22). Age and breed did not 
have any effect on milk composition (p>0.05).  
 
 
Table 22: ANOVA for significant effects for CSN1S1 genotype on milk composition. * 
significant at p < 0.05, ** highly significant at p < 0.01 based on ANOVA analysis.  
Milk composition 
p-value 
Farm A Farm B 
   
Milk Volume 0.279 0.017   * 
Protein (%) 0.048 * 0.001  ** 
Protein (kg) 0.349 0.493 
Fat (%) 0.103 0.003  ** 
Fat (kg) 0.241 0.456 
Milk solids (kg) 0.480 0.447 
SCC (000) 0.508 0.121 
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4.4.1 Milk Volume 
Milk volume was significantly affected by CSN1S1 genotype on Farm B,but 
not Farm A (Table 23). On Farm B goats with low CSN1S1 genotypes 
produced on average 1.6L per day more than those with high genotypes. The 
differences between CSN1S1 genotypes on each farm can be visualised below 
in Figure 23. 
 
Table 23: Average milk volume and standard deviations for both farms across the five 
genotype categories. SD = standard deviation. Genotypes within each category were 
determined by the predicted level of αs1-casein gene-expression associated with each variant. 
P-values were determined by ANOVA analysis.  
Genotype category 
Farm A  Farm B 
Mean (L) SD  Mean (L) SD 
Low 2.08 1.22  4.16 1.22 
Medium-low 1.97 0.83  3.68 0.83 
Medium 2.04 1.03  3.56 1.03 
Medium-high 2.07 0.86  3.11 0.86 
High 1.40 0.47  2.48 0.47 
p-value 0.279   0.017  
 
 
 
 
 
Figure 23: Mean milk volume (L) across the five CSN1S1 genotype categories on 
Farm A (orange) and Farm B (blue). Error bars represent the standard deviation of the 
mean. Significant differences were found on Farm B only (p<0.05).  
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4.4.2 Milk Protein 
Milk protein content (%) was significantly affected by genotype on both farms, 
particularly when comparing high CSN1S1 genotypes with low. High αs1-
casein genotype goats produced around 0.5% more protein on Farm A and 1% 
on Farm B compared to low genotypes (Table 24). This effect was significant 
on both Farm A (p=0.048) and Farm B (p=0.0012).  
 
Table 24: Milk protein % averages and standard deviations for both farms across the 
five genotype categories. SD = standard deviation. Genotypes within each category was 
determined by the predicted level of αs1-casein gene-expression associated with each 
variant. P-values were determined by ANOVA analysis. 
 
 
 
 
Figure 24: Mean protein content (%) across the five CSN1S1 genotype 
categories on Farm A (orange) and Farm B (blue). Error bars represent the 
standard deviation of the mean. Significant differences were found on Farm A 
(p<0.05) and Farm B (p<0.01). 
 
Genotype category 
Farm A  Farm B 
Mean (%) SD  Mean (%) SD 
Low 3.05 0.16  2.98 0.25 
Medium-low 3.30 0.21  3.31 0.58 
Medium 3.31 0.24  3.36 0.51 
Medium-high 3.22 0.23  3.86 0.59 
High 3.57 0.30  4.09 0.13 
p-value 0.048   0.0012  
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Despite a significant difference in protein content between genotypes, no 
differences in protein yield (kg) were observed between CSN1S1 genotype 
categories on either farm (Table 25).  
 
Table 25: Milk protein yield (kg) average and standard deviation for both farms 
across the five genotype categories.  SD = standard deviation. Genotypes within each 
category was determined by the predicted level of αs1-casein gene-expression associated 
with each variant. P-values were determined by ANOVA analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.3 Milk Fat 
Milk fat content was significantly influenced CSN1S1 genotype on Farm B 
only (Table 26). High αs1-casein genotypes had greater fat % than low 
genotype samples on Farm B, however this effect was not observed on Farm 
A. The average kilograms of fat produced however was not significant 
between CSN1S1 genotype categories (Table 27).  
 
Table 26: Milk fat % averages and standard deviations for both farms across the five 
genotype categories. SD = standard deviation. Genotypes within each category was 
determined by the predicted level of αs1-casein gene-expression associated with each 
variant. P-values were determined by ANOVA analysis. 
 
 
Genotype category 
Farm A  Farm B 
Mean (kg) SD  Mean (kg) SD 
Low 0.05 0.01  0.12 0.03 
Medium-low 0.07 0.02  0.12 0.03 
Medium 0.07 0.02  0.11 0.02 
Medium-high 0.07 0.03  0.11 0.03 
High 0.06 0.02  0.09 0.02 
p-value 0.349   0.493  
Genotype category 
Farm A  Farm B 
Mean (%) SD  Mean (%) SD 
Low 3.26 0.14  3.97 0.47 
Medium-low 3.30 0.33  4.02 0.49 
Medium 3.25 0.43  4.33 0.88 
Medium-high 3.34 0.32  4.70 0.93 
High 3.53 0.51  4.94 0.44 
p-value 0.103   0.033  
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Figure 25: Mean fat content (%) across the five CSN1S1 genotype categories on Farm 
A (orange) and Farm B (blue). Error bars represent the standard deviation of the mean.  
 
 
Table 27: Average Milk fat yield (kg) between farms across the five genotype 
categories. SD = standard deviation. Genotypes within each category was determined by 
the predicted level of αs1-casein gene-expression associated with each variant. P-values 
were determined by ANOVA analysis. 
 
 
 
 
 
 
 
   
 
 
4.4.4 Milk Solids 
Milk solids takes into account the protein and fat content (%) and volume 
(milk L) to give an overall yield of fat and protein. Although on average 
high CSN1S1 genotypes produced lower milk solids on Farm B, no 
significant effects of genotype category were found on either farm (p>0.05) 
(Table 28).  
Genotype category 
Farm A  Farm B 
Mean 
(kg) 
SD  Mean 
(kg) 
SD 
Low 0.06 0.01  0.16 0.05 
Medium-low 0.07 0.02  0.15 0.04 
Medium 0.07 0.02  0.15 0.05 
Medium-high 0.07 0.03  0.14 0.04 
High 0.07 0.02  0.12 0.03 
p-value 0.241   0.456  
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Table 28: Average milk solids (kg) between farms across the five genotype categories. 
SD = standard deviation. Genotypes within each category was determined by the predicted 
level of αs1-casein gene-expression associated with each variant. 
 
 
 
 
 
Figure 26: Mean milk solids (kg) across the five CSN1S1 genotype categories on Farm 
A (orange) and Farm B (blue). Error bars represent the standard deviation of the mean.  
 
 
 
 
Genotype category 
Farm A  Farm B 
Mean (kg) SD  Mean (kg) SD 
Low 0.16 0.04  0.28 0.09 
Medium-low 0.20 0.06  0.26 0.06 
Medium 0.14 0.05  0.26 0.07 
Medium-high 0.13 0.06  0.25 0.07 
High 0.10 0.03  0.21 0.05 
p-value 0.480   0.447  
 - 65 - 
 
4.4.5 Somatic Cell Count 
Although on average it appears high casein genotypes produce higher SCCs, 
no significant differences were found on either farm (p>0.05) with regard to 
CSN1S1 genotype and SCC (Table 29). Note the high variability of SCC in 
the standard deviations of each mean.  
 
Table 29: Average somatic cell count (SCC) between farms across the five genotype 
categories. SD = Standard deviation Genotypes within each category was determined by 
the predicted level of αs1-casein gene-expression associated with each variant. P-values 
were determined by ANOVA analysis. 
 
 
 
 
 
 
Figure 27: Mean somatic cell count (000) across the five CSN1S1 genotype categories 
on Farm A (orange) and Farm B (blue). Error bars represent the standard deviation of the 
mean. SCCs are plotted on a log10 scale due to the exponential nature of SCC.  
 
Genotype category 
Farm A  Farm B 
Mean (000) SD  Mean (000) SD 
Low 743.4 771.3  178.1 102.6 
Medium-low 779.3 646.6  322.1 211.6 
Medium 1295.6 1439.2  525.7 866.1 
Medium-high 1038.3 874.8  906.9 1194.8 
High 1385.2 3083.4  1133.8 1152.8 
p-value 0.508   0.121  
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4.4.6 Farm A seasonal correlation 
Given that herd test data was available for each month during mid-late lactation 
for Farm A, the correlation of genotype to milk composition was tried with 
herd test data collected in December and January. This analysis yielded no 
significant effects of CSN1S1 genotype (p<0.05) on any milk composition 
parameter in the later months.  
 
 
Table 30: Farm A p-values for CSN1S1 genotype and milk composition. * = 
statistically significant (p<0.05). P-values were determined by ANOVA analysis. 
Milk composition November December January 
    
Milk Volume 0.280 0.067 0.199 
Protein (%) 0.048 * 0.926 0.893 
Protein (kg) 0.349 0.254 0.630 
Fat (%) 0.103 0.123 0.244 
Fat (kg) 0.241 0.060 0.272 
Milk solids (kg) 0.481 0.082 0.362 
SCC  0.909 0.252 0.387 
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4.4.7 CSN1S1 genotype and fatty acid composition 
With a limited number of genotyped samples tested for fatty acids, medium 
and medium-low CSN1S1 genotypes used for previous analyses were grouped 
into one ‘low’ group, while high and medium-high genotypes were grouped as 
‘high’. The numbers in each category are outlined below in Table 31. 
 
Table 31: Genotype categories and genotypes of samples used for fatty acid analysis 
Genotype category Genotypes No. samples 
   
High AA, AE 5 
Low EF, FF 9 
 
Although on average ‘high’ CSN1S1 genotypes had a greater percentage of all 
saturated fatty acids and LA, significant differences between genotypes could 
only be found in two fatty acids; C10:0 (Capric acid) and C18:3n3 (ALA) 
(Figure 28 and Table 32). C10:0 and ALA levels were both significantly 
(p<0.05) greater in high CSN1S1 samples compared to low CSN1S1 genotypes. 
The difference in C10:0 and C18:3n3 between genotypes however reflected 
only a small percentage of total fatty acids (1.1% and 0.17% respectively). 
 
 
Figure 28: Fatty acid composition of 'High' CSN1S1 and 'Low' CSN1S1 genotypes. 
Significant differences (p<0.05) are indicated with a *. Common names are used for LCFA 
with lengthy symbols. Error bars are the standard deviation of the mean.  
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Table 32: Average fatty acid composition for high and low CSN1S1 samples. p-values 
were determined by ANOVA. * = p <0.05.  NS = not significant.  
Fatty Acid 
High CSN1S1  Low CSN1S1 
p-value Significance 
Mean SD  Mean SD 
        
C4:0 3.18 0.20  3.15 0.29 0.887 NS 
C6:0 2.53 0.33  2.41 0.26 0.452 NS 
C8:0 2.69 0.40  2.41 0.23 0.116 NS 
C10:0 9.24 0.94  8.14 0.70 0.029 * 
C12:0 3.49 0.47  3.04 0.46 0.106 NS 
C14:0 9.88 1.64  9.29 0.83 0.384 NS 
C14:1 0.30 0.04  0.22 0.17 0.322 NS 
C15:0 0.89 0.12  0.83 0.16 0.449 NS 
C15:1 0.14 0.13  0.08 0.12 0.351 NS 
C16:0 25.62 3.34  27.36 3.52 0.385 NS 
C16:1 0.69 0.06  0.75 0.10 0.280 NS 
C17:0 0.61 0.06  0.54 0.11 0.252 NS 
C18:0 11.47 1.79  10.47 1.51 0.286 NS 
TVA 2.38 0.90  2.67 0.56 0.473 NS 
Oleic 21.62 2.91  23.33 1.78 0.195 NS 
CVA 0.48 0.05  0.53 0.09 0.331 NS 
LA 2.02 0.14  1.93 0.24 0.451 NS 
ALA 0.77 0.17  0.60 0.12 0.048 * 
CLA 0.66 0.29  0.87 0.34 0.272 NS 
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4.5 Conclusions 
Analysis of exon 9, intron 12 and exon 19 allowed the genotyping of A (G,H,I,02) 
B(C,L), E, F, N and 01 alleles at the CSN1S1 locus. Sequence results verified the 
correct amplification of each variant. One unique genotype, which remains 
uncharacterised, was found at a reasonably high frequency on one farm. Of the 
126 goats genotyped for the major alleles of the CSN1S1 locus, E and F variants 
were the most common. Neither farm population was in Hardy-Weinberg 
equilibrium. CSN1S1 yielded a significant difference on protein content on both 
farms, while milk volume and fat percent were only significant on Farm B. 
Although on average there were trends with fat, protein and milk solid yields, 
statistically these were indifferent between genotypes. CSN1S1 had a significant 
effect on two fatty acids, C10:0 and C18:3n3, although the relative changes were 
small.  
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5 Chapter 5: Genetics Discussion 
Genetic factors play a pivotal role in milk composition, and the goat species is 
renowned for wide variations in milk trait production. The CSN1S1 locus was 
chosen for analysis in the New Zealand (NZ) population due to reported effects of 
CSN1S1 alleles on milk composition. Of particular interest was role of CSN1S1 in 
the production of fat, protein and fatty acid compositions which are highly 
important for infant formula and specialty nutritionals. This research has shown 
that NZ dairy goats are polymorphic at the CSN1S1 locus and that the CSN1S1 
genotype can impact milk composition. The following chapter evaluates the 
methods used for genotyping at this locus and discusses genotype frequency and 
milk composition findings. In doing so, this research outlines the first genetic 
evaluation of the CSN1S1 locus in NZ dairy goats.  
 
 
5.1 Evaluation of methods for CSN1S1 genotyping  
Goat genomic DNA is often extracted from blood samples, however this 
research showed DNA can be successfully extracted from milk and hair to allow 
the genotyping of 126 bucks and does.  DNA extraction proved more successful 
from milk (87%) than hair (63%), most likely due to differences in extraction 
methods and the number of nucleated cells present in each sample. Compared to 
other goat milk extraction methods, such as d’Angelo (2007) and Tokarska 
(2001b), the phenol-chloroform method used in this study produced better 
results for CSN1S1 genotyping purposes.   
 
No single method has been described for the simultaneous identification of all 
18 known CSN1S1 alleles. Alleles A, B1, B2, B3, B4, B’, C, H, L and M are 
high expressing or ‘strong’ alleles which produce around 3.5g/L of αs1-casein 
per allele (Bevilacqua et al., 2002, Brignon et al., 1990a, Chianese et al., 1997, 
Martin et al., 1999a). Intermediate alleles (E and I) produce 1.1g/L of αs1-casein 
each while low expressing ‘weak’ alleles (F, D and G) produce just 0.45g/L 
(Martin et al., 1999b). There are also three null alleles which produce no αs1-
casein, 01, 02 and N (Cosenza et al., 2003, Ramunno et al., 2005).  
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Six CSN1S1 alleles (A*, B*, E, F, N and 01) were chosen for genotyping based 
on their expected frequency in the NZ population and their proposed effect on 
milk production.  F and N alleles could be determined solely through the 
amplification and digestion of exon 9. A* and 01 required exon 9 and intron 12 
analyses while B* and E required exon 9 and real-time PCR of exon 19. A* 
included G, H, I and 02 while B* included all B-subtypes, C and L as these 
could not be differentiated using SNPs in exon 9, intron 12 and exon 19. 
Grouping such alleles was not considered to have a detrimental effect on 
analyses as these variants either produce a similar amount of casein or have been 
found in very low frequencies by other authors.   
 
The success of genotyping using PCR-RFLP of exon 9 highlights the 
effectiveness of this method for the initial screening of CSN1S1 variants. This is 
most likely why the majority of CSN1S1 genotyping studies today employ this 
method (Caravaca et al., 2008, Cosenza et al., 2008, Gigli et al., 2008, Maga et 
al., 2009, Soares et al., 2009, Torres-Vázquez et al., 2008, Vacca et al., 2009).  
However few use real-time PCR for identifying E alleles at exon 19, despite its 
effectiveness found in this study and reported by Feligini et al., (2005). This is 
surprising given the more accurate genotyping of the E variant, improved 
efficiency and avoidance of gels found in this research by using real-time PCR.  
 
Sequencing proved necessary to verify PCR reactions amplified the correct 
regions of interest. Importantly it identified the cytosine in exon 9 required for 
restriction digests with XmnI. Sequencing also clarified PCR uncertainties, 
especially for AN heterozygotes and samples carrying the CSN1S1 E allele.  
 
However sequence data did not always align to sequences documented in 
BLAST. This highlights the lack of complete sequences of CSN1S1 in public 
databases and that new variants may not yet be characterised.  The exon 9 
sequence of the E allele was determined in this study, which was previously 
unknown. This sequence data confirmed the presence of an 11bp insertion which 
explains why PCR-RFLP products of exon 9 E alleles are 161bp, not 150bp like 
the A allele. The sequence of this 11bp insertion is identical to the one 
characterising the F-allele which is thought to have arisen from a homologous 
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sequence duplication in the F allele (Leroux et al., 1992). Given E and F alleles 
both arise from the B2 lineage (Grosclaude et al., 1997), the presence of this 
11bp insertion could represent a commonality in the evolution of these two 
variants which differentiate them from other B2-lineage variants that do not have 
this insertion. Further sequencing of the entire CSN1S1 E allele would verify this 
suggested phylogeny.  
 
5.2 The ‘unknown’ genotype 
A relatively high frequency of bucks and does from Farm A were found with 
‘unknown’ genotypes. Amplification of exon 9 produced three bands over 200bp 
that could not be attributed to contamination as samples were re-collected and 
DNA re-isolated with the same result. Sequencing and real-time PCR revealed 
CSN1S1 N and E alleles are present in these samples. The top band (>220bp) 
however could not be identified despite multiple methods. Failure to identify this 
band could be due to low DNA concentration, DNA purity or the presence 
contaminants remaining from gel-extraction. Alternatively the top band could be 
a new variant that is difficult to sequence due to a LINE insertion similar to exon 
19. However this theory does not explain why three variants (E, N and ‘new’) 
would occur in one sample.  
 
Interestingly Tokarska et al., (2001a) found two goats in Poland with the 
presence of three alleles (‘High’, F and E) in cDNA sequencing results. They 
could not explain the presence of these ‘three transcript variants’ which were not 
alternatively spliced F-transcripts and remained even after re-collection and re-
isolation of the samples.  
 
Overall, the presence of three products in the current study is unusual and the 
cause unknown. This suggests some anomalies still exist with methods for 
identifying CSN1S1 variants and there is the potential for new variants to be 
found. Importantly however, goats carrying unknown genotypes showed no 
detrimental effects on milk composition, producing average milk protein, fat and 
yield. As such, their characterisation may only be of interest from a genetic and 
evolutionary point of view. 
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5.3 CSN1S1 allele and genotype frequencies  
Genotyping of two representative dairy goat farms show that CSN1S1 genotype 
EF was the most prevalent in the NZ dairy goat population (0.23 and 0.17 for 
Farm A and 0.21 and 0.25 for Farm B respectively). This most likely represents 
the dominance of the Saanen breed in DGC herds which show EF genotypes in 
other populations at a similar frequency (Clark and Sherbon, 2000, Grosclaude 
et al., 1987, Maga et al., 2009, Martin and Leroux, 2000, Ouafi et al., 2002, 
Soares et al., 2009, Torres-Vázquez et al., 2008). Slight differences were found 
between farms; in particular Farm B had a greater frequency of AE genotypes 
(0.254) while Farm had a higher frequency of unknown (0.16) and AN (0.036) 
genotypes. This could be attributed to different founder populations and 
subsequent breeding strategies on each farm. For example Farm A typically 
keeps kids based on birth order and the mother’s general health status while 
Farm B selects on milk production using extensive herd-testing records. With 
virtually no interbreeding with other populations, use of foreign bucks or AI, 
alleles become fixed within each herd. This is reflected in the HWE results in 
which both farms rejected HWE, especially Farm B.   
 
 
5.4 Effect of genotype on milk composition  
CSN1S1 genotype had a significant influence on milk composition, however the 
effect was not observed equally on each farm. One reason for this effect is that 
although the pasture and grain diets were similar, Farm B was an indoor system, 
whereas Farm A was outdoor. Outdoor diets are likely to be more heterogeneous 
as the goats can select and browse pasture, a factor which reportedly influences 
milk composition (Bonanno et al., 2008). Pasture for indoor diets is mown and 
carried to the goats and therefore is more homogenous. In this respect, individual 
animals were more consistent with dietary factors on the indoor farm and 
perhaps why more of an effect was observed on Farm B. Another alternative is 
that although both farms were feeding the same diet, Farm B produced more 
milk volume (on average 1-2L more per doe) than Farm A, suggesting the 
energy status of does on Farm B was greater. This aspect is discussed further in 
Chapter 9 regarding nutritional and genetic factors combined.  
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Another cause of different effects of CSN1S1 genotype between farms is that 
herd-test dates were 21 days apart. Therefore the herds may have been at a 
different stage of lactation. α and β caseins have been shown to decrease with 
lactation progression (Brown et al., 1995) and αs1-casein mRNA is known to be 
seasonally expressed (Tokarska et al., 2001b, Szumska et al., 2001). Pierre et al., 
(1998) found a maximum difference between A and 01 variants in fat content 
early in lactation which slowly decreased to similar levels in late lactation. 
Therefore the difference in herd-test date may have been significant enough to 
affect the influence of CSN1S1 genotype on milk composition. Certainly the 
monthly herd-test data results from Farm A highlight this with only the first 
month (mid-lactation) producing a statistically significant results. To confirm 
whether this is the cause an investigation into the seasonal expression of αs1-
casein mRNA or the alignment of CSN1S1 genotypes to more regular herd-test 
data would be required.   
 
Lastly, the difference could simply be due to the number of genotypes at the 
extremes of predicted-casein. Farm A had approximately half the number of 
‘high’ and ‘low’ αs1-casein genotypes as Farm B. Therefore, statistically this 
may not have been enough to determine an effect of genotype on milk 
parameters other than strongly implicated effects.  
 
 
5.4.1 Protein 
In line with other studies on CSN1S1 genotype and milk composition, CSN1S1 
has a strong effect (p<0.01 Farm B, <0.05 Farm A) on milk protein content. 
The protein percentage in goat milk supplied to DGC typically only varies by 
~2%. Therefore the ~1% difference between high and low genotypes could 
account for half approximately half of the variation in milk protein. Given that 
αs1-casein represents a small fraction of total protein in goat milk, around 8% 
(Park et al., 2007b), CSN1S1 must have wider effects on protein content than 
just the production of αs1-casein. 
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Electron microscopy, cell culture and protein labelling experiments in goat 
mammary epithelial cells (MECs) suggest αs1-casein is required for the 
optimal transport of all other caseins by promoting their transport to the Golgi 
apparatus (Chanat et al., 1999, Neveu et al., 2002). More recently knock-out 
trials in mice Kolb et al., (2011) have confirmed this observation and the 
chaperone mechanisms of both αs1- and αs2-caseins have been characterised in 
bovine milk (Treweek et al., 2011). Therefore the significantly higher protein 
content of high CSN1S1 genotypes could be due to an improved efficiency of 
total protein secretion as a result of higher αs1-casein present in MECs of high 
genotype goats.  
 
5.4.2 Milk Fat  
The significantly greater fat content produced by high CSN1S1 genotypes  has 
been reported as a surprising result by many authors (Barbieri et al., 1995, 
Barlowska et al., 2007, Grosclaude et al., 1994, Manfredi et al., 1993, Vassal et 
al., 1994, Zullo et al., 2005). This current research found a significant effect on 
fat, although only on one farm. The reasons for the association between fat % 
and high CSN1S1 genotypes are still not known but could include differences 
in secretory mechanisms as outlined for protein, linkage between fat and 
protein genes or differences in milk lipase activity.  
 
Investigations into milk fat gene expression profiles of high and low CSN1S1 
goats have produced mixed results. Leroux et al., (2003) found no association 
between genotype and the expression of genes encoding key lipogenic enzymes 
(ACC, FAS, LPL and SCD). However Ollier et al., (2008) found 41 
differentially expressed genes from high and low CSN1S1 goats using a bovine 
oligonucleotide microarray. In particular, they showed a down-regulation of 
FAS and G3P are in agreement with the low fat content associated with low 
CSN1S1 does. Thus although the mechanism is not fully understood, it appears 
that CSN1S1 genotype could be associated with the expression of some genes 
involved in fat synthesis.  
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5.4.3 Milk Volume 
CSN1S1 genotype had a significant effect on milk volume on one farm only. 
The reduced volume associated with high CSN1S1 genotypes on Farm B meant 
that the increase in fat and protein content did not translate into any greater 
yield of fat, protein or total milk solids from these genotypes. Grosclaude 
(1994) also found an effect of CSN1S1 genotype on fat percentage but not fat 
yield suggesting CSN1S1 is less influential on milk volume than other milk 
parameters. Similar to Chilliard et al (2006), Farm A showed no effect of 
CSN1S1 genotype on milk volume.  
 
However like the results found in this study on Farm B, Barbieri et al., (1995) 
found AA goats produced less milk yield than low genotypes. Thus the 
CSN1S1 genotype can have an effect on milk volume in certain circumstances, 
which based on these results may be due to differences between farms such as 
stage of lactation or energy balance of the animal.  
 
5.4.4 Somatic Cell Count  
A large number of factors influence SCC in ruminants, many of which are non-
pathological. For these reasons, the significant individual variation and lack of 
effect of CSN1S1 genotype on SCC found in the current study is not surprising. 
However a genetic basis for SCC has been found by others. A highly negative 
effect (p<0.001) of αs1-casein on SCC has been observed with  polymorphisms 
of the αs1-casein 5′flanking region (CSN1S1-5’) in German Holstein cows 
(Prinzenberg et al., 2005). Interestingly this polymorphism was also associated 
with QTL for udder shape, suggesting an association between casein and udder 
morphology genes, and providing a possible mechanism for its effect on SCC. 
CSN1S1 may also influence SCC through its association with the gene 
encoding β-casein (CSN2). These two casein genes are known to be tightly 
linked (discussed later in section 5.4.6) and in dairy cows CSN2 genotypes 
have a significant effect on SCC (Morris et al., 2005).  Thus the casein cluster 
haplotype, particularly with CSN1S1 and CSN2 genotypes or the association of 
CSN1S1 with other traits may generate more significant effects on SCC than 
CSN1S1 alone.   
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5.4.5 Fatty acid composition  
A number of investigations have noticed more ‘goaty’ flavours in milk from 
‘high’ CSN1S1 genotypes versus milk from low genotypes (Grosclaude et al., 
1994, Martin and Leroux, 2000, Vassal et al., 1994) suggesting an impact on 
fatty acid composition. In this research a significant (p<0.05) effect of high 
(AA, AE) versus low (EE, FF) CSN1S1 genotypes was found on two fatty 
acids, capric acid (C10:0) and ALA (C18:3n3). However only 14 genotyped 
goats had fatty acid data and therefore it was difficult to elucidate a trend. On 
the other hand Chilliard et al., (2006), using 71 does found significant 
differences in at least 17 fatty acids, including C10:0.  In both studies C10:0 
was significantly reduced in ‘low’ genotype goats. It could be that low CSN1S1 
genotypes are linked with lower activities of genes encoding, FAS and ACC 
activity, reducing the de novo synthesis of C10:0. However as outlined in 
section 5.4.2 the effect of CSN1S1 on genes involved in fat and fatty acid 
synthesis remains undetermined. Therefore why C10:0 is reduced in low 
genotypes is not yet known.  
 
The effect on ALA is not in agreement with Chilliard et al., (2006) who found 
no significant difference between high (AA) and low (FF) CSN1S1 genotypes. 
This could be explained by nutritional differences, whereby these authors used 
goats fed concentrates, versus this study in which goats were raised 
predominantly on pasture which is high in ALA. Interestingly CSN1S1 
genotype has been shown to influence diet selection in a free choice trial in 
dairy goats (Avondo et al., 2009). Therefore, in an outdoor system, high and 
low CSN1S1 genotype goats could select pasture differently, thereby 
influencing ALA concentrations in the milk.  However this speculation needs 
to be substantiated with further research. Moreover the changes to C10:0 and 
ALA were small as a proportion of total fatty acids and therefore the overall 
effect of CSN1S1 genotype on fatty acid composition was small. Thus more 
genotyped goats need to be analysed for fatty acid composition to more fully 
understand the effect of CSN1S1 on fatty acid composition.  
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5.4.6 Other considerations  
While conducting this research it was noted that some AF genotype does 
produced milk with high fat and protein content, while others produced low fat 
and protein content. It is possible that this could be attributed to alternatively 
spliced transcripts derived from exon skipping. Exon skipping is not rare in the 
caseins, with events characterised in ovine (Passey et al., 1996, Giambra et al., 
2010, Boisnard et al., 1991), equine (Lenasi et al., 2003, Mateos et al., 2009) 
bovine (Mohr et al., 1994, Bouniol et al., 1993, Mahe et al., 1999) and human 
caseins (Johnsen et al., 1995, Martin and Leroux, 1992, Menon et al., 1992). 
Leroux et al., (1992) found 9 different transcripts of the CSN1S1 F allele, most 
of which were ‘aberrantly spliced’ and lacked three exons, however the 
properly spliced messengers were also produced. These were attributed to 
various SNPs and insertions occurring in the introns downstream of exon 9, 
reducing the efficiency and accuracy of splicing machinery. It is therefore 
possible that at the time of herd-testing, some AF individuals produced more of 
the correctly transcribed CSN1S1 allele F mRNA, while others produced more 
short-form, exon-deprived transcripts. This could have resulted in high and low 
total protein respectively of AF variants.  
 
Another factor to consider is that CSN1S1 is not the only polymorphic casein 
gene and that whole casein haplotypes exist.  At present there are 5 β-casein 
(CSN2), 16 κ-casein (CSN3) and 5 αs2-casein (CSN1S2) variants identified to 
date, in addition to the 18 CSN1S1 alleles. Studies at the casein haplotype level 
have been conducted in Italian (Albenzio et al., 2009, Caroli et al., 2006, Gigli 
et al., 2008, Sacchi et al., 2005), Norwegian (Hayes et al., 2006) and African 
(Caroli et al., 2007, Vacca et al., 2009) dairy goat populations. These all 
suggest strong linkage disequilibrium between the casein genes, in particular 
between SNPs in CSN1S1 and CSN2 and SNPs in CSN1S2 and CSN3 (Hayes et 
al., 2006). Such haplotypes have been shown to have a significant effect on 
milk protein and fat content (Albenzio et al., 2009, Hayes et al., 2006).  One 
hypothesis is that when expression of one casein gene is down-regulated, the 
others can be up-regulated to compensate (Leroux et al., 2003). Thus the lack 
of correlation of CSN1S1 genotype to some aspects of milk production may be 
explained by the unknown genotypes of other casein variants and highlights the 
value of whole haplotype analysis rather than each gene in isolation.   
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5.5 Implications for the dairy goat industry  
As a result of this initial evaluation of CSN1S1 in the NZ dairy goat population, 
there are two key impacts for the NZ dairy goat industry. Firstly, CSN1S1 showed 
no significant effect on milk solids which translates into no economic gain for 
farmers based on the current pay-out scheme. Recent moves within the industry 
were to adjust the pay-out structure and reward for additional protein content. 
Similar schemes exist in Norway where farmers are paid for kilograms of milk, 
with a bonus for dry-matter content (Hayes et al., 2006). Encouraging a similar 
pay-out here could be worthwhile given the economic efficiency of producing, 
transporting and processing large volumes when nearly all goat milk is spray-
dried into powders. Therefore rewarding farmers for fat and protein content may 
make more sense from an efficiency perspective. In this instance, selecting for 
high CSN1S1 variants would be beneficial by significantly improving protein and 
fat percentages.  
 
However care must be taken when selecting based on a single trait due to the 
polygenic nature of milk production and possible implications on other functional 
traits. For example Barillet et al., (2007) modelled a system where selection was 
on milk traits only and found that in the long term such selection will lead to 
baggy udders that would be more difficult to milk by machine and more 
susceptible to mastitis. Therefore care must be taken if recommending a selection 
scheme, particularly when we do not fully understand the genetic structure of 
other linked casein genes and functional traits such as udder morphology and 
disease susceptibility in the NZ population.  
 
Lastly, if DGC were to encourage selection based on CSN1S1 for high protein and 
high fat percent, consideration must be given to the impact on milk allergenicity. 
Selecting for low or null αs1-casein genotypes has been shown to significantly 
reduce the allergenic burden (Ballabio et al., 2011, Park, 1994). Both αs1- and 
αs2-casein have been implicated in producing the allergenic response (Marletta et 
al., 2004, Bidat, 2010, Restani et al., 2009) and therefore a more effective strategy 
would be to select on the basis of a haplotypes that carry low CSN1S1 and 
CSN1S2 alleles. However, because low CSN1S1 genotypes decrease fat and 
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protein content in some situations, the production of low allergenicity milk would 
be best as a ‘niche’ production system, separate from the mainstream spray-dry 
powder business unit.  
 
5.6 Areas for future research  
Firstly better characterisation of the ‘unknown’ genotype would be of value for (a) 
improving methods used to genotype at the CSN1S1 locus and (b) to better 
understand polymorphisms of the CSN1S1 gene.  Improving sequence data would 
be the best strategy for achieving this characterisation. 
 
There is the potential to improve milk composition using genetic factors such as 
CSN1S1. Although this is one gene, it has clearly demonstrated a significant effect 
in some circumstances in a NZ dairy farming system. Further clarifying the 
situations which allow CSN1S1 to influence milk production could be useful. 
Based on the results of this study, diet and stage of lactation would be two worthy 
candidates.   
 
Additional research would also prove valuable with regard to the genetics of fatty 
acid composition and SCC in milk. Both are of great significance to the human 
health aspect of goat milk and understanding their genetic basis would add value 
to a proposed selection scheme. Similarly a better understanding on whole casein 
haplotypes and milk composition could improve milk quality. In particular, the 
polymorphism in β-casein would be of value given its contribution to total milk 
protein, as well as CSN1S2 for its effects on milk allergenicity.  
 
Overall, a stronger focus on dairy goat genetics would extend the findings from 
this initial study, and allow better breeding practices for the production of goat 
milk in NZ.  
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6 Chapter 6: Nutrition Methods 
The nutritional component of this study sought to determine the effect of key 
dietary supplements on milk composition. To achieve this, three feed trials were 
conducted. Feed Trial 1 compared fatty acid composition between farms under 
palm kernel extract (PKE) and biscuit waste (BW) feeding regimes. Feed Trial 2 
investigated milk composition of those same farms in the next season following 
the removal of PKE and BW supplements. Feed Trial 3 investigated the effect of 
yeast-supplementation on fatty acid profiles, milk volume, protein, fat, solids and 
somatic cell count from control and yeast-treated goats. The methods used to 
carry out these three feed trials are outlined below.  
 
6.1 General methods 
This section outlines the general methods employed for farm selection, milk 
composition analysis and data analysis.  
 
6.1.1 Farm selection 
A detailed record of every Dairy Goat Co-operative (DGC) farm is conducted 
annually by the DGC veterinarian. These cover all aspects of farm practice 
including animal feeding, animal health, farm management, breeding and 
housing. From these records, DGC farms were chosen for feed trial analyses. 
Key factors in farm selection were: 
 
 The type of primary feed supplement in addition to pasture / forage 
 Location of the farm (North Island, New Zealand).   
 Type of farm (indoor, outdoor or indoor plus loafing barn)  
 Similarity of other factors such as minor feed supplements, pasture 
composition or mineral supplementation.  
 No recent major animal health issues  
 No major changes in farm management, nutrition, herd size or breeding 
planned between 2009 and 2011.  
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6.1.2 Sample collection – fatty acid samples 
Milk samples for Feed Trial 1 were collected December-January 2009-2010 
while Feed Trial 2 samples were collected through the same period in 2010-
2011. These periods were chosen as they are mid-lactation and typically the 
most stable between farms in terms of milk composition. For both of these 
trials a total of four vat samples were taken from each farm; two in December 
and two in January. Milk was taken from the vat following the evening milking. 
Vat samples were collected and stored in a 50mL tube (Sterlin) and labelled 
with the farm identification number and date. Samples for Feed Trial 3 were 
collected in December. One milk sample was collected from each control or 
yeast-treated goat by hand-milking into a 50mL tube, as per genetic sample 
collection described in Chapter 3. All samples were stored at -20°C until they 
could be sent to AgResearch for fatty acid profile analysis using GC-MS.  
 
 
6.1.3 Sample collection – herd test samples 
Herd testing was used to measure animal performance and milk composition of 
individual goats in Feed Trial 3. Farm A’s herd tests were conducted once each 
month from November 2010-March 2011. Farm B had one herd test in October. 
All herd test sampling and analysis were conducted as per LIC herd-testing 
protocols outlined in Chapter 3.   
 
 
6.1.4 Data Analysis 
All milk composition data from AgResearch and LIC was directly imported 
into Microsoft Excel and analysed using STATISTICA software. Significant 
differences were calculated using one-way ANOVA. ANOVA determined 
whether the differences between groups (farms in Feed Trial 1, seasons in Feed 
Trial 2 and treatment in Feed Trial 3) were more significant than the internal 
variation within each group. A p-value of less than 0.05 was considered 
significant. Graphs were plotted in Microsoft Excel using means and standard 
deviation as the estimate of error.    
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6.2 Feed Trial 1: PKE, Biscuit Waste and Control Farms 
Suitable farms based on the criteria outlined in section 6.1.1 were categorised by 
whether they were supplementing with PKE, BW or a control diet of forage and 
grain. For all farms pasture remained the main diet. Farms that were selected and 
used in Feed Trial 1 are outlined below in Table 33. Herd sizes ranged from 270 
to 1,300 does, with the average farm having 640 milking does. The total number 
of does from all 15 farms used in Feed Trial 1 was 9,602. 
 
Table 33: Farms used in Feed Trial 1, selected based on the predominant feed supplement 
in 2009-2010. Each farm is given an identification (ID) letter and the number of farms in each 
category is outlined.  
Feed Supplement Farm ID no.  farms 
Control E,F,G,H,J,K,M 7 
Biscuit Meal A, B, D 3 
PKE C,I,L,N,O 5 
Total   15 
 
 
All farms were managed as per normal commercial dairy goat farming 
operations. All supplements were sourced from NZ suppliers and the provision 
of PKE and BW supplements were as recommended by feed suppliers and the 
DGC veterinarian. Typically PKE was supplemented at 0.3kg/doe/day and BW 
at 0.2kg/doe/day which was fed to the goats in the shed during milking. 
Compositions of the two supplements are outlined below in Table 34.  
  
 
Table 34: Typical compositions of PKE and BW commercial animal feed supplements. n/a 
no data available. NDF = Neutral Detergent Fibre. ADF = Acid Detergent Fibre. Data sourced 
from RD1 (2011) and SourceNZ (2011). 
Composition PKE BW 
Energy (MJ/kg) 11.5 14.1 
Crude Protein % 17 10.7 
Dry matter % 92 92 
NDF % 67 n/a 
ADF % 42 n/a 
Fat % 8 6.1 
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6.3 Feed Trial 2: Removal of PKE and BW Supplements 
Feed Trial 2 investigated fatty acid composition in the same period as Feed Trial 
1 (December and January) but in the next season (2010-2011). In the 2010-2011 
season PKE and BW farms from Feed Trial 1 were no longer feeding the 
supplements.  The effect of these supplements was determined by comparing 
fatty acid composition in 2009-2010 season with 2010-2011 data. The 
differences between seasons was analysed relative to seasonal changes in control 
farms which did not change diets. All farms were checked using updated farm 
record data to ensure they still met the initial farm selection criteria.  
 
6.4 Feed Trial 3: Yeast Supplement versus Control 
One Waikato outdoor farm was used for the investigation of yeast 
supplementation on milk composition. 20 randomly selected does were fed a 
yeast supplement mixed with a concentrate (Yeast Group) with another 20 
randomly selected goats fed concentrate (Control Group). This was in addition to 
normal outdoor feeding conditions applied to both groups. The yeast was an 
active dry yeast (Saccharomyces cerevisiae) supplied by Coultar Grain. The 
concentrate was a cereal mix of maize (74%), peas (17%), soybean oil (3.8%) 
and molasses (2.8%) supplied by The Straw Warehouse (Cambridge, New 
Zealand). The nutritional characteristics of concentrate blended with yeast is 
outlined in Table 35 and quantity fed to each treatment group in Table 36. 
 
 
Table 35: Nutritional characteristics of active dry yeast + concentrate supplement. 
The yeast had a minimum of 15 billion cells / gram. DM = Dry matter. NDF = Neutral 
detergent fibre. ADF= Acid detergent fibre.  
 
 
 
 
 
 
 
 
 
Nutrient Unit Quantity 
ME MJ/kg 12.7 
Protein % DM 9.9 
Oil % DM 6.9 
Fibre % DM 2.4 
NDF % DM 9.2 
ADF % DM 3.0 
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Table 36: Quantities of each supplement fed to Control and Yeast treated goats.  
Group Treatment 
Control 1kg concentrate / doe 
Yeast 1kg concentrate  + 20g yeast / doe 
 
All yeast and control treatment goats were the same breed, multiparous, of good 
health and similar in age (2-5 years). Yeast and control goats were fed the 
supplement after morning milking once a day for four months. Supplementation 
began in November 2010 and remained until February. The whole herd (n=320) 
went onto the yeast treatment from February to the end of lactation in March.  
 
The effect of yeast supplementation with the whole herd in March 2011 was 
unable to be compared to March 2010 when no yeast was supplemented as the 
herd milked for three weeks longer in 2011. This meant the herd was at a 
different stage of lactation in March of each year and thus milk composition data 
was incomparable.  
 - 86 - 
 
 
7 Chapter 7: Nutrition Results 
This chapter outlines results from the three feed trials investigating palm kernel 
extract (PKE), biscuit waste (BW) and yeast supplementation.  
 
7.1 Feed Trial 1 – PKE, BW and Control Farms 
Significant differences between PKE, BW and Control farms were found in 14 
fatty acids. Most of these differences were highly significant, with p-values less 
than 0.01 (Table 37). Although significant, some differences were only small in 
terms of proportion of fatty acids.  
 
Table 37: Differences in fatty acid composition between farms based on supplementation 
category in the 2009-2010 season. p-values were determined by ANOVA analysis using 
STATISTICA. Significant results were denoted by a * (p<0.05), ** (p<0.01) or NS for non-
significant data (p>0.05). 
Fatty Acid 
Control  PKE  BW 
p-value Significance 
Mean SD  Mean SD  Mean SD 
C4:0 3.29 0.02  3.28 0.05  3.25 0.02 0.70 NS 
C6:0 2.88 0.03  2.74 0.04  2.91 0.05 <0.01 ** 
C8:0 2.85 0.04  2.58 0.05  2.92 0.08 <0.01 ** 
C10:0 8.98 0.14  8.03 0.17  9.12 0.25 <0.01 ** 
C12:0 4.50 0.24  7.52 0.61  4.03 0.14 <0.01 ** 
C14:0 10.32 0.14  11.87 0.44  9.32 0.25 <0.01 ** 
C14:1 0.36 0.02  0.36 0.02  0.28 0.03 0.050 Borderline 
C15:0 1.06 0.03  0.97 0.02  0.79 0.02 <0.01 ** 
C15:1 0.26 0.01  0.19 0.00  0.24 0.02 <0.01 ** 
C16:0 25.98 0.13  24.76 0.37  28.96 0.98 <0.01 ** 
C16:1 0.61 0.01  0.72 0.03  0.76 0.04 <0.01 ** 
C17:0 0.60 0.02  0.50 0.02  0.47 0.02 <0.01 ** 
C18:0 9.13 0.12  8.43 0.49  8.20 0.19 0.08 NS 
TVA 0.33 0.05  0.43 0.05  0.75 0.11 <0.01 ** 
C18:1 cis9 20.07 0.27  19.68 0.50  20.29 0.29 0.56 NS 
CVA 0.74 0.01  0.92 0.04  0.82 0.04 <0.01 ** 
LA 2.21 0.09  1.49 0.18  2.03 0.06 <0.01 ** 
CLA 0.83 0.03  0.83 0.04  0.74 0.05 <0.01 ** 
ALA 0.99 0.04  0.74 0.06  0.69 0.06 0.25 NS 
 
 
PKE had a significant effect (p<0.01) on MCFAs C12:0 and C14:0, with a 
higher percentage of these fatty acids relative to control farms (Figure 33 and 
Figure 34). BW farms produced milk with significantly more C16:0 (Figure 31) 
and trans-vaccenic acid (TVA) (Figure 32).   
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Figure 29: PKE farms had significantly higher C12:0 % (p<0.01) compared to Control and 
BW farms. Error bars denote the standard deviation.  
 
 
Figure 30: PKE farms had significantly higher C14:0 % (p<0.01) compared to Control and 
BW farms. Error bars denote the standard deviation. 
 
 
Figure 31: BW farms had significantly (p<0.01) higher C16:0 % compared to Control and 
PKE farms. Error bars denote the standard deviation. 
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Figure 32: BW-supplemented farms had significantly more TVA % in milk compared to 
control and PKE farms (p<0.01). Error bars denote the standard deviation.  
 
Butyric (C4:0), stearic (C18:0), oleic (C18:1 cis9) and ALA (C18:3n3) showed 
no significant difference between farm supplementation categories. Myristoleic 
acid (C14:1) showed borderline effects (p=0.05).  
  
Therefore most farms showed a statistically significant difference from each 
other based on their respective feeding regimes. The most notable effects were 
on MCFAs for PKE and C16:0 / TVA for BW supplementing farms.  
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7.2 Feed Trial 2: Removal of PKE and BW nutritional factors 
Most fatty acids exhibited significant seasonal variation, as shown by significant 
p-values generated from differences between 2009-2010 and 2010-2011 seasons 
on control farms (Table 38). Therefore, to factor in seasonal variations in fatty 
acid composition, significant effects of PKE and BW removal were determined 
relative to control-farm changes. 
 
The most notable effect was the removal of PKE on C12:0, C14:0. The 
percentages of C12:0 (Figure 33) and C14:0 (Figure 34) were reduced to control 
farm levels following the removal of PKE relative to control farms.  
 
Table 38: Fatty acid composition between 2009-2010 and 2010-2011 seasons for control, PKE and BW 
farms.  2010-2011 season no PKE or BW was supplemented on ‘PKE’ and ‘BW’ farms. P-value highly 
significant at ** <0.01, * p=<0.05 or NS (not significant, p>0.05).  
 
Fatty 
Acid 
Control Farms PKE Farms BW Farms 
2009-2010 2010-2011 p-
value 
 
2009-2010 
(PKE) 
2010-2011 
(no PKE) 
p-
value 
2009-2010 
(BW) 
2010-2011 
(no BW) 
p-
value 
 Mean SD Mean SD Mean SD Mean SD 
 
Mean SD Mean SD 
C4:0 3.29 0.02 2.78 0.04 ** 3.28 0.05 2.78 0.03 ** 3.25 0.02 2.75 0.03 ** 
C6:0 2.88 0.03 2.29 0.03 ** 2.74 0.04 2.40 0.04 ** 2.91 0.05 2.39 0.03 ** 
C8:0 2.85 0.04 2.36 0.05 ** 2.58 0.05 2.56 0.06 NS 2.92 0.08 2.59 0.06 ** 
C10:0 8.98 0.14 8.45 0.23 NS 8.03 0.17 8.91 0.29 ** 9.12 0.25 9.56 0.38 NS 
C12:0 4.50 0.24 3.31 0.10 ** 7.52 0.61 3.23 0.13 ** 4.03 0.14 3.68 0.17 NS 
C14:0 10.32 0.14 9.67 0.28 * 11.87 0.44 8.43 0.25 ** 9.32 0.25 9.73 0.41 NS 
C14:1 0.36 0.02 0.33 0.01 NS 0.36 0.02 0.29 0.01 ** 0.28 0.03 0.28 0.01 NS 
C15:0 1.06 0.03 0.96 0.02 ** 0.97 0.02 0.85 0.05 * 0.79 0.02 0.84 0.03 NS 
C15:1 0.26 0.01 0.25 0.01 NS 0.19 0.00 0.23 0.01 ** 0.24 0.02 0.24 0.01 NS 
C16:0 25.98 0.13 28.63 0.31 ** 24.76 0.37 27.32 0.39 ** 28.96 0.98 28.70 0.55 NS 
C16:1 0.61 0.01 0.79 0.02 ** 0.72 0.03 0.68 0.02 NS 0.76 0.04 0.77 0.01 NS 
C17:0 0.60 0.02 0.67 0.01 * 0.50 0.02 0.61 0.02 ** 0.47 0.02 0.61 0.02 ** 
C18:0 9.13 0.12 10.30 0.27 ** 8.43 0.49 10.36 0.33 ** 8.20 0.19 9.51 0.34 ** 
TVA 0.33 0.05 1.79 0.11 ** 0.43 0.05 2.44 0.15 ** 0.75 0.11 2.07 0.24 ** 
C18:1c9 20.07 0.27 21.55 0.39 ** 19.68 0.50 20.99 0.52 NS 20.29 0.29 20.58 0.73 NS 
CVA 0.74 0.01 0.35 0.01 ** 0.92 0.04 0.39 0.02 ** 0.82 0.04 0.39 0.02 ** 
LA 2.21 0.09 2.63 0.10 ** 1.49 0.18 4.55 0.35 ** 2.03 0.06 2.41 0.20 ** 
CLA 0.83 0.03 0.67 0.04 ** 0.83 0.04 0.92 0.04 NS 0.74 0.05 0.72 0.07 NS 
ALA 0.99 0.04 0.67 0.04 ** 0.74 0.06 0.73 0.04 NS 0.69 0.06 0.72 0.08 NS 
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Figure 33: A significant reduction (p<0.01) in C12:0 % following the removal of PKE in 
2010-2011. Although control farms also decreased (p<0.01) between these two periods, the 
relative change of PKE farms was almost double that of controls. Removal of PKE reduced C12:0 
down to non-PKE farm levels. Error bars represent the standard deviation of the mean.  
 
 
Figure 34: A significant reduction (p<0.01) in C14:0 following the removal of PKE in 2010-
2011. Although less pronounced than C12:0, relative to control farm reduction PKE removal 
caused a significant decrease in C14:0. Error bars represent the standard deviation of the mean. 
 
 
Figure 35: A significant increase in Linoleic Acid (LA) following the removal of PKE in 
2010-2011 season. Relative to control farms, PKE significantly increased LA, while BW followed 
the same trend as Control farms. 
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Although BW elevated C16:0 and TVA in Feed Trial 1 relative to control farms, 
removal of these supplements had no effect on C16:0 (Figure 36). In the case of 
TVA, removal of BW increased this fatty acid even further (Figure 37).  
 
 
 
Figure 36: Removal of BW in 2010-2011 season had no effect on C16:0 %.  Error bars 
represent the standard deviation of the mean.  
 
 
 
 
Figure 37: Removal of BW did not decrease TVA to control farm levels. Instead these farms 
showed significant seasonal increases in TVA (p<0.01). Error bars represent the standard deviation. 
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Variable effects of supplement removal were observed in C14:1, C15:0, C15:1, 
C16:1, C17:0 and CLA (Appendix G). These fatty acids were present in milk at 
less than 1% and thus the relative changes to fatty acid composition were small.  
 
C4:0, C6:0, C8:0, C16:0, C18:0, C18:1 cis9 and TVA showed significant 
seasonal effects. As such they were unaffected by the removal of PKE and BW 
supplements (Appendix G).  
 
 
7.3 Feed Trial 3: Yeast supplementation 
Sufficient fat for fatty acid analysis could be recovered from milk samples of 17 
control and 12 yeast-treated goats. No significant effect of yeast supplementation 
was found for any fatty acid (Table 39).  
 
Table 39: Fatty acid comparison of control and yeast supplemented goats. p-values were 
determined by ANOVA analysis. Significant effect determined by a p-value <0.05. SD = standard 
deviation. NS = not-significant (p >0.05). 
Fatty Acid 
Control  Yeast 
p value Significance 
Mean SD  Mean SD 
C4:0 3.20 0.28  3.33 0.25 0.20 NS  
C6:0 2.55 0.32  2.65 0.22 0.39 NS  
C8:0 2.62 0.29  2.68 0.36 0.63 NS  
C10:0 8.92 1.14  8.87 0.97 0.90 NS  
C12:0 3.31 0.57  3.23 0.53 0.71 NS  
C14:0 9.65 1.28  9.20 1.00 0.32 NS  
C14:1 0.25 0.13  0.16 0.15 0.11 NS  
C15:0 0.84 0.12  0.80 0.12 0.41 NS  
C15:1 0.14 0.15  0.09 0.15 0.40 NS  
C16:0 26.49 2.74  26.21 3.83 0.82 NS  
C16:1 0.70 0.10  0.74 0.11 0.25 NS  
C17:0 0.57 0.09  0.54 0.05 0.33 NS  
C18:0 10.36 1.27  10.97 1.48 0.24 NS  
TVA 2.32 0.65  2.82 0.82 0.08 NS  
C18:1 cis 9 22.90 2.64  22.35 1.78 0.54 NS  
CVA 0.46 0.09  0.50 0.07 0.32 NS  
LA 1.91 0.22  2.04 0.24 0.15 NS  
CLA 0.74 0.31  0.83 0.27 0.44 NS  
ALA 0.66 0.14  0.66 0.14 0.99 NS  
 
 
Results from herd test data showed no significant effect of yeast supplement on 
milk volume, fat, protein, solids or somatic cell count. Herd tests from mid-
lactation (November) to the end of lactation (March) show that the 
supplementation of yeast had no effect throughout this period.  
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Figure 38: No effect of yeast was found on any fatty acid in milk of control and yeast treated 
does (p>0.05). Error bars represent the standard deviation of the mean.   
 
Table 40: No effect of yeast supplementation was found on herd-test parameters in any 
month. A p-value of <0.05 was considered significant. SD= standard deviation.  
Milk 
composition 
Herd 
Test 
Control 
 
Yeast p-
value 
Significance 
Mean SD 
 
Mean SD 
Milk vol (L) 
Nov 1.92 0.77 
 
1.91 0.77 0.96 NS  
Dec 1.99 0.63 
 
2.01 0.66 0.86 NS  
Jan 2.10 0.71 
 
1.98 0.74 0.42 NS  
Mar 1.38 0.48 
 
1.38 0.46 0.93 NS  
Milk Fat % 
Nov 3.55 0.50 
 
3.39 0.60 0.15 NS  
Dec 3.39 0.57 
 
3.29 0.52 0.37 NS  
Jan 3.33 0.57 
 
3.21 0.51 0.28 NS  
Mar 4.02 0.77 
 
3.83 0.70 0.23 NS  
Milk Fat kg 
Nov 0.07 0.03 
 
0.07 0.02 0.85 NS  
Dec 0.07 0.02  0.07 0.02 0.85 NS  
Jan 0.07 0.02  0.07 0.03 0.78 NS  
Mar 0.06 0.02  0.05 0.02 0.41 NS  
Protein % 
Nov 3.23 0.30  3.29 0.36 0.44 NS  
Dec 3.19 0.30 
 
3.19 0.31 0.95 NS  
Jan 3.17 0.31  3.15 0.36 0.75 NS  
Mar 3.36 0.31  3.39 0.33 0.72 NS  
Protein kg 
Nov 0.06 0.02  0.06 0.03 0.74 NS  
Dec 0.06 0.02  0.06 0.02 0.99 NS  
Jan 0.07 0.02 
 
0.07 0.02 0.35 NS  
Mar 0.05 0.01 
 
0.05 0.01 0.93 NS  
Milk Solids (kg) 
Nov 0.13 0.05  0.14 0.12 0.44 NS  
Dec 0.13 0.03  0.13 0.04 0.89 NS  
Jan 0.14 0.04  0.13 0.04 0.41 NS  
Mar 0.15 0.05  0.15 0.05 1.00 NS  
SCC (000) 
Nov 1623.4 2846.4  1401.4 1910.9 0.65 NS  
Dec 1791.3 3155.2 
 
1749.3 4250.8 0.96 NS  
Jan 1160.7 1593.3  1287.1 1477.4 0.69 NS  
Mar 1513.3 2082.1  1447.8 1284.5 0.87 NS  
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7.4 Conclusions 
The supplementation of PKE resulted in milk with significantly higher levels of 
C12:0 and C14:0 fatty acids. Removal of PKE from these farms reduced C12:0 
and C14:0 down to control farm levels. Farms feeding BW had higher levels of 
C16:0 and TVA in Feed Trial 1, however the removal of these supplements had 
variable and inconclusive effects. Yeast supplementation had no effect on any 
fatty acid, nor on milk volume, protein, fat, solids or SCC. Significant seasonal 
effects on fatty acid composition were observed, particularly in SCFAs and TVA. 
Therefore supplementing NZ dairy goats with PKE is the only diet which had a 
discernible effect on milk composition.  
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8 Chapter 8: Nutrition Discussion 
The successful marketing of goat milk produced in New Zealand (NZ) relies on a 
positive perception of milk quality in overseas markets.  Nutrition is one of the 
fastest and most effective ways to modulate milk composition and can be used to 
improve the healthfulness and quality of goat milk. The aim of this project was 
to determine the effect of some alternative supplements, namely palm kernel 
extract (PKE), biscuit waste (BW) and yeast on goat milk composition. This 
chapter presents a discussion of key results and findings from this research, with 
specific reference to the implications for the NZ dairy goat industry. An 
evaluation of methods and areas for future research are also outlined later in the 
chapter.  
 
8.1 Seasonal effects of Feed Trials 1 and 2  
Regardless of feed category, all farms showed a similar decrease in C4:0, C6:0, 
and CVA and increase in C17:0, C18:0 and TVA content between Feed Trials 
1 and 2, indicating a significant seasonal effect on these fatty acids. The 2009-
2010 season was characterised by a significant drought throughout the North 
Island, the peak of which occurred during the Feed trial 1 sampling period. 
Such events are known to alter the quantity and type of pasture, as well as the 
fatty acid composition of forages (Langer, 1990, Mel'uchova et al., 2008), 
ryegrass in particular (Khan et al., 2011, Boufaied et al., 2003). Moreover, 
during times of pasture shortages more concentrated energy feeds are 
supplemented which are also known to impact milk fatty acid composition 
(Samkova et al., 2009, Slots et al., 2009).  
 
Such seasonal effects on goat diets could explain the significantly higher levels 
of TVA and C18:0 in milk collected from all farms during the 2010-2011 
season compared to 2009-2010 samples.  Fresh green pasture is very high in 
ALA (C18:3n3) and LA (C18:2n6) which are isomerised and hydrogenated in 
the rumen to TVA and C18:0. Thus the TVA and C18:0 data suggest more 
fresh pasture was available in the 2010-2011 season compared to the drier 
2009-2010 season. Additionally, all farms experienced a significant reduction 
in CVA in milk collected during the 2010-2011 season. CVA is predominantly 
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formed by the desaturation of C18:0 in the mammary gland by SCD, which is 
known to be inhibited by C18 isomers, particularly the trans-fatty acids. Thus 
the increased TVA (arising from high ALA in pasture) could have down-
regulated SCD activity to reduce CVA content in 2010-2011 season milk. An 
analysis of SCD gene expression would be required to verify this, however 
similar observations have been noted in goats and sheep (Addis et al., 2005, 
Cabiddu et al., 2005). In particular the CVA decrease and C18:0 increase relate 
strongly to the effect on stearic acid desaturation ratios (CVA:C18:0) following 
pasture consumption described by Sans Sampelayo et al., (2007).  
 
The physiology of ruminants during dry periods also needs consideration. 
Although goats are renowned for their climatic tolerance, high yielding dairy 
goats can suffer from heat-stress which can affect milk production and 
composition (Ishler et al., 1996). The significantly (p<0.01) elevated levels of 
C4:0 and C6:0 during the dry 2009-2010 season could be due to increased rates 
of lipolysis arising from the mobilisation of body reserves during periods of 
low feed (Chilliard et al. 2003). Such effects have been observed in milk of 
heat-stressed dairy ewes which also showed higher proportions of these short-
chain fatty acids (Sevi et al., 2001) and thus could explain the seasonal effect 
on these fatty acids in goat milk.   
 
Therefore changes associated with dry weather, pasture composition and heat-
stress on dairy goats are likely to have had more of an effect on some fatty 
acids (particularly C4:0, C6:0, C18:0, CVA and TVA) than PKE or BW diets 
alone.  Climatic variations are a natural part of dairy goat farming in NZ and as 
shown in this research, can have a significant impact on milk composition.  
 
 
8.2 Palm kernel extract 
New Zealand is one of the largest importers of PKE for stock-feed purposes 
and up until late 2010 over 80% of Dairy Goat Co-operative farms were 
feeding the supplement. As outlined in Chapter 7, this research has shown that 
PKE significantly increased C12:0 and C14:0 fatty acids in goat milk. Removal 
of this supplement reduced C12:0 and C14:0 back to non-PKE levels and thus 
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indicates a very clear effect of PKE on these medium-chain fatty acids 
(MCFA).  
 
Fatty acid data for PKE is scarce, however palm kernel oil (PKO) is known to 
be rich in C12:0 and C14:0 (53.2 and 19.3% of total fatty acids respectively) 
(Bora et al., 2003). Thus assuming a similar composition of PKE to PKO, the 
C12:0 and C14:0 consumed in PKE diets would appear to be transferred 
directly to milk. This is a likely scenario as C12:0 and C14:0 are predominantly 
formed via the ‘diet’ pathway, rather than by de novo synthesis (refer Chapter 2) 
and therefore are strongly impacted by dietary factors. Given these fatty acids 
are already saturated, no biohydrogenation or isomerisation processes can 
modify C12:0 or C14:0 in the rumen. Moreover, this study showed no effect of 
PKE supplementation on C14:1 which suggests minimal Stearoyl-CoA-
desaturase (SCD) modification in the mammary gland, at least for C14:0. 
Therefore C12:0 and C14:0 consumed in PKE diets do not appear to be 
modified by rumen bacteria or mammary enzymes and are thereby transferred 
directly from this diet into the milk.  
 
 
8.3 Biscuit waste 
Biscuit waste is a unique supplement in which little is known of its effects on 
milk composition. Results from this research showed no clear effects of BW 
supplementation on milk composition. Although significant differences were 
observed in Feed Trial 1, removal of BW did not reverse these effects. The 
majority of fatty acids either showed no significant difference between seasons 
or mirrored control farm changes.  
 
This is surprising given that biscuits and confectionery are typically high in 
saturated and trans-monounsaturated fats  (USDA, 2011). Based on other 
studies it would be expected that increasing such fats in the diet would result in 
higher levels of C18:1, C18:0, C16:0 and C14:0 due to microbial 
hydrogenation and isomerisation processes acting on long-chain saturated and 
unsaturated fats in the rumen. A high level of conjugated and trans-fats are 
known to reduce SCD activity in sheep, cows and goats (Perfield et al., 2006, 
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Baumgard et al., 2000, Harvatine and Bauman, 2011, Peterson et al., 2002, 
Loor and Herbein, 1998, Bernard et al., 2005) and therefore result in higher 
levels of saturated fats in ruminant milk. However without fatty acid 
compositional data for BW supplements it is difficult to predict likely 
outcomes for the effect of BW in the diet.  
 
A factor that may have affected BW non-significant results is that following 
the elimination of BW supplements not all farms reverted to a control-type diet. 
In most cases alternative supplements were introduced, namely dried distillers 
grain (DDG) or brewers grain (BG). In dairy cows both distillers and brewers 
grains have been shown to alter fatty acid composition (Sasikala-Appukuttan et 
al., 2008, Schingoethe et al., 1999, Miyazawa et al., 2007). Thus fatty acid 
changes following the removal of BW may have been masked by the effects of 
DDG / BG supplements. This could also apply to fatty acids that did not show 
any effects with PKE supplementation and removal.  
 
8.4 Yeast 
Yeast supplementation has been used as a non-hormonal feed additive to 
promote growth by improving digestion and increasing feed intake in 
ruminants (Higginbotham et al., 1994, Enjalbert et al., 1999, Castro et al., 2002, 
Alshaikh et al., 2002, Harrison et al., 1988, Sune and Muhlbach, 1998).  There 
are however mixed reports on yeast and milk composition in dairy goats 
(Desnoyers et al., 2009). Results from this research show no significant effect 
of 20g/yeast/doe/day on fatty acid composition, milk volume, protein, fat, 
solids or somatic cell count from mid-late lactation.  
 
Other yeast experiments in dairy cows and goats have similarly shown yeast 
addition did not produce any difference in milk composition. For example 10g 
of yeast did not affect feed intake, milk yield, milk fat, milk protein or milk 
casein in dairy goats (Salama et al., 2002). Hadjipanayiotou et al., (1997) also 
found no  effect on ewe or goat milk composition with 12.5g yeast/kg of 
concentrate while multiple studies found no of effect of 3-90g/day of yeast in 
dairy cows (Arambel and Kent, 1990, Chiquette, 1995, Kamalamma et al., 
1996, Yalcin et al., 2011). No published results were found for yeast and fatty 
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acid composition in dairy goats, however no effect was found in with ewes 
(Masek et al., 2008) or cows (Castillo et al., 2006). 
 
On the contrary research by El Ghani (2004) et al., found that supplementing 
early-mid lactation Zairaibi does with 6g yeast mixed with 60% concentrate 
and 40% roughage (straw) did increase milk volume, protein content and milk 
solids. Stella et al., (2007) also found an effect using just 0.2g/day with early 
lactation Saanen does on milk production. Thus lower quantities of yeast than 
used in the current study yielded significant effects in some circumstances.  
 
It could be that yeast only impacts milk composition during pre-kidding or 
early lactation periods.  However this would need to be verified with another 
trial during these periods as such a conclusion is not consistent with successful 
yeast feed trials in the literature.  Other influences such as the basal diet, strains 
of yeast, yeast activity, rumen microbe populations, level of drenching or 
climate may also be important and could warrant further investigation.  
 
 
 
8.5 Implications for the dairy goat industry 
The increase in C12:0 and C14:0 following PKE supplementation could have 
important implications for powdered nutritional products produced from NZ 
goat milk. Infant formula has a strict maximum requirement of 20% for C12:0 
and C14:0 combined. Farms which supplemented PKE in the 2009-2010 
season produced milk with an average C12:0+C14:0 total of 19.3% ± 0.53, 
versus non PKE farms at 14.8% ±0.19. Therefore farms supplementing with 
PKE were producing milk with less suitable fatty acid profiles for infant 
formula production. Consequently, if all farms produced fatty acid profiles 
with more than 20% C12:0+C14:0, extensive modifications would be needed 
to alter the fatty acid composition of powdered products. Doing so would 
require additional processing costs and be of detriment to the quality 
perception of naturally produced goat milk products from NZ. 
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Additionally, C12:0 and C14:0 are the two fatty acids with the least beneficial 
health effects for humans due to their contribution in raising blood plasma 
levels, low density lipoprotein, cholesterol and the risk of heart disease. 
However a key driver for the consumption of goat milk instead of cow milk is 
the higher proportion of MCFAs which enhance digestibility and nutrient 
absorption (Greenberger et al., 1966, Guillot et al., 1993). Although PKE 
removal reduced C12:0 and C14:0 MCFAs, goat milk from these farms still 
had more small and medium chain fatty acids (28.3%) than the average cow 
milk (25.1% according to Mansson (2008)). Therefore goat milk without PKE 
supplementation markedly reduced the atherogenicity index while retaining a 
digestive advantage over cow milk. As such, DGC’s decision to remove PKE 
as an allowable diet is likely to have improved milk composition for human 
consumption by being better suited to infant formula needs as well as general 
health.  
 
Regarding BW it could be suggested that the removal of BW did not produce 
any significant alterations to milk composition and therefore could be used 
again as an allowable feed. This is purely from a nutritional view, as other 
factors such as milk production, rumen function or animal health were not 
investigated as part of this study. Moreover the perception from overseas 
buyers of NZ dairy goats consuming high fat and sugar would also need to be 
taken into consideration.  
 
CLA content has been gradually decreasing in spray-dry powders produced by 
DGC over the last ten years. It was thought this may be due to an increase in 
supplements like PKE and BW in conjunction with a reduction of pasture 
consumption. From these results it is unclear whether PKE and BW 
supplementation were the cause of decreasing CLA. Variable effects were 
found on CLA content following the removal of PKE and BW, while control 
farms showed a significant seasonal effect on this fatty acid. Replacement of 
PKE/BW diets with DDG/BG supplements could explain the inconclusive 
effects of PKE/BW removal, while seasonal variations in pasture composition 
may be the cause of decreased CLA in 2010-2011 on control farms.  
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However fresh pasture is thought to increase CLA content (Chilliard and 
Ferlay, 2004, Pajor et al., 2009, Bargo et al., 2006), not decrease as observed 
on control farms in the 2010-2011 season. TVA, the precursor of CLA was 
significantly increased in the 2010-2011 season, however this did not translate 
into higher levels of CLA. As discussed previously, this could be due to high 
levels of TVA inhibiting the conversion of TVA to CLA by SCD in the 
mammary gland. Overall, it cannot be concluded from these results whether 
PKE and / or BW supplementation has caused the gradual decline in CLA 
content of DGC goat milk and requires further investigation.  
 
With regard to yeast supplementation it is clear from the current research that 
under NZ goat farming conditions, yeast (20g/doe with 1kg of maize 
concentrate) has no effect on milk composition parameters tested in this study.  
Effects on body condition score, animal health, digestion or rumen function 
were not investigated as part of this research however from a milk fatty acid 
composition, yield, protein and fat viewpoint the supplementation of yeast is 
not effective for this purpose. Thus for the dairy goat industry it would be 
suggested that, at least during mid-late lactation, the supplementation of yeast 
is not an effective feed additive to increase production or alter composition of 
goat milk.  
 
 
8.6 Evaluation of methods and areas for future research 
This research has allowed the investigation of nutritional factors using three 
different feed trial methods. The use of commercial dairy goat farms in such 
research has a number of benefits including large sample numbers, ease of 
animal management and the production of results which are commercially 
relevant and applicable to ‘normal’ farming situations. However the downside 
to such experiments is the inherent variability associated with multiple, 
independently managed farms, sampled across two seasons.  
 
In this respect results from Feed Trial 1 detected between-farm differences, 
however additional studies such as supplement removal (conducted in Feed 
Trial 2) or isolated feed trials are required to verify that a particular diet caused 
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that effect and not some other factor of farm management. Alternatively, 
extending PKE and BW supplementation through a number of seasons and 
increasing the number of samples collected could assist in determining such 
dietary effects.  Similarly Feed Trial 2 could be improved by more focussed 
feed trials (e.g. control versus treatment goats on the same farm, during the 
same period) to ensure supplement removal effects are not associated with 
seasonal variations such as climate and pasture composition. 
 
Feed trial 3 had a more controlled experimental design in that it reduced many 
of the varying factors present in Feed Trials 1 and 2. In saying this, the results 
may only be applicable to that particular farm’s basal diet, climate and farm 
management and may not represent the potential effect of yeast 
supplementation on NZ dairy goat farms as a whole. As such, extending the 
yeast trial to other NZ farming systems (different base diets, indoor farming) 
and periods of lactation could add value to the results. Similarly trialling 
different concentrations and types of yeast may produce significant effects of 
this supplement on milk composition.    
 
A further investigation into why previous PKE farms showed elevated LA 
content in the 2010-2011 season may also be of interest given the health 
benefits regularly promoted for this fatty acid. It may be that newer DDG and 
BG supplements are promoting increased LA milk content. This would need to 
be verified using controlled feed trials similar to Feed Trial 3. Since many 
farmers are now feeding these two supplements it may be worth investigating 
the effect of these diets on milk composition.   
 
Lastly, in light of the fact that PKE is the major supplement fed to New 
Zealand’s expansive dairy cow industry, it would be interesting to see if PKE 
supplementation also increases C12:0 and C14:0 milk content from dairy cows.  
Cow milk produced in NZ is also used for a similar infant formula and spray-
dry powder purposes and predominantly exported to overseas markets, 
however no milk compositional studies of PKE supplementation have been 
reported to date.  
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9 Chapter 9: Interaction of Nutritional and 
Genetic Factors 
The formation of milk constituents is a complex process, one which involves 
many interacting elements. Nutritional and genetic factors are no exception and 
can have combined effects on milk composition. Diet is known to influence gene 
expression, as reflected in the growing field of nutrigenomics. One of the  most 
noted ‘nutrigenomic’ effects observed in ruminants is the regulation of milk fat 
synthesis by long-chain trans and conjugated fatty acids such as TVA and CLA 
which can result in milk fat depression, particularly in dairy cows (Bernard et al., 
2008, Bauman et al., 2008, Harvatine et al., 2009b, Shingfield and Griinari, 2007). 
In this way, diet can influence the expression of genetic factors to have a 
significant impact on milk composition.  
 
The reverse can also occur, where genetic factors influence the effectiveness of 
ruminant diets. This has been shown for CSN1S1, where Pagano et al., (2010) 
trialled 27 goats of three genotypes (AA, AF and FF) with three different diets at 
100%, 65% and 30% energy levels (hay concentrate). They found a significant 
energy x genotype effect (p<0.05), where AA goats only showed effects on milk 
yield increase when fed 100% concentrate. The authors concluded that strong 
alleles are associated with a greater efficiency of feed utilisation and seem to show 
that a high energy level of the diet can further improve this efficiency. 
 
The same group (Valenti et al., 2010) also analysed the effect on fatty acid 
composition of AA and FF goats at 100% and 65% concentrate. The genotype x 
diet interaction was significant for 11 different milk fatty acids. In particular, C8:0, 
C10:0, C12:0, C14:0 increased when FF animals shifted from 100% to 65% 
concentrate, while the same fatty acids did not significantly change in AA animals. 
Additionally LCFAs increased in AA and decreased in FF goats, leading the 
authors to conclude that CSN1S1 causes goats to respond in a different way when 
fed diets with different energy levels.  
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Although not specifically studied as part of this research, the interaction of dietary 
and genetic factors can be considered in some instances where unexpected results 
have occurred. For example where Farm A had no effect of genotype while Farm 
B did. Although both were on the same basal diet of pasture and forage, the 
dietary energy is likely to have been more on Farm B which regularly fed more 
concentrated forages such as maize and lucerne silage.  This higher energy level 
may be why Farm B produced significant differences in milk yield, protein and fat 
as a result of CSN1S1 genotype. Although stage of lactation and farming system 
differences may also have had an effect, the significantly higher milk production 
on Farm B compared to Farm A is in agreement with the higher energy theory for 
diet x genetic interaction effects.  
 
In a commercial situation it is necessary to understand the circumstances in which 
a particular genotype or diet is effective. Thus where interactions are known to 
occur, such as CSN1S1 genotype and dietary energy level, this may influence 
selective breeding or supplementation strategies. The benefits of doing so have 
long been exploited in the NZ dairy cow industry. Extensive breeding records, 
progeny testing and artificial insemination have all allowed the genetic gain to be 
optimised in combination with significant nutritional research. Although it is 
common knowledge that well-fed animals produce more milk, understanding the 
mechanisms and effects of genetic and nutritional factors in dairy goats is under-
studied compared to dairy cows. As such, further research into these interactions 
would be useful in the application of genotype, nutrition and milk composition 
effects identified in this research.  
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10  Chapter 10: Conclusions 
Overall this research has highlighted the complexity of genetic and nutritional 
factors in the synthesis of milk components. This study is the first of its kind in 
New Zealand dairy goats and shows that milk produced by NZ dairy goats has the 
potential to be modified through genetic and dietary means.  
 
From this research we can conclude that PCR-RFLP, AS-PCR and real-time PCR 
methods allow the successful identification of A* (G,H,I,02) B*(C,L), E, F, N and 
01 alleles at the CSN1S1 locus. EF and A*E genotypes are the most common. One 
unique genotype, which remains uncharacterised, was found at a reasonably high 
frequency on one farm. This genotype contains CSN1S1 E and N variants, 
however peculiarities remain with the additional PCR product which could not be 
identified. This genotype had a medium effect on milk composition so is unlikely 
to be a detrimental variant for milk composition. New Zealand goat farms are not 
in Hardy-Weinberg equilibrium at the CSN1S1 locus, as would be expected of 
populations with significant selection pressure, founder effects and in-breeding.  
 
CSN1S1 genotypes can have a significant effect on milk composition, but the 
effects are not necessarily standard between farms. Protein content is the most 
significantly affected by CSN1S1, however this gene may also affect fat content 
and milk yield under certain circumstances. The exact situations in which CSN1S1 
has an effect on milk composition requires further investigation, but may include 
high energy status of the goats and early lactation.  
 
Fatty acid composition was significantly affected by ‘high’ versus ‘low’ CSN1S1 
genotypes, although the relative changes were small.  Fatty acid composition was 
most affected by nutritional factors, particularly palm kernel extract (PKE). Farms 
feeding PKE produced milk with significantly elevated levels of C12:0 and C14:0. 
It is likely these fatty acids were transferred into milk directly from PKE diets, 
with little modification by rumen microbes or mammary enzymes. The increase of 
C12:0 and C14:0 fatty acids in the milk of PKE-supplemented goats decreases the 
healthfulness of goat milk. 
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Biscuit waste (BW) and yeast had no significant effects on milk composition. 
Farms feeding BW had higher levels of C16:0 and TVA in Feed Trial 1, however 
the removal of these supplements had variable and inconclusive effects. Yeast 
supplementation had no effect on any fatty acid, nor milk volume, protein, fat, 
solids or SCC.  
 
The effect of drought and other seasonal variations were inadvertently included in 
the study through the experimental design of Feed Trial 2. Seasonal differences 
appeared to have a significant effect on the milk fatty acid profile, especially TVA 
and SCFA.  
 
Overall, this study has found significant effects of both genetic and nutritional 
factors on milk composition. Milk quality could be improved on the basis of these 
results by altering breeding strategies and feeding practices based on the desired 
milk composition. This study has provided the foundation for future research into 
NZ dairy goats, particularly regarding CSN1S1 genotypes, PKE, BW and yeast. 
Ultimately the findings from this research will allow better decisions to be made 
which will improve the healthfulness and quality of goat milk produced in NZ.  
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Appendix A: Genotype Frequencies 
Table 41: Overview of allele frequencies from other caprine CSN1S1 studies. •= unable to be distinguished from other alleles or not determined. Note most A alleles are used as 
‘all other’. Some alleles may be grouped together with the A, B, N, E, F and O alleles – see original paper(s) for specific details. PCR = Polymerase chain reaction. AS-PCR = Allele 
specific  PCR. RFLP = Restriction fragment length polymorphism. SDS-PAGE = Sodium dodecyl sulphate polyacrylamide gel electrophoresis. IEF = Isoelectric focussing.  
MALDI-TOF-MS= Matrix-assisted laser desorption/ionization- time-of-flight mass spectrometry. RP-HPLC = Reversed phase high performance liquid chromatography. PCR-SSCP 
= PCR-single strand conformation polymorphism.  
Country Breed No. 
CSN1S1 allele 
Methods Reference 
A B N E F O 
Brazil Alpine 83 0.20 • • 0.48 0.28 0.01 AS-PCR, PCR-RFLP (Soares et al., 2009) 
Brazil Saanen 62 0.30 • • 0.35 0.30 0.02 AS-PCR, PCR-RFLP (Soares et al., 2009) 
Czech Republic Brown Shorthair 45 0.98 • • • • 0.02 AS-PCR (Sztankoova et al., 2006) 
Czech Republic White Shorthair 123 0.95 • • • • 0.05 AS-PCR (Sztankoova et al., 2006) 
Czech Republic Brown Shorthair 165 0.30 • • 0.09 0.06 0.02 PCR-RFLP, AS-PCR (Sztankoova et al., 2007) 
Czech Republic White Shorthair 333 0.27 • • 0.05 0.66 • PCR-RFLP, AS-PCR (Sztankoova et al., 2007) 
France Alpine 213 0.15 0.05 • 0.34 0.41 0.05 SDS-PAGE (Grosclaude et al., 1987) 
France Saanen 159 0.07 0.06 • 0.41 0.43 0.03 SDS-PAGE (Grosclaude et al., 1987) 
France Corse 106 0.06 0.13 • 0.14 0.59 0.08 PCR-RFLP (Martin and Leroux, 2000) 
France Poitevine 209 0.05 0.35 • 0.45 0.14 0.00 PCR-RFLP (Martin and Leroux, 2000) 
France Rove 147 0.12 0.05 • 0.62 0.10 0.11 PCR-RFLP (Martin and Leroux, 2000) 
France Alpine (1990) 400 0.52 0.33 0.02 0.27 0.17 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
France Alpine (2000) 312 0.71 0.11 0.01 0.12 0.05 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
France Poitevine 243 0.08 0.48 0.01 0.34 0.08 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
France Pyreneenne 213 0.09 0.15 0.03 0.60 0.13 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
France Saanen (1990) 312 0.17 0.04 0.01 0.59 0.19 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
France Saanen (2000) 261 0.27 0.07 0.01 0.58 0.08 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
Hungary Hungarian milking  103 0.09 0.29 • 0.08 0.46 0.00 AS-PCR, PCR-RFLP (Kusza et al., 2007) 
Hungary Hungarian milking 109 0.61 • • 0.08 0.31 • AS-PCR, PCR-RFLP (Veress et al., 2004) 
India Barbari 475 0.77 0.01 • 0.00 0.12 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Beetal 45 0.72 0.00 • 0.00 0.17 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Jakhrana 68 0.68 0.00 • 0.00 0.18 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Jamunapari 179 0.72 0.01 • 0.00 0.15 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Local MP 42 0.52 0.00 • 0.00 0.08 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
Table continued over 
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Country Breed No. 
CSN1S1 allele 
Methods Reference 
A B N E F O 
India Local UP 110 0.59 0.00 • 0.00 0.19 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Marwari 70 0.56 0.01 • 0.00 0.41 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Sirohi 69 0.77 0.07 • 0.00 0.04 • PCR-RFLP, SDS PAGE (Kumar et al., 2007) 
India Barbari 475 0.74 0.01 • • 0.12 0.09 SDS-PAGE (Rout et al., 2010) 
India Beetal 45 0.72 0.00 • • 0.17 0.11 SDS-PAGE (Rout et al., 2010) 
India Ganjam 40 0.45 0.00 • • 0.10 0.45 SDS-PAGE (Rout et al., 2010) 
India Jakhrana 68 0.68 0.00 • • 0.18 0.15 SDS-PAGE (Rout et al., 2010) 
India Jamunapari 179 0.72 0.01 • • 0.15 0.13 SDS-PAGE (Rout et al., 2010) 
India Marwari 70 0.56 0.01 • • 0.41 0.01 SDS-PAGE (Rout et al., 2010) 
India Sirohi 69 0.77 0.07 • • 0.04 0.13 SDS-PAGE (Rout et al., 2010) 
Italy Garganica 71 0.51 0.20 0.02 0.01 0.24 0.01 AS-PCR, PCR-RFLP (Albenzio et al., 2009) 
Italy Camosciata 88 0.44 0.20 0.01 0.11 0.23 0.01 IEF, PCR RFLP, AS-PCR (Caroli et al., 2006) 
Italy Frisa 70 0.13 0.01 0.00 0.20 0.56 0.12 IEF, PCR RFLP, AS-PCR (Caroli et al., 2006) 
Italy Orobica 66 0.00 0.01 0.00 0.01 0.96 0.02 IEF, PCR RFLP, AS-PCR (Caroli et al., 2006) 
Italy Verzasca 67 0.00 0.04 0.00 0.20 0.75 0.01 IEF, PCR RFLP, AS-PCR (Caroli et al., 2006) 
Italy Neopolitan Goat 285 0.14 0.17 0.23 0.08 0.37 0.00 AS-PCR, PCR-RFLP (Cosenza et al., 2008) 
Italy dell'Etna 42 0.25 0.27 0.00 0.00 0.17 • AS-PCR, PCR-RFLP (Gigli et al., 2008) 
Italy Derivata di Siria 47 0.30 0.10 0.00 0.00 0.33 • AS-PCR, PCR-RFLP (Gigli et al., 2008) 
Italy Girgentana 263 0.35 0.13 0.04 0.00 0.19 • AS-PCR, PCR-RFLP (Gigli et al., 2008) 
Italy Maltese 139 0.25 0.11 0.01 0.01 0.33 • AS-PCR, PCR-RFLP (Gigli et al., 2008) 
Italy Messinese 49 0.24 0.23 0.00 0.00 0.23 • AS-PCR, PCR-RFLP (Gigli et al., 2008) 
Italy dell'Etna 183 0.63 • • • 0.37 
 
AS-PCR, PCR-RFLP (Marletta et al., 2007) 
Italy Girgentana 341 0.60 • • • 0.40 • AS-PCR, PCR-RFLP (Marletta et al., 2007) 
Italy Garganica 54 0.61 0.37 • 0.00 0.02 0.00 PCR-RFLP (Martin and Leroux, 2000) 
Italy Maltese 81 0.33 0.28 • 0.11 0.27 0.01 PCR-RFLP (Martin and Leroux, 2000) 
Italy Saanen 70 0.03 0.03 • 0.49 0.46 0.00 PCR-RFLP (Martin and Leroux, 2000) 
Italy Garganica 38 0.27 0.41 0.00 0.00 0.22 0.00 AS-PCR, PCR-RFLP (Sacchi et al., 2005) 
Italy Jonica 110 0.35 0.31 0.00 0.06 0.28 0.00 AS-PCR, PCR-RFLP (Sacchi et al., 2005) 
Italy Maltese 70 0.41 0.16 0.00 0.06 0.37 0.00 AS-PCR, PCR-RFLP (Sacchi et al., 2005) 
Italy Roccaverano 77 0.23 0.12 0.02 0.21 0.38 0.05 AS-PCR, PCR-RFLP (Sacchi et al., 2005) 
Italy Vallesana 83 0.03 0.13 0.00 0.28 0.39 0.18 AS-PCR, PCR-RFLP (Sacchi et al., 2005) 
Italy Cilentana Milking 86 0.16 0.30 • 0.21 0.33 • disc-PAGE, IEF (Zullo et al., 2005) 
Table continued over 
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Country Breed No. 
CSN1S1 allele 
Methods Reference 
A B N E F O 
Mexico  Saanen 97 0.03 0.11 0.07 0.42 0.37 • AS-PCR, PCR-RFLP (Torres-Vázquez et al., 2008) 
Mexico  Alpine 81 0.19 0.14 0.15 0.24 0.28 • AS-PCR, PCR-RFLP (Torres-Vázquez et al., 2008) 
Mexico  Mosaico Lagunero 30 0.18 0.35 0.18 0.05 0.23 • AS-PCR, PCR-RFLP (Torres-Vázquez et al., 2008) 
Mexico  Murciano-Granadina 26 0.25 0.14 0.06 0.44 0.12 • AS-PCR, PCR-RFLP (Torres-Vázquez et al., 2008) 
Mexico  Toggenburg 92 0.14 0.21 0.18 0.15 0.32 • AS-PCR, PCR-RFLP (Torres-Vázquez et al., 2008) 
Montenegro Balkan 196 0.63 • • • 0.37 • AS-PCR, Sequencing (Markovic et al., 2009) 
Morocco Draa 132 0.24 0.51 0.04 0.02 0.20 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
Morocco Noire-Rahalli 102 0.27 0.67 0.01 0.03 0.02 • AS-PCR, PCR-RFLP (Ouafi et al., 2002) 
Norway Norwegian Dairy  254 0.17 • 0.70 0.02 0.11 • AS-PCR, IEF, MALDI-TOF (Devold et al., 2011) 
Spain Canaria 74 0.28 0.32 • 0.20 • 0.20 SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Spain Majorera 21 0.07 0.38 • 0.24 • 0.31 SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Spain Malaguena 373 0.09 0.09 • 0.65 0.04 0.13 SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Spain Murciano-Granadina 109 0.08 0.23 • 0.59 0.08 0.02 SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Spain Palmera 22 0.68 0.23 • 0.09 • • SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Spain Payoya 111 0.05 0.19 • 0.76 • • SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Spain Tinerfena 31 0.15 0.35 • 0.32 • 0.18 SDS-PAGE, IEF, AS-PCR (Jordana et al., 1996) 
Tunisia Arbi 111 0.27 0.34 0.14 0.06 0.19 0.01 AS-PCR, PCR-RFLP (Vacca et al., 2009) 
USA Alpine 42 0.12 0.07 0.00 0.36 0.46 • multiplex PCR (Maga et al., 2009) 
USA Dwarf Nigeria 23 0.48 0.50 0.00 0.00 0.02 • multiplex PCR (Maga et al., 2009) 
USA La Mancha 48 0.58 0.08 0.00 0.19 0.15 • multiplex PCR (Maga et al., 2009) 
USA Nubian 26 0.37 0.52 0.12 0.00 0.00 • multiplex PCR (Maga et al., 2009) 
USA Oberhasli 24 0.25 0.00 0.00 0.54 0.21 • multiplex PCR (Maga et al., 2009) 
USA Saanen 39 0.00 0.00 0.00 0.71 0.30 • multiplex PCR (Maga et al., 2009) 
USA Toggenburg 55 0.03 0.00 0.02 0.03 0.93 • multiplex PCR (Maga et al., 2009) 
USA Alpine 37 0.04 0.08 • 0.20 0.62 0.05 RP-HPLC (Clark and Sherbon, 2000) 
USA La Mancha 17 0.23 0.06 • 0.18 0.53 0.00 RP-HPLC (Clark and Sherbon, 2000) 
USA Nubian 6 0.33 0.08 • 0.00 0.50 0.08 RP-HPLC (Clark and Sherbon, 2000) 
USA Oberhasli 2 0.00 0.00 • 0.50 0.50 0.00 RP-HPLC (Clark and Sherbon, 2000) 
USA Saanen 11 0.09 0.14 • 0.32 0.46 0.00 RP-HPLC (Clark and Sherbon, 2000) 
USA Toggenburg 9 0.06 0.06 • 0.06 0.83 0.00 RP-HPLC (Clark and Sherbon, 2000) 
West Africa Borno 37 0.19 0.38 • 0.00 0.03 • RCR-RFLP, PCR-SSCP (Caroli et al., 2006) 
West Africa Dwarf Cameroon 39 0.08 0.62 • 0.00 0.01 • RCR-RFLP, PCR-SSCP (Caroli et al., 2006) 
West Africa Dwarf Nigeria 27 0.26 0.44 • 0.00 0.00 • RCR-RFLP, PCR-SSCP (Caroli et al., 2006) 
West Africa Red Sokoto 57 0.18 0.48 • 0.02 0.01 • RCR-RFLP, PCR-SSCP (Caroli et al., 2006) 
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Appendix B: DNA Extraction Results  
Initial extraction results and clean-up methods required for each sample. IS= insufficient DNA or sample. LE= Lab error. NHT= No herd test data. 
Breeds: S= Saanen, BA= British Alpine, T= Toggenberg, N=Nubian.  
 
Goat ID Breed Age Date sampled Farm 
Sample 
Type 
Status 
DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
7 S 2 17-Jan-11 A Milk Genotyped 221.72 0.89 1.86 Yes    
10 S 5 13-Feb-11 A Milk Genotyped 44.70 0.26 1.79 Yes    
15 S 3 17-Jan-11 A Milk Genotyped 42.04 0.49 1.96     
16 S 3 17-Dec-10 A Milk Genotyped 115.34 0.24 1.10 Yes    
19 S 3 17-Dec-10 A Milk Withdrawn 100.90 0.21 1.24 Yes  LE, sample mix-up  
24 S 8 4-Nov-10 A Milk Genotyped 3337.60 1.98 1.89     
38 S 3 17-Dec-10 A Milk Genotyped 429.43 0.51 1.48 Yes    
47 S 3 13-Feb-11 A Milk Genotyped 411.33 1.15 1.99     
49 S 6 13-Feb-11 A Milk Withdrawn 0.89 0.66 1.16   IS DNA 
50 BA/S 8 4-Nov-10 A Milk Genotyped 328.09 1.09 2.09     
59 S 7 13-Feb-11 A Milk Genotyped 183.30 1.11 1.85     
68 S 4 13-Feb-11 A Milk Genotyped 198.98 0.92 1.27 Yes    
83 S 5 4-Nov-10 A Milk Withdrawn 35.26 2.28 1.80   IS to complete g/t 
84 S 2 17-Dec-10 A Milk Genotyped 812.81 0.63 1.24 Yes    
88 S 7 17-Dec-10 A Milk Withdrawn 60.21 0.21 1.08 Yes  Low DNA post CTAB 
89 S 2 20-Feb-11 A Hair (buck) Genotyped 27.27 0.24 1.92     
90 S 2 20-Feb-11 A Hair (buck) Withdrawn 23.82 2.00 1.87   PCR fail 
91 S 3 20-Feb-11 A Hair (buck) Withdrawn 47.60 2.17 1.93   PCR fail 
92 S 2 20-Feb-11 A Hair (buck) Genotyped 43.11 2.13 1.90     
93 S 3 20-Feb-11 A Hair (buck) Withdrawn 40.64 2.17 1.96   PCR fail 
94 S 4 20-Feb-11 A Hair (buck) Genotyped 43.37 2.12 1.89     
Table continued over 
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Table continued over 
Goat ID Breed Age Date sampled Farm 
Sample 
Type 
Status 
DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
96 S 3 20-Feb-11 A Hair (buck) Genotyped 16.46 0.53 1.49 Yes    
98 S 3 20-Feb-11 A Hair (buck) Genotyped 44.40 1.96 1.79     
99 S 5 20-Feb-11 A Hair (buck) Withdrawn 13.20 2.10 1.79   PCR fail 
110 S 2 17-Jan-11 A Milk Genotyped 304.97 1.06 1.85     
119 S 4 13-Feb-11 A Milk Genotyped 185.02 1.21 1.87     
125 S 3 17-Jan-11 A Milk Genotyped 164.84 0.50 1.81     
130 S 7 13-Feb-11 A Milk Genotyped 149.20 0.79 1.89     
135 S 4 17-Jan-11 A Milk Genotyped 196.10 0.90 1.89     
149 S 2 17-Jan-11 A Milk Genotyped 82.85 0.56 1.70     
150 S 2 13-Feb-11 A Milk Genotyped 97.23 0.32 1.99  Yes   
151 S 6 17-Dec-10 A Milk Genotyped 74.34 0.11 1.52 Yes    
153 T/S 7 13-Feb-11 A Milk Genotyped 84.10 0.73 1.74     
170 S 6 17-Dec-10 A Milk Withdrawn 56.17 0.16 1.09 Yes  Low  260/230 post 
CTAB 
187 S 2 4-Nov-10 A Milk Genotyped 126.16 0.33 1.63     
195 S 6 13-Feb-11 A Milk Genotyped 34.93 0.45 1.64     
208 S 9 17-Dec-10 A Milk Genotyped 338.35 0.84 1.39 Yes    
219 S 5 13-Feb-11 A Milk Genotyped 562.36 0.67 1.66     
219 S 2 13-Feb-11 A Milk Withdrawn 1.55 1.66 1.58   IS DNA 
222 S 6 13-Feb-11 A Milk Genotyped 454.02 1.34 1.57     
225 S 9 17-Dec-10 A Milk Genotyped 82.76 0.24 1.10 Yes    
234 S 5 17-Jan-11 A Milk Genotyped 67.54 0.04 1.25 Yes    
236 S 8 17-Jan-11 A Milk Genotyped 166.09 0.98 1.85     
239 S 6 17-Dec-10 A Milk Genotyped 66.59 0.24 1.52     
242 S 4 17-Dec-10 A Milk Genotyped 248.44 0.33 1.41 Yes    
243 S 4 13-Feb-11 A Milk Genotyped 204.57 1.05 1.48 Yes    
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Table continued over 
Goat ID Breed Age Date sampled Farm 
Sample 
Type 
Status 
DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
251 S 2 17-Jan-11 A Milk Genotyped 101.55 1.83 1.73     
262 S 3 17-Jan-11 A Milk Genotyped 582.27 1.34 1.95     
293 S 2 13-Feb-11 A Milk Genotyped 293.00 1.07 1.99     
296 S 2 17-Dec-10 A Milk Genotyped 225.33 0.48 1.33 Yes    
300 S 8 17-Dec-10 A Milk Genotyped 102.37 0.26 1.26 Yes    
302 S 2 17-Dec-10 A Milk Genotyped 89.47 0.49 1.02 Yes    
303 S 4 17-Jan-11 A Milk Genotyped 103.29 0.37 1.89     
307 S 3 13-Feb-11 A Milk Withdrawn 456.42 0.90 1.46   LE, Extraction 
320 S 6 17-Dec-10 A Milk Genotyped 101.25 0.16 1.06 Yes    
324 T/S 8 13-Feb-11 A Milk Genotyped 61.82 0.85 1.51     
326 S 3 13-Feb-11 A Milk Genotyped 621.26 0.42 1.55 Yes    
330 S 8 17-Jan-11 A Milk Genotyped 189.84 0.46 1.60     
332 S 6 17-Jan-11 A Milk Genotyped 341.33 1.09 1.91     
334 S 2 17-Dec-10 A Milk Genotyped 116.55 0.28 1.09 Yes    
334 S 7 17-Dec-10 A Milk Withdrawn 102.37 0.79 1.62   LE, Extraction 
349 S 6 4-Nov-10 A Milk Genotyped 96.70 1.89 1.79     
354 S 5 13-Feb-11 A Milk Genotyped 55.23 0.61 1.44 Yes    
355 S 7 13-Feb-11 A Milk Genotyped 244.60 0.33 1.68 Yes    
357 S 4 4-Nov-10 A Milk Withdrawn 72.56 0.55 1.64   LE, Extraction 
358 S 2 17-Dec-10 A Milk Genotyped 105.16 0.19 1.00  Yes White pellet 
364 S 6 13-Feb-11 A Milk Genotyped 498.88 0.66 1.99  Yes   
370 S 8 17-Dec-10 A Milk Genotyped 150.00 0.27 1.17 Yes    
376 S 2 13-Feb-11 A Milk Genotyped 126.89 0.64 1.26     
376 S 3 17-Dec-10 A Milk Withdrawn 23.56 0.23 1.90  Yes   
395 S 5 17-Dec-10 A Milk Withdrawn 114.32 0.15 0.99 Yes  Low 260/230 post CTAB 
  
 
- 1
3
2
 - 
Goat ID Breed Age Date sampled Farm 
Sample 
Type 
Status 
DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
396 S 3 17-Dec-10 A Milk Genotyped 118.32 0.17 1.50 Yes    
262a S 9 17-Dec-10 A Milk Withdrawn 135.40 0.21 1.04   triplicate 
262b S 9 17-Dec-10 A Milk Withdrawn 64.95 0.40 1.98   triplicate 
vat S 7 4-Nov-10 A Milk Genotyped 23.40 0.97 1.93   Frozen sample, low 
DNA 
2 S 8 2-Jul-11 B Hair (doe) Genotyped 13.44 1.00 1.63     
8 S 5 3-Jul-11 B Milk Genotyped 456.61 0.81 1.53     
9 S 4 1-Oct-11 B Milk Genotyped 331.90 1.30 1.90     
17 S 2 1-Oct-11 B Milk Genotyped 483.63 0.56 1.85     
22 S 6 2-Jul-11 B Hair (doe) Genotyped 8.66 1.18 1.78     
25 S 4 1-Oct-11 B Milk Genotyped 72.96 0.54 1.50     
42 S 2 1-Oct-11 B Milk Genotyped 18.12 0.03 2.61     
49 S 5 3-Jul-11 B Milk Genotyped 327.01 0.89 1.56   NHT 
55 S 4 3-Jul-11 B Milk Genotyped 281.29 1.36 1.82   NHT 
71 S 2 1-Oct-11 B Milk Genotyped 1057.60 1.40 1.79     
72 S 6 1-Oct-11 B Milk Genotyped 122.67 0.46 1.44     
73 S 8 1-Oct-11 B Milk Genotyped 480.31 1.24 1.84     
77 S 5 1-Oct-11 B Milk Genotyped 448.03 1.70 1.56     
79 S 4 11-Jul-11 B Milk Genotyped 285.28 0.32 1.50 Yes  PCR fail 
80 S 6 1-Oct-11 B Milk Genotyped 159.36 0.27 1.90     
82 S 2 1-Oct-11 B Milk Genotyped 36.09 1.45 1.31     
83 S 3 3-Jul-11 B Milk Withdrawn  56.27 0.96 0.45 Yes  Low DNA post CTAB 
91 S/N 2 3-Jul-11 B Milk Genotyped 2341.50 0.36 1.48 Yes  NHT 
103 S 4 11-Jul-11 B Milk Genotyped 498.36 0.34 1.53   NHT 
111 S 8 1-Oct-11 B Milk Genotyped 71.82 0.33 1.48 Yes    
124 S 3 3-Jul-11 B Milk Genotyped 59.31 0.34 1.41 Yes    
127 S 5 1-Oct-11 B Milk Genotyped 101.17 0.26 1.59     
Table continued over 
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Table continued over 
Goat ID Breed Age Date sampled Farm Sample 
Type 
Status DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
137 S 2 1-Oct-11 B Milk Genotyped 2101.40 2.08 1.84     
140 S 6 1-Oct-11 B Milk Genotyped 115.60 0.76 1.75     
151 S 4 2-Jul-11 B Hair (doe) Genotyped 317.58 0.69 1.84     
153 S 2 1-Oct-11 B Milk Genotyped 87.99 0.72 2.25  Yes   
156 S 4 1-Oct-11 B Milk Genotyped 380.73 1.33 1.73     
160 S 2 1-Oct-11 B Milk Genotyped 107.04 0.85 1.55     
162 S 5 1-Oct-11 B Milk Genotyped 2869.50 2.22 1.77     
163 S 6 1-Oct-11 B Milk Genotyped 84.15 2.29 1.64     
165 S 4 1-Oct-11 B Milk Genotyped 155.80 1.32 1.75     
182 S 4 3-Jul-11 B Milk Genotyped 196.96 2.12 1.85     
186 S 6 1-Oct-11 B Milk Genotyped 71.90 4.54 1.60  Yes White pellet 
209 S 4 11-Jul-11 B Milk Genotyped 410.13 0.50 1.68     
210 S 4 2-Jul-11 B Hair (doe) Genotyped 14.78 0.12 1.83   NHT 
224 S 8 11-Jul-11 B Milk Genotyped 124.92 0.32 1.44   NHT 
226 S 6 1-Oct-11 B Milk Genotyped 74.33 1.71 1.66     
232 S 4 11-Jul-11 B Milk Withdrawn 5.60 0.12 1.23   NHT 
234 S/N 7 1-Oct-11 B Milk Genotyped 17.63 1.66 3.11     
236 S 4 3-Jul-11 B Milk Genotyped 92.24 0.24 1.35 Yes  NHT 
254 S 5 1-Oct-11 B Milk Genotyped 208.49 0.10 1.79  Yes Un-dissolvable pellet 
257 S 4 1-Oct-11 B Milk Withdrawn  8.95 0.02 2.84   PCR fail 
263 S 6 1-Oct-11 B Milk Genotyped 37.33 0.11 1.39 Yes    
275 S 3 11-Jul-11 B Milk Genotyped 288.90 0.26 1.50 Yes    
284 S 4 11-Jul-11 B Milk Genotyped 239.44 0.50 1.74   NHT 
298 S 3 1-Oct-11 B Milk Genotyped 36.42 -10.90 1.57  Yes White pellet 
316 S 4 3-Jul-11 B Milk Genotyped 149.96 2.11 1.90     
321 S 7 1-Oct-11 B Milk Genotyped 284.62 0.99 1.68     
327 S 2 1-Oct-11 B Milk Genotyped 772.82 1.13 1.85     
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3
4
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Goat ID Breed Age Date sampled Farm 
Sample 
Type 
Status 
DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
332 S 2 1-Oct-11 B Milk Genotyped 256.07 0.32 1.91 Yes    
333 S/N 2 11-Jul-11 B Milk Genotyped 301.01 0.38 1.49 Yes    
338 S/N 2 11-Jul-11 B Milk Genotyped 280.51 0.38 1.43 Yes  NHT 
339 S 4 11-Jul-11 B Milk Genotyped 93.70 0.22 1.56 Yes    
343 S/N 2 1-Oct-11 B Milk Genotyped 36.65 0.71 2.22     
348 S 2 1-Oct-11 B Milk Genotyped 108.46 0.15 3.26  Yes White pellet 
350 S 3 1-Oct-11 B Milk Genotyped 62.52 0.36 1.93 Yes    
355 S 5 3-Jul-11 B Milk Genotyped 164.43 0.22 1.33  Yes NHT 
359 S 9 1-Oct-11 B Milk Genotyped 1588.80 1.43 1.55  Yes   
376 S 3 1-Oct-11 B Milk Genotyped 73.74 1.54 1.88     
380 S 4 3-Jul-11 B Milk Genotyped 237.15 1.28 1.70     
388 S 5 3-Jul-11 B Milk Genotyped 56.54 0.96 1.92     
398 S 5 1-Oct-11 B Milk Genotyped 11.02 0.20 5.11  Yes White pellet.  
407 S 3 2-Jul-11 B Hair (doe) Withdrawn  8.14 0.09 1.91     
416 S 7 1-Oct-11 B Milk Genotyped 12.75 0.23 2.02     
418 S/N 2 1-Oct-11 B Milk Genotyped 116.94 0.79 1.75     
427 S 5 1-Oct-11 B Milk Genotyped 1716.70 1.52 1.86     
1073 S 3 3-Jul-11 B Hair (buck) Withdrawn  7.35 0.92 1.24   IS 
9302 S 5 2-Jul-11 B Hair (buck) Genotyped 50.40 0.52 1.59     
10101 S 3 3-Jul-11 B Milk Withdrawn  13.20 0.69 1.55   IS 
BKM S 5 2-Jul-11 B Hair (doe) Withdrawn  13.40 0.86 1.67   IS 
BKSF S/N 4 2-Jul-11 B Hair (buck) Genotyped 22.32 0.32 1.77     
DOLLY S 6 3-Jul-11 B Milk Genotyped 624.30 2.08 1.66  Yes Small while pellet 
MACK N 8 2-Jul-11 B Hair (buck) Genotyped 43.18 1.00 1.75     
NICK S/N 6 2-Jul-11 B Hair (buck) Withdrawn  13.25 0.02 1.10   PCR fail 
Nub Big N 4 2-Jul-11 B Hair (doe) Genotyped 35.26 0.19 1.28   PCR fail 
Nub Med N 4 2-Jul-11 B Milk Genotyped 172.19 0.82 1.77     
Table continued over 
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Goat ID Breed Age Date sampled Farm 
Sample 
Type 
Status 
DNA 
(ng/μL) 
260/230 260/280 CTAB SDS Notes 
Nub 
Small 
N 4 2-Jul-11 B Hair (doe) Withdrawn  7.54 0.32 1.35   IS 
PFB S 6 2-Jul-11 B Hair (buck) Genotyped 34.65 0.29 1.80     
RASTUS N 8 2-Jul-11 B Hair (buck) Genotyped 28.54 0.19 1.80     
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Appendix C: Individual Genotyping Results 
Genotyping table for each goat sample. Genotyping at Intron 12 and exon 19 
depended on the exon 9 genotype. Some samples were characterised at exon 19 
twice (both regular PCR and Real-time PCR) as Exon 19 PCR results were often 
ambiguous. UTD= unable to determine. E-pos = E-allele positive.  
 
Goat # Farm Exon 9 Intron 12 
Exon 19 
PCR 
Exon 19 Real-time 
Final g/t 
F2/R F1/R 
7 A EF  AE EF  EF 
10 A EF   EF  EF 
15 A EF  AE EF  EF 
16 A Unknown  UTD E-pos  Unknown 
24 A Unknown  UTD E-pos  Unknown 
38 A AE A UTD AE  AE 
47 A EE  UTD EE AE BE 
50 A EF  UTD EF  EF 
59 A AE A UTD AE  AE 
84 A EE  EE EE EE EE 
89 A EF   EF  EF 
92 A Unknown  AE E-pos  Unknown 
94 A Unknown  AE E-pos  Unknown 
96 A FF     FF 
98 A Unknown  UTD E-pos  Unknown 
110 A Unknown  AE E-pos  Unknown 
119 A Unknown  UTD E-pos  Unknown 
125 A FF     FF 
130 A AE A AE AE  AE 
135 A AA A AA   AA 
149 A Unknown  AE E-pos  Unknown 
150 A AE A  AE  AE 
151 A EF  AE EF  EF 
153 A AN A AA AN  AN 
187 A AE A AE AE  AE 
195 A AE A AE AE  AE 
208 A AE A AE AE  AE 
219 A EE   EE EE EE 
222 A EE  UTD EE EE EE 
225 A EE   EE AE BE 
234 A EF   EF  EF 
236 A EF   EF  EF 
239 A EF   EF  EF 
242 A EF   EF  EF 
243 A EE  EE EE EE EE 
251 A AN A AA AN  AN 
262 A Unknown  AE E-pos  Unknown 
293 A EE   EE EE EE 
296 A AA A AA   AA 
300 A FF     FF 
302 A FF     FF 
303 A AA A AA   AA 
320 A EF  AE EF  EF 
324 A FF     FF 
326 A AA A AA   AA 
330 A EF   EF  EF 
332 A EF  UTD EF  EF 
        Table continued over 
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Goat # Farm Exon 9 Intron 12 
Exon 19 
PCR 
Exon 19 Real-time 
Final g/t 
F2/R F1/R 
334 A AE A UTD AE  AE 
349 A EE   EE BE BE 
354 A FF     FF 
355 A EF  AE EF  EF 
358 A EF   EF  EF 
364 A AF A    AF 
370 A AE A UTD AE  AE 
376 A AF A    AF 
396 A EF   EF  EF 
vat A AFEN A AE IS  AFEN 
2 B EF  UTD EF  EF 
8 B EE  EE EE EE EE 
9 B EF   EF  EF 
17 B AE A  AE  AE 
22 B EF  AE EF  EF 
25 B EE   EE EE EE 
42 B AA A    AA 
49 B EF   EF  EF 
55 B AA A    AA 
71 B AE A  AE  AE 
72 B EE   EE EE EE 
73 B AE A  AE  AE 
77 B AA A    AA 
79 B AE A  AE  AE 
80 B EF   BF BF BF 
82 B AF A    AF 
91 B EF   BF BF BF 
103 B AE A  AE  AE 
111 B EE   EE EE EE 
124 B FF     FF 
127 B AE A  AE  AE 
137 B AE A AE AE  AE 
140 B FF     FF 
151 B EE   EE EE EE 
153 B FF     FF 
156 B AE A  AE  AE 
160 B FF     FF 
162 B AA A    AA 
163 B AF A    AF 
165 B AA A    AA 
182 B AF A    AF 
186 B AF A    AF 
209 B AA A    AA 
210 B EF  AE EF  EF 
224 B AA A    AA 
226 B AE A UTD AE  AE 
234 B FF     FF 
236 B EF   EF  EF 
254 B EF   EF  EF 
263 B AE A UTD AE  AE 
275 B EF   EF  EF 
284 B FF     FF 
298 B FF     FF 
316 B AE A  AE  AE 
321 B AE A AE AE  AE 
Table continued over 
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Goat # Farm Exon 9 Intron 12 
Exon 19 
PCR 
Exon 19 Real-time 
Final g/t 
F2/R F1/R 
327 B EF   EF  EF 
332 B AF A    AF 
333 B AE A  AE  AE 
338 B EF   EF  EF 
339 B EF   EF  EF 
343 B AF A    AF 
348 B EF   EF  EF 
350 B EF   BF BF BF 
355 B AF A    AF 
359 B EE   AE AE BE 
376 B EF   EF  EF 
380 B AF A    AF 
388 B FF     FF 
398 B EF   EF  EF 
416 B AA A    AA 
418 B AF A    AF 
427 B FF     FF 
9302 B EF   EF  EF 
BKSF B AE A  AE  AE 
DOLLY B AE A  AE  AE 
MACK B AE A  AE  AE 
Nub Big B AE A  AE  AE 
Nub Med B AF A    AF 
PFB B AF A    AF 
RASTUS B AE A  AE  AE 
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Appendix D: Real-Time PCR Genotyping Results  
Real-time genotyping results. G/t = genotype. Req = required. IS = insufficient 
DNA or sample 
Goat # Farm 
Exon 9 
g/t 
F2/R primers F1/R primers 
Notes 
Ct Melt  F2 g/t Ct Melt F1 g/t 
7 A EF 22.3 77.15 EF      
10 A EF 22.3 77.40 EF      
15 A EF 23.4 77.40 EF      
16 A Unknown         
24 A Unknown         
38 A AE 22.0 77.50 AE      
47 A EE 22.3 77.50 EE or BE 20.9 76.20 BE  F1 req 
50 A EF 22.4 77.50 EF      
59 A AE 24.9 77.40 AE      
84 A EE 23.7 77.10 EE or BE 26.5 76.60 EE  F1 req 
89 A EF 22.0 77.50 EF      
92 A Unknown         
94 A Unknown         
96 A FF         
98 A Unknown         
110 A Unknown 21.9 77.25 E-positive 26.8 77.50 E - het Unknown +ve 
control  
119 A Unknown         
125 A FF         
130 A AE 24.0 77.50 AE 25.3 77.20 AE AE +ve control 
135 A AA         
149 A Unknown         
150 A AE 24.3 77.40 AE      
151 A EF 22.7 77.50 EF      
153 A AN         
187 A AE 24.3 77.30 AE      
195 A AE 22.4 77.15 AE      
208 A AE 20.0 77.25 AE      
219 A EE 24.5 77.30 EE or BE 22.3 76.00 EE  F1 req 
222 A EE 21.9 77.50 EE or BE 21.0 74.10 EE  F1 req 
225 A EE 25.3 77.30 EE or BE 22.0 77.50 BE  F1 req 
234 A EF 23.5 77.50 EF      
236 A EF 23.8 77.40 EF      
239 A EF 22.4 77.50 EF      
242 A EF 23.5 77.25 EF      
243 A EE 22.1 77.50 EE or BE 28.2 76.50 EE  F1 req 
251 A AN 29.2 73.0/75.3/ 
81.0 
AN 20.4 77.50 AN AN +ve control  
262 A Unknown         
293 A EE 25.6 77.60 EE or BE 26.2 76.30 EE  F1 req 
296 A AA 32.0 81.40 AA 23.6 77.30 AA AA +ve control 
sample 
300 A FF         
302 A FF         
303 A AA         
320 A EF 25.6 77.70 EF      
324 A FF         
Table continued over 
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Goat # Farm 
Exon 9 
g/t 
F2/R primers F1/R primers Notes 
   Ct Melt  F2 g/t Ct Melt F1 g/t  
326 A AA         
330 A EF 22.3 77.50 EF      
332 A EF 22.1 77.40 EF      
334 A AE 21.9 77.25 AE      
349 A EE 22.3 77.35 EE or BE 21.1 75.90 EE  F1 req 
354 A FF         
355 A EF 23.1 77.25 EF      
358 A EF 29.3 77 / 81.5 BF 21.3 77.00 BF  F1 to check 
364 A AF         
370 A AE 24.6 77.50 AE      
376 A AF         
396 A EF 22.0 77.10 EF      
vat A AFEN   IS   IS   
2 B EF 26.5 77.40 EF      
8 B EE 24.9 77.25 EE or BE 30.7 76.50 EE  F1 req 
9 B EF 26.3 77.60 EF      
17 B AE 22.1 77.40 AE      
22 B EF 23.2 77.80 EF      
25 B EE 22.1 77.25 EE or BE 31.1 76.11 EE  F1 req 
42 B AA         
49 B EF 25.3 77.30 EF      
55 B AA         
71 B AE 22.0 77.50 AE      
72 B EE 22.0 77.50 EE or BE 26.3 75.80 EE  F1 req 
73 B AE 20.0 77.50 AE      
77 B AA         
79 B AE 22.3 77.50 AE      
80 B EF 32.1 75/77/81.3 BF 20.2 76.20 BF  F1 to check 
82 B AF         
91 B EF 28.3 72/75/81.5 BF 22.0 76.60 BF  F1 to check 
103 B AE 23.6 77.40 AE      
111 B EE 24.6 77.25 EE or BE 31.4 76.10 EE  F1 req 
124 B FF         
127 B AE 22.8 77.35 AE      
137 B AE 22.3 77.40 AE      
140 B FF         
151 B EE 19.3 77.50 EE or BE 29.6 75.80 EE  F1 req 
153 B FF         
156 B AE 20.6 77.50 AE      
160 B FF 32.5 75/81.52 FF 23.4 77.40 FF F +ve control.  
162 B AA         
163 B AF         
165 B AA         
182 B AF         
186 B AF 25.6 81.30 AF 22.8 77.30 AF  AF +ve control 
209 B AA         
210 B EF 24.2 77.10 EF      
224 B AA         
226 B AE 26.5 77.40 AE      
Table continued over 
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Goat # Farm 
Exon 9 
XmnI 
F2/R F1/R Notes 
Ct Melt  F2 g/t Ct Melt F1 g/t  
234 B FF         
236 B EF 21.2 77.35 EF      
254 B EF 28.9 77.02 EF      
263 B AE 25.2 77.25 AE      
275 B EF 21.0 77.35 EF      
284 B FF         
298 B FF         
316 B AE 27.3 77.50 AE      
321 B AE 24.4 77.50 AE      
327 B EF 21.0 77.35 EF      
332 B AF         
333 B AE 21.1 77.35 AE      
338 B EF 24.2 77.20 EF      
339 B EF 22.5 77.40 EF      
343 B AF         
348 B EF 22.8 77.60 EF      
350 B EF 28.9 77/ 81.6 BF 22.0 78.00 BF  F1 to check 
355 B AF         
359 B EE 22.2 77.40 EE or BE 21.5 76.20 BE  F1 required 
376 B EF 25.8 77.25 EF      
380 B AF         
388 B FF         
398 B EF 32.0 77.10 EF      
416 B AA         
418 B AF         
427 B FF         
9302 B EF 26.8 77.35 EF      
BKSF B AE 28.9 77.75 AE      
DOLLY B AE 26.5 77.50 AE      
MACK B AE 30.2 77.52 AE      
Nub Big B AE 29.3 77.90 AE      
Nub Med B AF         
PFB B AF         
RASTUS B AE 28.5 77.25 AE      
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Appendix E: Sequence Alignment Results 
 
Exon 9 Allele A 
Forward sequence of AA product amplified at exon 9 aligned using BLAST to 
Capra hircus CSN1S1 gene for alpha s1 casein, allele A, exons 1-19 
(AJ504710.2). The cytosine insertion (required for XmnI digestion) is highlighted. 
Query = AA genotype sample sequence. Sbjct= documented BLAST sequence for 
CSN1S1 allele A.  
 
Score = 283 bits (153),  Expect = 2e-73 
 Identities = 153/153 (100%), Gaps = 0/153 (0%) 
 Strand=Plus/Plus 
 
Query  1      AGCAGTTCGTCAAGTGAGGTATACCATTTTTATGTTAATTAAGTATCCCAATTAGAAAAT  60 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  9879   AGCAGTTCGTCAAGTGAGGTATACCATTTTTATGTTAATTAAGTATCCCAATTAGAAAAT  9938 
 
Query  61     GTTTATGAAAGTTTGTTGAACCATAAAGTTTCATTGTACAAGGCACTATGTATGTAGCTC  120 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  9939   GTTTATGAAAGTTTGTTGAACCATAAAGTTTCATTGTACAAGGCACTATGTATGTAGCTC  9998 
 
Query  121    TATCCTAATTTTAACATACAAGGCTATCAACCC  153 
              ||||||||||||||||||||||||||||||||| 
Sbjct  9999   TATCCTAATTTTAACATACAAGGCTATCAACCC  10031 
 
 
Exon 9 allele F  
Forward sequence of FF sample amplified using exon 9 primers aligned using 
BLAST to Capra hircus CSN1S1 gene for alpha s1 casein, allele F (AJ504711.2). 
The 11bp insertion characterising the F allele is highlighted. Query = FF genotype 
sample sequence. Sbjct= documented BLAST sequence for CSN1S1 allele F. 
 
Score =  296 bits (160),  Expect = 3e-77 
 Identities = 160/160 (100%), Gaps = 0/160 (0%) 
 Strand=Plus/Plus 
 
Query  1      AGCAGTTGTCAAGTGAGGTATACCATTTTTATGTTGATTAAGTATCTCAATTAGAAAATG  60 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  9881   AGCAGTTGTCAAGTGAGGTATACCATTTTTATGTTGATTAAGTATCTCAATTAGAAAATG  9940 
 
Query  61     TTTATGAAAGTTTGTTGAACCATAAAGTTTCCGTAATGTTTCATTGTACAAGGCACTATG  120 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  9941   TTTATGAAAGTTTGTTGAACCATAAAGTTTCCGTAATGTTTCATTGTACAAGGCACTATG  10000 
 
Query  121    TATGTAGCTCTATCCTAATTTTAACATACAAGGCTATCAA  160 
              |||||||||||||||||||||||||||||||||||||||| 
Sbjct  10001  TATGTAGCTCTATCCTAATTTTAACATACAAGGCTATCAA  10040 
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Exon 9, A*N heterozygote 
Clean sequence of the AN heterozygote amplified at exon 9 occurred up until 
position 9886 of the A-allele, at which point the N-allele has the G deleted (C 
deleted in the forward strand sequence).  
 
Query  1     AATGAAACTTTATGGTTCAACAAACTTTCATAAACATTTTCTAATTGGGATACTTAATTA  60 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  9973  AATGAAACTTTATGGTTCAACAAACTTTCATAAACATTTTCTAATTGGGATACTTAATTA  9914 
 
Query  61    ACATAAAAATGGTATACCTCACTTGAC  87 
             ||||||||||||||||||||||||||| 
Sbjct  9913  ACATAAAAATGGTATACCTCACTTGAC  9887 
      
Aligning the known CSN1S1 A allele forward sequence with the N allele reverse-
complement sequence (manually derived off the electropherogram) shows the 
region of sequence alignment (underlined) and the point where the 1-nt shift 
occurred following the C deletion (G in reverse strand sequence data).   
 
 
9864  CAAATGAAAGCTGGAAGCAGTTCGTCAAGTGAG  9896  A-allele sequence 
      |||||||||||||||||||||| |||||||||| 
9862  CAAATGAAAGCTGGAAGCAGTT-GTCAAGTGAG  9894  N-allele RC sequence  
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Exon 19, Allele A* 
Forward sequence of A*A* sample amplified using exon 19 primers (standard 
PCR). Alignment shows correct amplification of exon 19 and aligns with 
previously documented exon 19 of the A allele (AJ504710.2). Query = A* 
homozygote sample sequence. Sbjct= documented BLAST sequence for CSN1S1 
allele A. 
 
 Score =  894 bits (484),  Expect = 0.0 
 Identities = 487/487 (100%), Gaps = 0/487 (0%) 
 Strand=Plus/Plus 
 
Query  1      TAAAGTGTATCTTATCATAACAGTAGCTTCTCCTTTCAAAACATGCAGCATAACTAACCA  60 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18291  TAAAGTGTATCTTATCATAACAGTAGCTTCTCCTTTCAAAACATGCAGCATAACTAACCA  18350 
 
Query  61     CATATTTCTTTTTTGATTTACAGATGGAATTGAAAATTCCATGCTTTACATGTCTTTTCA  120 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18351  CATATTTCTTTTTTGATTTACAGATGGAATTGAAAATTCCATGCTTTACATGTCTTTTCA  18410 
 
Query  121    TCTATCATGTCAAACCATTCTATCCAAAGGCTTCAATTGCTGTTTTAGAATAGGACAACC  180 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18411  TCTATCATGTCAAACCATTCTATCCAAAGGCTTCAATTGCTGTTTTAGAATAGGACAACC  18470 
 
Query  181    TCAAATTGAAGGCACTCTTTCTTCTTGAGTTCTCTACTGTATTTTAGATTGTGTAACATC  240 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18471  TCAAATTGAAGGCACTCTTTCTTCTTGAGTTCTCTACTGTATTTTAGATTGTGTAACATC  18530 
 
Query  241    CTTAAGTGAAATTGTCCTAAGAGCTTGTTACCTAAATTCCAGTAGTATCACGCTGGTATA  300 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18531  CTTAAGTGAAATTGTCCTAAGAGCTTGTTACCTAAATTCCAGTAGTATCACGCTGGTATA  18590 
 
Query  301    AAGGCCACTGACTCAAAGGGAATTACAGTCTTCATTAAATTTCTATATGGAAAATGTTTT  360 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18591  AAGGCCACTGACTCAAAGGGAATTACAGTCTTCATTAAATTTCTATATGGAAAATGTTTT  18650 
 
Query  361    TAAAGCCTTTGAATCACCTCTCCTGTAAGTGCCATCATTTCAAATAACTGTGTGCAGTAA  420 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18651  TAAAGCCTTTGAATCACCTCTCCTGTAAGTGCCATCATTTCAAATAACTGTGTGCAGTAA  18710 
 
Query  421    CTGAGATTTTGTCTTTCTTCTTTTCAATAAATTACATTTTAAGGCACTATTCCTATTTTT  480 
              |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  18711  CTGAGATTTTGTCTTTCTTCTTTTCAATAAATTACATTTTAAGGCACTATTCCTATTTTT  18770 
 
Query  481    GTCATTA  487 
              ||||||| 
Sbjct  18771  GTCATTA  18777 
 
 
Real time – Exon 19 
Only sequences from the A-variant produced useable sequence results with the 
F2/R primer, although the quality was poor. Despite this, the alignment shows that 
exon 19 was correctly amplified. Query = A* homozygote sequence. Sbject = 
Exon 19 for the A allele (AJ504710.2). 
 
 Score = 75.8 bits (38),  Expect = 1e-11 
 Identities = 38/38 (100%), Gaps = 0/38 (0%) 
 Strand=Plus/Plus 
 
Query  1      TGTGTAACATCCTTAAGTGAAATTGTCCTAAGAGCTTG  38 
              |||||||||||||||||||||||||||||||||||||| 
Sbjct  18520  TGTGTAACATCCTTAAGTGAAATTGTCCTAAGAGCTTG  18557
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Appendix F: Feed Trial 1 Graphs  
Presented below are the mean fatty acid (% of total fatty acids) values of control, 
PKE and BW farms for each fatty acid. Error bars are the standard deviation of 
the mean. Significant differences are outlined in Table 37 of section 7.1.   
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Appendix G: Feed Trial 2 Graphs 
Presented below are the mean fatty acid (% of total fatty acids) values of control, 
PKE and BW farms for each fatty acid between 2009-2010 and 2010-2011 
seasons. Error bars are the standard deviation of the mean. Significant differences 
are outlined in Table 38 of section 7.2.   
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